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ABSTRACT 
Stromal cells and the extracellular matrix (ECM) components provide the 
microenvironment that is pivotal for cell growth, motility, attachment and 
differentiation. Fibroblasts are some of the cells responsible for the synthesis of most 
of the extracellular matrix proteins. Type I collagen is the most abundant extracellular 
matrix protein in the human body and is found in tissues requiring high tensile 
strength. In this study we investigated the effect of a pre-formed fibroblast-derived 
extracellular matrix on the expression of type I collagen and associated matrix 
metalloproteinases in fibroblasts. Both cellular and secreted type I collagen protein 
levels were decreased in fibroblasts grown on a pre-formed fibroblast-derived matrix 
compared to controls. This decrease was associated with a decrease in pro-α2(1) 
collagen mRNA while pro-α1(1) mRNA remained unchanged. These results 
suggested that the regulation of type I collagen occur at both transcriptional and post 
transcriptional levels. To determine transcriptional regulation of the α2(1) collagen 
promoter, deletion constructs were used in promoter assays. Deletion analysis 
identified the -375 to -107 region in the COL1A2 promoter as containing a potential 
matrix responsive element (MRE). Using siRNA technology, this study provided 
evidence that Sp1, possibly in combination with other transcription factors, binds to 
the COL1A2 promoter to repress the expression of the COL1A2 gene in the 
presence of the fibroblast-derived ECM. The stabilities of collagen α1(1) and α2(1) 
mRNAs were measured by blocking transcription with actinomycin D and measuring 
the rate of disappearance of the transcripts. Similar decay curves were obtained for 
both α1(1) and α2(1) mRNAs, matrix versus control, implying that the fibroblast-
derived matrix does not affect the stabilities of the type I collagen mRNAs.  
 
Kinase inhibition studies demonstrated that the fibroblast-derived matrix activates the 
MEK/ERK signaling pathway in fibroblasts. This was confirmed through the use of 
the dominant negative mutant MEK (dn MEK). The use of the dominant negative 
Ras, N17Ras, showed that the activation of the MEK/ERK signaling pathway is Ras-
dependent. The fibroblast-derived matrix did not induce a change in protease 
expression patterns as shown by the mRNA levels, promoter activity and gelatinase 
activity. Cell-matrix interactions play fundamental roles in the development and 
function of various tissues. These interactions transmit an array of information that 
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influence gene expression patterns. The ECM has been proposed to act as a 
reservoir for a number of growth factors that can be released from the ECM to allow 
extracellular signaling to proceed without the need for new protein synthesis. No 
apparent effect could be attributed to the conditioned media or a suspended matrix 
when used in these experiments. Thus it appears no soluble factor, that would affect 
type I collagen synthesis, was released into the growth media, and that the 
fibroblasts required direct contact with the matrix for the response to occur. By using 
purified matrix components, type I collagen and fibronectin, it was shown that there 
is a specific negative feedback mechanism via type I collagen within the fibroblast-
derived matrix. 
 
We further explored the effects of the α2β1 and α3β1 integrin receptors on the 
expression of type I collagen in fibroblasts cultured on a fibroblast-derived matrix. 
Blocking α2β1 integrin function through the use of monoclonal antibodies reversed 
the effect of the matrix on type I collagen gene expression whilst blocking α3β1 
integrin function did not reverse this effect. Furthermore, fibroblasts cultured on the 
fibroblast-derived matrix dramatically up-regulated the steady state levels of mRNA 
encoding the α2 and β1 integrin subunits, compared to fibroblasts cultured on 
plastic. The steady state levels of the mRNA encoding the α3 integrin subunit did not 
change, matrix versus plastic. The transcription of the α2 and β1 integrin subunit 
genes was influenced by the substratum. Our results demonstrate that the 
extracellular matrix controls the expression of α2 and β1 integrin subunits and that 
the regulation is exerted at least on the transcriptional level. This study provides 
novel insights into the mechanisms by which a fibroblast-derived matrix activates the 
MEK/ERK signaling pathway in fibroblasts and is the first such report to show the 
presence of a matrix-responsive element within the proximal α2(1) collagen promoter 
region. The MEK-ERK pathway and transcription factors binding to the MRE might 
be targeted in diseases where there is altered type I collagen synthesis such as 
fibrosis. 
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CHAPTER 1 INTRODUCTION                                   
 
1.1The Extracellular matrix 
The Extracellular Matrix (ECM) is the relatively stable structural material that 
lies under the epithelia and surrounds connective tissue cells (Hay, 1991). It is 
composed of a variety of macromolecules, with the four major classes of 
macromolecules being the collagens, proteoglycans, elastic fibres and 
glycoproteins. Most eukaryotic cells are in contact with an ECM whose 
composition and structure vary with developmental stage (Gout and Huot, 
2008). The cells producing these ECM components continue to interact with 
their own ECM and the ECM produced by other cells. The most typical form of 
ECM is that found in connective tissue, comprising mainly type I collagen and 
the fibroblasts that produce the ECM. The connective tissue is surrounded by 
specialised ECM called the basal lamina, which underlies epithelial cells.  
 
Many properties of the cell such as shape and movement are related to and 
are dependent on the organisation of the ECM. The interaction between the 
ECM scaffolds and cells represents the basis for organ structure and function 
(Stetler-Stevenson et al, 1993). In a healthy organism, the ECM forms a 
stable physical environment for cells and the ECM also undergoes a slow and 
regulated turnover leading to structural remodelling.  The best recognised role 
of the ECM is the ability of its major constituent, the collagens, to polymerise 
and provide structural support to connective tissue, vasculature and cartilage 
and to generate the basement membrane. The ECM plays at least three 
important roles: 
• Mechanical: tensile and compressive strength and elasticity.  
• Protection: buffering against extracellular change and retention of 
water.  
• Organisation: control of cell behaviour by binding of growth factors and 
interaction will cell-surface receptors.  
Extracellular matrices have many specialised roles. The matrix of bone and 
tooth enamel for example are highly mineralised to withstand compression, 
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whilst the ECM that forms the cornea of the eye is transparent to light and 
highly elastic ECM is found in tendons. The ECM is also involved in regulating 
other biological functions. It serves as a reservoir for a variety of growth 
factors, such as TGF-β, TNF-α, VEGF and IL-3. Furthermore, ECM proteins 
can directly generate cellular responses. Type IV collagen has been shown to 
stimulate DNA synthesis in liver cells while fibronectin can act to inhibit 
tumour angiogenesis and metastasis (Ruoslahti, 1999). The ECM can also 
bind to and regulate the availability of matrix metalloproteinases (MMPs), 
which are involved in regulating matrix turnover and in modulating other 
biological functions. 
The extracellular matrix is composed of a three-dimensional scaffold of 
collagen, fibronectin and other proteins, interlaced with proteoglycans. The 
properties of the extracellular matrix components provide a considerable 
amount of complexity to the potential interactions between cells and the ECM 
as well as between various matrix molecules (Yamada, 1991). The most 
important cells responsible for extracellular matrix synthesis are the 
fibroblasts and other mesenchymal cells. The balance between extracellular 
matrix synthesis and degradation plays a crucial role in extracellular 
homeostasis, and disruption of this balance causes alteration in ECM integrity. 
This can result in deleterious consequences including establishment of 
fibroproliferative disorders such as organ fibrosis. ECM synthesis is regulated 
through the action of growth factors and cytokines whilst degradation of the 
ECM is accomplished in part by matrix metalloproteinases.   
Although many studies have been directed at understanding the interaction 
between the ECM and cells, most of these use artificial matrices of purified 
extracellular matrix proteins such as fibronectin and laminin (Fukuda et al, 
2006; Elliot et al, 2005; Feng et al, 2005; Che et al, 2006). In fact, most 
studies defining mechanistic responses of cells and cancer cells to ECM 
signals have utilised isolated cultures of cloned and immortalised cells grown 
on a rigid surface comprising one isolated ECM component such as laminin or 
type I collagen (Bissell et al, 2002). These studies have vastly increased our 
knowledge on the molecular constituents and structures within focal adhesion 
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complexes, integrin receptors and their interaction with the ECM. However, a 
2-D surface imposes an artificially rigid environment on the cell that contrasts 
with the pliability, molecular complexity and three-dimensionality (3-D) of the 
normal stromal environment in vivo (Beacham and Cukierman, 2005; Wozniak 
et al, 2004). Thus to study cells in a microenvironment that more reliably 
recapitulates a natural microenvironment rather than tissue culture plastic, 
investigators have cultured cells in 3-D support systems (Fischbach et al, 
2007; Kim, 2005; Yamada and Cukierman, 2007). Recent studies have 
demonstrated the ability of the 3-D ECM to regulate gene expression in a 
variety of cell types and conditions. In monocytes, a different subset of genes 
is regulated depending on the 3-D ECM on which the cells are cultured 
(Adams and Watt, 1993). Cells also elicit different signaling pathways in 
response to matrix rigidity, indicating that both the biophysical as well as the 
biochemical states of the ECM are important in tissue homeostasis (Wozniak 
et al, 2004).  
Many pathological processes such as fibrosis, invasion and metastasis are 
characterised by dynamic changes in ECM synthesis, deposition and turnover, 
thereby altering the mechanical properties of the ECM. Changes in rigidity of 
the stromal ECM could modify in vivo matrix adhesion properties and 
structure with subsequent changes in signaling mechanisms and cellular 
phenotypes (Wozniak et al, 2003, 2004). In addition, the matrix organisation is 
very important for efficient performance of cellular function. Fibroblasts grown 
in a relaxed matrix display a decreased level of cell proliferation in response 
to stimulation by PDGF when compared to those grown in monolayers. This 
was shown to be due to decreased levels of receptor autophosphorylation 
(Grinnel et al, 1999, 2005), suggesting that cell proliferation may be regulated 
by interaction between the cells and the ECM. 
In vivo-like 3-D culture systems can achieve a close approximation to 
biochemical and biophysical properties of the in vivo microenvironment, 
without sacrificing opportunities for experimental manipulation (Beacham and 
Cukierman, 2005). During tumour invasion, the degradation of the basement 
membrane facilitates a more direct contact between neoplastic epithelial cells 
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and the adjacent mesenchymal compartments. In addition, during tumour 
growth, fibroblasts have been shown to be associated with the tumour mass 
and help in the production, and eventually alter the tumour ECM. This altered 
ECM is also used by epithelial cells and the fibroblasts for growth and as a 
pre-intravasation microenvironment. These and several other observations 
suggest that in vivo-like mesenchymal matrices represent a more accurate 
way to mimic in vivo microenvironments, providing an advantage over artificial 
culture systems in assessing the physiological growth properties of both 
stromal cells such as fibroblasts and cancer cells.  
1.2 The Collagens 
Collagens are the most abundant of the ECM proteins. Collagen fibrils and 
proteoglycans are ubiquitous components of the ECM and are present in all 
connective tissues. So far 27 collagen types have been characterised and the 
number may continue to increase (Sderhall et al, 2007; Veit et al, 2006; Pace 
et al, 2003). The collagens occur in unique tissue- and cell-specific patterns, 
arising during development in defined temporal and spatial patterns, and 
exhibit different functional properties (Linsenmayer, 1991). Collagens are 
involved in cell attachment, differentiation and in chemotactic processes. In 
many immunopathological processes, they act as antigens and also as the 
defective component in certain pathological conditions. Their primary function 
is to maintain the three-dimensional shape of tissues.  
 
Collagens are homo- or heterotrimeric proteins built up from type-specific α 
chains to form stretches of triple-helical domains. The α chains are composed 
of a series of triplet Gly-X-Y repeats in which X and Y can be any amino acid, 
but frequently X is proline and Y is hydroxyproline (Linsenmayer, 1991; 
Prockop et al, 1979). Since every third amino acid in the α chain is a glycine, 
this allows narrow turns (Myllyharju and Kivirikko, 2001, 2004). The other 
common amino acids in collagens are proline and lysine. Non-collagenous 
domains include the fibronectin type III repeat and the A-domain of von 
Willebrand factor. In fibril-forming collagens a single triple-helical domain 
comprises more than 95% of the molecule while other collagens have multiple 
triple-helical domains (Prockop et al, 1979; Prockop and Kivirikko, 1995). A 
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triple-helical domain consists of three separate α-chains, twisted in the form of 
a left handed helix (Prockop and Kivirikko, 1995; Ramakrishman et al, 1998; 
Rossert et al, 2000) and stabilised by inter-chain hydrogen bonds. The triple-
helical region is wound in such a way that the peptide bonds are hidden within 
the interior of the molecule. This makes the triple-helical region highly 
resistant to attack by general proteases such as pepsin. The only enzymes 
that are capable of cleaving the helical region are the collagenases (matrix 
metalloproteinases-MMPs).  
 
Each of the 27 known collagen types has been assigned a number 
designated by roman numerals e.g. type I, II, III (Bornstein and Sage, 1980, 
1989). Where all collagen chains are identical they are all designated α1. 
Where two chains occur they are designated α1 and α2 and so on .The ratio 
in which the chains occur is also included in the complete designation of a 
collagen molecule. Collagens can be subgrouped into several classes: fibrillar 
collagens, fibril-associated collagens with interruptions in their triple helix 
(FACITS), network-forming collagens, filamentous collagens, anchoring 
collagen fibrils, transmembrane-domain containing collagens, non-collagen 
collagens (Table 1.1) (Prockop and Kivirikko, 1995; Pace et al, 2003).   
 
There are five types of collagens within the fibrillar collagen group: type І, II, III, 
V and XI. Type І, II and III are the most abundant collagens in this group while 
type V and XI are the minor fibrillar collagens. They provide a scaffolding 
network in the extracellular matrices of the tissues in which they are 
expressed, largely skin, bone, tendon, blood vessels, cornea, sclera and 
cartilage (Pace et al, 2003). The fibrillar collagens have rigid uninterrupted 
triple-helical domains of more than 300 Gly-X-Y repeats and the procollagens 
have globular amino (N)-and carboxyl (C)-terminal extension peptides that 
differ substantially in length and sequence characteristics (Ramirez et al, 1990; 
Prockop and Kivirikko, 1995). Fibrillar collagens are synthesised as 
procollagens, containing N- and C-terminal propeptides that are cleaved after 
secretion into the extracellular space. In addition to their scaffolding functions, 
fibrillar collagens also serve as attachment sites for other constituents of the 
ECM and cell surface receptors such as the integrins. Type I collagen is the 
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prototype fibrillar collagen and most of the information available has been 
obtained from studies on this collagen as it is the most abundant collagen 
isolated from many connective tissues (Ghosh, 2002). 
 
Table 1.1 Members of the collagen family  
Subfamily            Type Chains                Isoforms 
Fibril-forming collagens              I             α1(І), α 2(І)                        [α1(І)]2 α 2(І) 
                                                   II            α1(IІ)                                 [α1(IІ)]3 
                                                   III           α1(IIІ)                                [α1(IIІ)]3 
                                                   V            α1(V), α2(V),α3(V)            [α1(V)]2 α 2(V)   
                [α1(V)α2(V)α3(V)] 
                                                   XI           α1(XI), α2(XI),α3(XI)         [α1(XI) α2(XI)α3(XI)] 
                                                                                                           and α(V)/ α(XI) chimeras 
Network-forming collagens        IV           α1(IV), α2(IV),α3(IV)          [α1(IV)]2 α 2(IV)   
                                                                 α4(IV), α5(IV),α6(IV)          [α3(IV) α4(IV)α5(IV)] 
                                                                                                           α1/ α2(IV), α5/α6(IV)]? 
                                                  VIII          α1(VIIІ), α 2(VIIІ)               [α1(VIIІ)]2 α 2(VIIІ) 
                                                  X             α1(X)                                 [α1(X)]3             
Micro-fibrillar collagens             VI            α1(VI), α2(VI),α3(VI)          [α1(VI)α2(VI)α3(VI)] 
FACIT collagens                       IX            α1(IX), α2(IX),α3(IX)          [α1(IX) α2(IX)α3(IX)] 
                                                 XII           α1(XII)                                [α1(XII)]3      
                                                 XIV          α1(XIV)                              [α1(XIV)]3      
                                                 XVI          α1(XVI)                              [α1(XVI)]3        
Transmembrane collagens      XIII           α1(XIII)                              [α1(XIII)]3      
                                                XVII          α1(XVII)                             [α1(XVII)]3      
Bundle-forming collagens        VII            α1(VII)                               [α1(VII)]3      
 
 
1.2.1 Type I Collagen 
Type I collagen is expressed at high levels in tissues requiring high tensile 
strength but is known to induce specific signals upon cell attachment and that 
it is vital for several cellular functions including migration and proliferation. It is 
composed of a heterotrimer of two α1(1) and one α2(1) polypeptide chains. 
The chains are encoded by separate genes, with the α1(1) chain being 
encoded by a gene on chromosome 17 and α2(1) being encoded by a gene 
on chromosome 7. Type I collagen α chains are synthesised by many cell 
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types such as fibroblasts in connective tissue, osteoblasts in bone and 
odontoblasts in dentine matrices.  
 
1.2.1.1 Type I collagen synthesis 
The collagen mRNAs are translated in the rough endoplasmic reticulum (RER) 
where they are modified. Two α1(1) and one α2(1) chains form a triple helix 
with N-terminal and C-terminal extension peptides. Glycosylation occurs on 
the asparaginyl and hydroxylysyl residues by the addition of either glucose or 
galactose, whilst the proline and lysines residues are often hydroxylated and 
the collagen molecules are secreted into the extracellular space through 
secretory granules. The N- and C-terminal extension peptides are cleaved by 
procollagen N- and C-endopeptidase respectively (Fig 1.1) (Cummings et al, 
2005). The N- and C-terminal extension peptides are essential in chain 
association, triple helical formation, intracellular transport and have been 
implicated in regulation of collagen synthesis (Widom, 2000; Uitto et al, 1979; 
Ghosh, 2000; Myllyharju and Kirivikko., 2001; Karsenty et al, 1998).  
 
Fibers are formed by crosslinking several triple helices via inter-chain 
disulphide bonds. Concise regulation of collagen metabolism is extremely 
important as a disturbance may cause a large variety of pathological 
conditions. The overproduction of type I collagen has been implicated in many 
fibroproliferative disorders such as organ fibrosis, systemic sclerosis whilst 
decreased production of collagen or mutation results in conditions such as 
osteogenesis imperfecta and Ehlers-Danlos syndrome (Bornstein and Sage, 
1989; Slemp and Kirschner, 2006; Mimura et al, 2006; Prockop and Kivirikko, 
1984; Olsen, 1991). To date, many factors and signal transduction pathways 
have been found to be involved in the regulation of collagen gene expression 
in fibroblasts (Ghosh, 2002; Slemp and Kirschner, 2006; Mimura et al, 2006; 
Prockop and Kivirikko, 1984).  
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Figure 1.1 The synthesis of collagen in cells showing (1) the formation of the triple 
helix (2) the removal of N-terminal and C-terminal propeptides, (3) the incorporation of 
the mature collagen molecule into the fibres and (4) assembly of collagen fibres 
(Cummings et al, 2005).  
 
1.2.1.2 Regulation of type I collagen synthesis  
The type I collagen genes have been studied in detail with the human α2(1) 
collagen gene (COL1A2) proving to be an especially informative model to 
study the molecular mechanisms and cellular factors that control extracellular 
matrix assembly and degradation in both normal and pathophysiological 
conditions (Ghosh, 2002). Many nuclear factors have been implicated in 
regulating transcription of the COL1A2 genes in human and mouse models. 
There are subtle differences between mouse and human COL1A2 regulatory 
elements. It has also been proven that COL1A2 transcription is under the 
control of a complex regulatory network that includes multiple overlapping 
DNA elements and several other trans-acting factors.  
 
1.2.1.2.1 Transcriptional regulation of type I collagen gene expression 
Many studies have focussed on transcription as the primary level of regulation 
(Slack et al, 1993; Bou-Gharios et al, 1996; Bornstein and Sage, 1989). 
Parker et al (1992) showed that α2(1) collagen synthesis is associated with 
differences in trans-acting factor binding to the proximal promoter of the gene. 
The regulatory regions within the two collagen promoters contain many 
repressor and enhancer elements (Ghosh, 2002; Ponticos et al, 2004). 
Several cis-acting regulatory elements and trans-acting protein factors are 
8 
 
Un
ive
rsi
ty 
of 
Ca
p
 To
wn
involved in basal as well as cytokine-modulated type I collagen gene 
expression. The transcription of both COL1A1 and COL1A2 genes are 
regulated by elements in the promoter as well as in the first intron (Rossouw 
et al, 1987; Sherwood et al, 1990; Bornstein et al, 1996).  
 
The COL1A1 and COL1A2 genes are co-ordinately regulated and the ratio of 
their steady-state mRNAs is tightly maintained at 2:1 (de Wet et al, 1987). 
Several transcription factors interact with upstream regulatory elements and 
control the basal, cell-type-specific gene expression (Ihn et al, 1996; Goldberg 
et al 1992). DNA methylation has been implicated in the downregulation of the 
collagen genes (Eckes et al, 1993; Ghosh, 2002).  Gene inactivation by DNA 
methylation may be due to repression of binding of positive transcription 
factors or to increased binding of methyl-cytosine binding proteins (MeCPs) to 
methylated cytosine thus disrupting specific binding of transcription factor(s) in 
the regulatory region (Collins et al, 1997; Ghosh, 2002). The characteristic 
TATA box is present in both COL1A1 and COL1A2 promoters. A common 
CCAAT motif is also present in the two procollagen promoters to which the 
CCAAT binding factor (CBF) binds. CBF is a heterotrimeric protein comprising 
of three subunits, CBF-A, CBF-B and CBF-C (Maity et al, 1992). CBF has 
been shown to bind to the mouse COL1A1 and COL1A2 promoters to activate 
transcription (Maity et al, 1988).  
 
Several other transcription factors have been identified and their binding sites 
located on the collagen promoter. Nuclear factor 1 is involved in replication as 
well as transcription control of several genes including COL1A2 (Rossi et al, 
1988).  Two negative factors, initiation factors 1 and 2 (IF1 and IF2), also 
interact with both COL1A1 and COL1A2 genes and their binding sites have 
been identified in the mouse promoters (Ravazzolo et al, 1991). Another 
transcription factor that has received much attention is Sp1, a zinc-finger 
transcription factor that binds to a GC-rich consensus sequence. Multiple 
binding sites for Sp1 have also been identified in the COL1A2 promoter. It 
appears Sp1 is involved in both downregulation and upregulation of COL1A2 
promoter activity depending on the other transcription factors it associates 
with (Asano et al, 2009). Fli-1, a member of the ERG subfamily, has been 
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shown to be a repressor of COL1A2 promoter activity and functional 
interaction of Fli-1 with Sp1 is essential for this inhibitory action. A Fli-1 
response element has been mapped between -353 and -186 bp of the 
COL1A2 promoter containing Ets and Sp1/Sp3 binding sites (Czuwara-
Ladykowska et al, 2001). Evidence from many studies also implicates Sp1 
and Sp3 along with other factors such as Fli1 and NF-1 in the control of type I 
collagen synthesis.   
 
The AP-1 transcriptional complex contains Jun D, c-Jun and c-Fos that binds 
to their consensus sequence as homodimers or heterodimers. AP-1 has been 
shown to regulate type I collagen gene expression in fibroblasts (Katabani et 
al, 2005). Other proteins involved in collagen regulation include Smad 3 and 
Smad 4. Transient expression of Smad 3 and Smad 4 in human skin 
fibroblasts lead to stimulation of COL1A2 promoter activity. A Smad binding 
element was located at -263 to -258 bp and was shown to interact with Smads 
and reduce COL1A2 promoter activity (Chen et al, 1999, 2000).  
 
1.2.1.2.2 Regulation of type I collagen gene expression by cytokines 
Transcription of COL1A1 and COL1A2 is regulated by different cytokines with 
a number of transcription factors having been identified that have a regulatory 
function in the expression of the collagens (Uitto et al, 1979; Kahari et al, 
1990, 1991; Trojanowska, 1998; Ihn et al, 1996). Cytokine responsive 
elements in the COL1A1 and COL1A2 genes have been identified and 
characterised (Rossert et al, 2000). Cytokines involved in regulation of type I 
collagen gene expression include TGF-β, interleukin-1, interferons and TNF-α, 
effecting mRNA levels, turnover and stability (Mauviel et al, 1991).  TGF-β is 
known to stimulate transcription of COL1A2 promoter. Chen et al (1999) 
demonstrated that TGF-β stimulates human COL1A2 promoter activity 
through Smad signaling. Another cytokine, TNF-α, is known to counteract the 
stimulation of collagen gene expression by TGF-β through overlapping 
nuclear signaling pathways (Inagaki et al, 1995).  
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1.2.1.2.3 Regulation of type I collagen gene expression by oncogenes 
Oncogenes, Ras, c-Myc, v-Fos and v-Src, play significant roles in the 
regulation of cell growth and division in both normal and neoplastic cells. Ras 
downregulates COL1A1 and COL1A2 mRNA synthesis via an AP-1 site 
located in the first intron (Slack et al, 1993). Oncogenic Ras regulates type I 
collagen at the transcriptional and post-transcriptional levels. Oncogenic Ras 
has been shown to downregulate the function of an intronic AP1 site in the 
COL1A1 gene (Slack et al, 1993) and to activate ERK MAP kinases, which 
phosphorylate the linker region of Smad 2 and 3 to inhibit their nuclear 
accumulation and thus repress TGF-β signaling (Ghosh, 2002). 
 
1.2.1.2.4 Post-transcriptional regulation 
Inhibition of procollagen mRNAs translation by cleaved peptides has been 
shown to regulate collagen synthesis. The N- and C-terminal peptides of type 
I collagen inhibit collagen production by affecting polypeptide chain elongation 
and/or termination (Aycock et al, 1986; Wiestner et al, 1979). This suggests 
that collagen production is either induced or inhibited depending on the 
availability of specific proteases needed for the generation of the peptides 
from the procollagens and the production of the procollagens in the first place. 
This implies that collagen feedback regulation may be controlled at any stage 
of collagen biosynthesis from synthesis, secretion and extracellular 
proteolysis.  
 
1.2.2 The ECM and Diseases 
The synthesis and degradation of the extracellular matrix and its components 
such as collagens are in constant flux. Excessive accumulation of ECM 
components leads to fibrosis. Deficiency or mutations in ECM protein 
production is associated with conditions such as cancer, atherosclerosis, 
osteogenesis imperfecta and Ehlers–Danlos syndrome (Slemp and Kirschner, 
2006). A balance must therefore be achieved between synthesis and 
degradation of ECM components to ensure that excess accumulation does 
not occur. Cells such as fibroblasts synthesise most of the collagens in fibrillar 
ECM but also secrete ECM-degrading proteases, growth factors and 
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chemokines. These cells are therefore important in achieving the balance 
necessary under normal conditions.   
 
Currently no acceptable therapeutic strategies exist for the treatment of  
prevalent fibroproliferative disorders. A great deal of research is being 
pursued to understand the molecular basis for the development and 
progression of fibroproliferative disorders and other pathological conditions 
such as cancer in order to identify effective therapeutic approaches. Most of 
these disorders are characterised by either a decrease or an increase in the 
synthesis and deposition of collagen. Therapies against myofibroblasts 
(carcinoma-associated fibroblasts) are being considered as a way to control 
cancer. Such therapies can be seen as a ‘normalisation step’ of the 
myofibroblasts. Many pathological processes including invasion and 
metastasis as described below are characterised by dynamic changes in ECM 
synthesis, deposition and turnover, thereby altering the mechanical properties 
of the ECM. Changes in rigidity of the stromal ECM could modify in vivo 
matrix adhesion properties with subsequent changes in signaling mechanisms 
and cellular phenotypes (Wozniak et al, 2003, 2004).  
 
1.3 Tumour cell invasion and metastasis 
During metastasis tumour cells detach from the primary tumour site to invade 
adjacent tissues and travel to distant sites. The processes of tissue invasion 
and metastasis involve both a change in tissue microenvironment and also 
activation of extracellular proteases. The series of interactions which take 
place in these two processes involve the release of normal cellular contacts 
within the primary tumour, followed by invasion through the underlying 
basement membrane, the destruction of and passage through the ECM and 
lastly the penetration into blood or lymphatic vessels for circulation to distant 
sites. At the moment there is a poor understanding of the genetic and 
biochemical determinants in the regulation of tissue invasion and metastasis.  
 
1.3.1 Tumour cell Invasion 
The interstitial matrix stroma contains many cells including fibroblasts and 
interstitial proteins comprising predominantly type I and type III collagens, 
12 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
fibronectins, glycoproteins and proteoglycans. The matrix functions as a 
support scaffold mediating cell attachment and determines overall tissue 
architecture (Liotta and Kohn, 2001). The matrix influences many processes 
such as morphogenesis and mitogenesis.  
 
One of the key characteristics of malignant cells is their ability to override the 
microenvironmental control by the host in order to invade tissue to 
metastasise to distant sites (Coussens and Werb, 1996, 2002). Invasion and 
metastasis are mechanistically closely related since both utilise similar 
strategies involving changes in the physical coupling of cells to their 
microenvironment and activation of extracellular proteases (Keleg et al, 2003). 
During the process of tumour invasion, tumour cell(s) must traverse the ECM 
as they cross tissue boundaries and interact with ECM components such as 
type I collagen molecules and stromal cells such as fibroblasts. 
 
A great deal of effort has been made in understanding the molecular and 
cellular processes involved in cell-cell and cell-matrix interactions during 
tumour invasion and metastasis (Zigrino et al, 2005). Intra-epithelial tumors 
have to cross an intact basement membrane that separates the epithelium 
from the stromal tissue. During the transition from carcinoma in situ to 
invasive carcinoma, tumour cells degrade the basement membrane in order to 
traverse the underlying stroma (Liotta and Kohn, 2001; Stetler-Stevenson et 
al, 1993; Gout and Huot, 2008). In general, tumor cell invasion through the 
basement membrane is thought to be a three-step process (Stetler-Stevenson 
et al, 1993; Gout and Huot, 2008). Firstly, neoplastic cells attach to the 
underlying basement membrane. Secondly, the malignant cells produce 
proteolytic enzymes to degrade the basement membrane and thirdly, the 
tumor cells pass through the basement membrane and penetrate the stromal 
tissue.  
 
Invasion of the ECM is not unique to tumour cells, but is also performed by 
normal cells. Trophoblasts invade the endometrial stroma and blood vessels 
to establish contact with the maternal circulation during the development of 
hemocorial placenta (Stetler-Stevenson et al, 1993). During the process of 
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angiogenesis, endothelial cells invade basement membranes as well as the 
interstitial stroma. The difference between normal and tumour cells is that in 
normal cells the invasive phenotype is controlled whereas in tumour cells it is 
deregulated.  
 
The loss of the basement membrane has been positively correlated with 
invasive carcinomas which may be due to a combination of decreased 
synthesis of ECM proteins and increased degradation of the same proteins. 
The interaction between tumour cells and the basement membrane has been 
described as the most critical stage during the initiation of the metastatic 
cascade (Stetler-Stevenson et al, 1993; Gout and Huot, 2008). Recent studies 
have contributed to our understanding of the role of the host stromal tissue in 
promoting tumour cell invasion and metastasis. Within a tumour-host 
microecology, stromal and tumour cells exchange signals that modify the local 
ECM, stimulate migration, proliferation and survival (Hanahan and Weinberg, 
2000). The three steps occurring during tumour invasion of the ECM are 
briefly described below. These are (1) attachment or adhesion of tumour cells 
to the ECM (2) Degradation of the ECM (3) Tumour migration into the region 
of the matrix modified by proteolysis. 
 
1.3.1.1 Attachment to the ECM 
A number of specific cell-surface associated molecules or proteins and other 
diffusible factors have been implicated in the process of cell invasion and 
metastasis. These proteins modulate cell-matrix and cell-cell interactions and 
include integrins, cadherins, CD44, and the matrix metalloproteinases 
(MMPs). Adhesion and proteolysis regulate many processes associated with 
metastasis including how cancer cells interact with the host stroma or 
microenvironment, cancer cell migration, invasion, resistance to apoptosis 
and the ability to induce angiogenesis (Bacac and Stamenkovic, 2007). 
Adhesion molecules affect the metastatic potential of malignant tumours by 
serving as both positive and negative modulators and may direct tumours to 
specific tissues. Adhesion molecules on the cell surface play an important role 
in tumour cell migration and regulate the potential for epithelial cells to 
metastasise (Keleg et al, 2003).  
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A number of surface proteins involved in these interactions have been 
described and chief among them are the integrins. In addition to mediating 
specific binding of cells to components of the ECM, integrins transduce 
signals from the ECM into cells and regulate the expression of various genes 
including matrix degrading enzymes. Integrins recognise certain specific 
sequences in many adhesion proteins such as collagen, fibronectin and 
thrombospondin (Tiger et al, 2001; Aplin et al, 1990). When bound to the 
ECM, integrins aggregate on the cell membrane and associate in a molecular 
complex composed of adaptor, signaling and cytoskeletal proteins (focal 
adhesion complex). Actin fibres are converted into stress fibres that promote 
further integrin aggregation. This results in increased ECM binding as a result 
of this positive feedback loop. Integrins trigger both mechanical and chemical 
signals that regulate adhesive versus migratory interactions with the ECM.  
 
Another important function of integrins in tumour metastasis is their role in 
cellular adaptation to changing tissue microenvironments as found in 
metastatic organs (Keleg et al, 2003). Highly malignant melanoma cells show 
an increased synthesis of the α2β1 integrin when cells are cultivated in a 
collagen matrix (Zigrino et al, 2005). Other cell receptors involved in mediating 
cell-matrix and cell-cell binding include cadherins and the immunoglobulin (Ig) 
superfamily. Normal epithelial cells communicate with the microenvironment 
through E-cadherin-mediated cell-cell interaction and the β1 integrin-mediated 
adhesion to the basement membrane. Cancer cells however have N-cadherin 
instead of E-cadherin and it plays an important role in invasion (Bacac and 
Stamenkovic, 2007). A positive correlation was found between the invasion 
into type I collagen of human cancer cell lines and the lack of E-cadherin 
(Mareel and Leroy, 2003).  
 
1.3.1.2 Degradation of the ECM 
ECM invasion is not a passive growth process but requires active biochemical 
mechanisms. Many proteases are involved in the proteolysis of the ECM 
proteins during processes such as cancer invasion and metastasis. These 
include MMPs, plasminogen activators, cathepsins and heparanases. Matrix 
metalloproteinases and their involvement in ECM degradation are described 
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in a later section (see section 1.5.1). Data from many researchers suggest 
that members of the MMP family also enhance tumour angiogenesis by 
triggering the angiogenic switch (Bergers et al, 2000). Released proteases 
degrade components of the ECM to reveal cryptic sites in extracellular 
matrices. Extracellular proteases are important in transforming cancer into an 
invasive and metastatic phenotype. Several studies have shown that 
proteases are upregulated, protease inhibitors are downregulated and inactive 
zymogen forms are converted into active enzymes in different/ several 
cancers (Bloomston et al, 2002; Bergers et al, 2000). The secretion of MMPs 
and their tissue inhibitors of matrix metalloproteinases (TIMPs) is balanced 
under normal conditions. During embryo morphogenesis, tissue remodelling, 
bacterial invasion and angiogenesis, the degradation of the ECM is done in a 
controlled manner (Liotta et al, 2001). During tumour invasion this process is 
deregulated. 
 
1.3.1.3 Movement through the ECM 
Once the ECM has been degraded and the basement membrane has been 
disrupted, cancer cells come into contact with structural and cellular 
components of the stroma, bringing them into contact with fibroblasts. 
Fibroblast behaviour is then modified to better serve the requirements of 
tumour cell growth, invasion, migration and survival (Bacac and Stamenkovic, 
2007; Owens and Watt, 2001). Their phenotypes are altered to form 
myofibroblasts (cancer associated fibroblasts, CAFs). The aberrant 
phenotypic expression of fibroblasts surrounding tumours has been widely 
documented (Kalluri and Zeisberg, 2006; Olumi et al, 1999). CAFs are a 
source of proteolytic enzymes, growth factors, ECM proteins and participate in 
regulating the inflammatory response to tumour invasion. They have been 
shown to either increase or decrease ECM synthesis depending on the stage 
of the tumour (Kalluri and Zeisberg, 2006, Orimo et al, 2005).  
 
As a tumour grows, the advancing front activates enzymes whilst the rear 
front remains attached to the ECM. Once the path for the tumour has been 
cleared, the tumour’s rear front detaches from the ECM and it moves forward. 
The tumour cell attaches itself to the ECM ahead of its advancing front and 
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pulls itself forward. Tumour cells do not stop moving, even if the stimulus for 
movement has been removed. They migrate and penetrate tissue barriers 
until the host dies (Fidler, 2003; Chang and Werb, 2001). The three steps of 
ECM invasion as exemplified by the description above for tumour cells are 
linked and continuous and little information is available about the regulation of 
each step. The genes that control each step are still to be determined and it is 
hoped once this is done, this would contribute to a much better understanding 
of the process of invasion. 
 
1.3.2 Metastasis 
Metastasis is a complex, multistep and organ-selective process that is 
governed by many different classes of molecules (Yeatman and Nicolson, 
1993). Loss of junctional contact between adjacent epithelial cells and cell-
extracellular matrix associations are essential prerequisites for tumour cell 
detachment from the primary tumour (Tawil et al, 1996). These cancer cells 
are capable of establishing new tumours in locations remote from the site of 
the primary tumour and to subvert the tissue microenvironment in a way that 
is conducive to their continued proliferation and survival. The process of 
metastasis involves other processes such as angiogenesis, survival during 
circulation, intravasation and extravasation (Fidler, 2003; Gout and Huot, 
2008). The host extracellular matrix or stroma is degraded by proteolytic 
enzymes and subsequently invaded by malignant tumour cells from the 
primary tumour. Tumour cells can penetrate the lymph node and blood 
vessels (intravasation) and enter circulation.  
 
The stromal reaction to the presence of tumour cells is variable depending on 
the tumour cell properties and, in part, upon the local stromal composition. 
Assessment of the expression profile of stroma associated with invasive 
cancer revealed a gene profile reminiscent of that associated with wound 
healing. Genes found to be upregulated in the reactive stroma were found to 
have predictive value for both overall and metastasis-free survival of prostate 
and breast carcinoma patients (Bacac and Stamenkovic, 2007; Chang et al, 
2005; Allinen et al, 2004). These observations suggest that the stromal 
response to carcinoma growth may hold the key to subsequent growth and 
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spread of the carcinoma. The modified stroma can be considered as a main 
tumorigenic agent ‘as a whole’ and is susceptible to therapeutic intervention 
sometimes called ‘stroma-directed therapy’ in cancer. However several key 
questions remain unresolved. Most importantly is the role played by stromal 
cells such as fibroblasts not only in the crosstalk with cancer cells but also the 
crosstalk between these stromal cells and the extracellular matrix.  
 
1.4 Tumour Microenvironment 
The tumour microenvironment was originally considered to only play a 
supporting role in metastasis and cancer progression but its active function in 
tumour development is now firmly established. Numerous studies have shown 
that tumour invasion and metastasis involve complex interactions between 
stromal and tumour compartments (Beacham and Cukierman, 2005; Wozniak 
et al, 2004). This profound role of the microenvironment in tumour 
development begins early in the neoplastic process, before cancer cells have 
crossed the basement membrane.  
 
The tumour microenvironment includes the following: 
o Cancer cells 
o Non-cancer cells such as fibroblasts 
o Secreted soluble factors 
o Non-cellular material- ECM  
The actual composition of each of these in the tumour microenvironment is 
highly variable. The conditions within the tumour microenvironment do not 
affect cancer cells only. The ECM, which forms the immediate environment of 
the invading malignant cells contains cells such as fibroblasts which 
biosynthesise the collagens among other proteins (Nakoman et al, 2005). 
Normal cells around a tumour exhibit altered characteristics compared to 
corresponding cells in normal tissue. Several studies indicate that fibroblasts 
within tumours harbour mutations that activate them into myofibroblasts or 
cancer associated fibroblasts (CAFs). Interestingly lung endothelial cells are 
transformed into CAFs by the presence of TGF-β (Zeisberg and Kalluri, 2004; 
Zeisberg et al, 2005, 2007; Gout and Huot, 2008)). Most mammalian cells are 
in contact with an ECM whose composition and structure vary with 
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development and diseases such as cancer (Gout and Huot, 2008). 
Inappropriate synthesis or degradation of any ECM molecules alters cell 
physiology and can cause disease (Kim, 2005; Wetzels et al, 1991; Nagle et 
al, 1995). 
 
1.4.1 Cells synthesising the ECM  
Fibroblasts are widely distributed and are the predominant cells producing the 
extracellular matrix proteins in the stroma (Kalluri and Zeisberg, 2006). In 
addition to being responsible for the production of the ECM, fibroblasts play a 
role in the regulation of differentiation and homeostasis of adjacent epithelia. 
Fibroblasts are key cellular component of tumours and are thought to facilitate 
angiogenesis and cancer progression. Pathologists have reported increased 
fibroblast proliferation and enhanced collagen deposition in the stroma 
surrounding many tumour types. This provided evidence that changes in the 
host stromal compartment occur concomitantly with epithelial transformation 
(Kunz-Schughart et al, 2002). Fibroblasts are the most abundant stromal cells 
in the desmoplastic response of tumours (Tuxhorn et al, 2002; Kunz-
Schughart et al, 2002; 2003) and can be activated by various stimuli including 
growth factors such as  TGF-β, EGF, PDGF, and FGF-2. 
 
The most salient feature indicative of phenotypic switching to these activated 
fibroblasts (cancer-associated fibroblasts) is a myofibroblasts ultra structure 
(Beacham and Cukierman, 2005). These activated fibroblasts express α-
smooth muscle actin, hence the term myofibroblasts (Fig 1.2) (Kalluri and 
Zeisberg, 2006). Markers used to distinguish activated fibroblasts from normal 
fibroblasts are vimentin and tenascin C. Activated fibroblasts also modulate 
the immune response through secretion of cytokines such as IL-1 (Rollins et 
al, 1989). Fibroblasts interact with their surrounding microenvironment 
through receptors such as integrins. Once fibroblasts acquire the activated 
phenotype, their proliferative activity increase and there is enhanced secretion 
of ECM proteins such as type I collagen and tenascin C. Activated fibroblasts 
also communicate with cells through secretion of growth factors and 
chemokines. Activated fibroblasts deposit high levels of collagen type I and III 
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to induce an altered ECM microenvironment, and also interact with the 
microvasculature by secreting MMPs and VEGF.  
      
Figure 1.2 Activation of normal fibroblasts (a) by growth factors, proteases and 
chemokines results in an altered phenotype and the synthesis of large amounts of the 
ECM as shown in (b). (Kalluri and Zeisberg, 2006). 
 
Activated fibroblasts are present in healing wounds and sclerosing tissues. 
Fibroblast activation in wound healing is reversed once the activating stimulus 
is removed. In tissue fibrosis however fibroblasts sustain their activated state 
often until organ death. Both cancer-associated fibroblasts and activated 
fibroblasts isolated from fibrotic tissue maintain their phenotype over several 
passages in vitro, until they enter senescence (Gout and Huot, 2008). 
Immortalised prostate epithelial cells grafted in mice together with CAFs, 
taken from the primary site, resulted in the development of intraepithelial 
neoplasia of the prostate (Olumi et al, 1999). This clearly indicates that CAFs 
have the potential to initiate tumour formation. CAFs are also thought to 
initiate the metastatic cascade through producing cytokines such as TGF-β 
that activate cancer cells and trigger their detachment from the primary 
tumour site. CAFs or activated fibroblasts secrete increased levels of ECM-
degrading proteases such as MMPs particularly MMP 2, MMP 3 and MMP 9. 
This increases ECM turnover and alter ECM composition. 
 
1.5 Enzymes responsible for the degradation of the ECM 
The degradation of the ECM together with adhesion and detachment enable 
cells including tumour cells to move through the stroma. In the case of tumour 
cells, they secrete proteolytic enzymes and other factors which stimulate host 
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cells to secrete proteases to degrade matrix proteins. The degradation of the 
stroma is an irreversible process that can only be corrected through synthesis 
of new matrix proteins. Inhibitors of the MMPs constitute a viable strategy for 
interfering with the processes of ECM degradation.  
1.5.1 Matrix metalloproteinases (MMPs) 
MMPs comprise a family of at least 28 secreted or transmembrane enzymes 
collectively capable of processing and degrading various ECM proteins, of 
which about 22 MMPs have so far been found to be expressed in human 
tissues. MMPs share high protein sequence homology and have defined 
domain structures and thus, according to their structural properties, MMPs are 
classified either as secreted MMPs or membrane anchored MMPs, which are 
further divided into eight discrete subgroups. Secreted MMPs include minimal-
domain MMPs, simple hemopexin domain-containing MMPs, gelatin-binding 
MMPs, furin-activated secreted MMPs and vitronectin-like insert MMPs, while 
membrane bound MMPs include type I transmembrane MMPs, glycosyl-
phosphatidyl inositol (GPI)-linked MMPs and type II transmembrane MMPs 
(Egeblad and Werb, 2002; Fang et al, 2000.)  
Crystal structures of MMPs, reveals the domain organization, polypeptide fold 
and specificity determinants (Bode et al. 1994). The crystal structures of the 
catalytic domains of most human MMPs in addition to porcine full length 
MMP-1 and human proMMP-2 have been resolved (Bode et al. 1994; Kiyama 
et al. 2006; Morgunova et al. 1999; Alexander, 2002). All MMPs are 
synthesized with a prodomain containing a leader sequence, which targets 
the protein for secretion (Sternlicht and Werb, 2001; Fang et al, 2000). The 
prodomain of MMPs contains a well conserved cysteine switch motif essential 
for maintaining a latent pro-MMP (Springman et al. 1990; Suzuki et al, 2004). 
The overall three dimensional structure of the hemopexin domain is a four-
bladed propeller, with a calcium binding site nestled in the folds. Calcium 
seems to be required for some MMP/substrate interactions, and not others. 
Final activation of the MMPs often includes shedding of the hemopexin 
domain (Bode et al. 1999; Sternlicht and Werb, 2001.). Tissue inhibitors of 
MMPs (TIMPs) are secreted by fibroblasts, endothelial cells, and 
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chondrocytes (Liotta, 1992). These may guard against excessive breakdown 
of the ECM.  
The interaction between the ECM components and cells plays a very 
important role in regulating the expression of matrix degrading proteases. 
Langhoz et al (2003) showed the important role of α2β1 integrin receptors in 
the regulation of MMP 1 expression in human skin fibroblasts. Zigrino et al 
(2005) showed that MT1 MMP expression is regulated by the activation of 
α2β1 integrins receptors. The α1β1 and α2β1 integrins are very important in 
the induction of MMP-1 secretion in human breast fibroblasts cultured on type 
I collagen (Moon et al, 2001; Nutt and Lunec, 1996). In addition to degrading 
ECM components, MMPs are involved in the processing of growth factors, 
cytokines, chemokines and adhesion molecules, hence they play an important 
role in maintaining tissue integrity. MMPs are involved in normal processes 
such as tissue remodelling, wound healing, trophoblast implantation and 
organ morphogenesis.  Several studies have indicated an important role of 
the ECM in the induction of MMPs such as gelatinases (MMP 2 and MMP 9). 
MMPs also act as sheddases to cleave membrane-bound receptor molecules. 
Some of the most important MMPs are the fibrillar-degrading MMPs. 
1.5.1.1 Fibrillar collagen-degrading MMPs 
 Fibrillar collagens are degraded by collagenases, MMP-1, MMP-8, MMP-13 
and MMP-14 (MT1 MMP) at a specific site of the α chain resulting in 
generation of 3/4 N-terminal and 1/4 C-terminal fragments that are 
denaturated at body temperature. The fragments are further degraded by 
MMP-2, MMP-9 and MMP-13. Furthermore MMP-13 cleaves type I collagen in 
non-helical telopeptide while MMP-2 shows weak collagenolytic activity (Ala-
aho and Kähäri, 2005). Obtaining information about the functional state of 
MMPs (pro-, active, or inhibited) is difficult. MMPs have an important role in 
the progression of many diseases and therefore profiling the levels of MMP 
activities rather than overall MMP abundance is necessary. This is because in 
pathological situations, tissue damage or other pathological effects are likely 
caused by active enzymes.  
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1.6 Focal Adhesion Complexes 
Cell-matrix interactions are mediated mainly by integrins. Cytoskeletal and 
cytoplasmic proteins are recruited to the adhesion sites. Specialised 
structures called focal adhesion complexes are formed and these serve as a 
structural link between the ECM and the cytoskeleton. Other functions of focal 
adhesion complexes include serving as sites for signal transduction by 
recruiting a large number of signaling molecules, such as integrins. 
Proliferation and differentiation are some of the cellular processes controlled 
by adhesion-dependent signaling pathways (Wozniak et al, 2004; Schwartz 
and Yap, 2002; Parson, 2003). Beside integrins, other transmembrane 
proteins are also involved at the focal adhesion complex sites and these 
include integrin associated proteins (IAP), layilin, and growth factor receptors 
such as EGFR and VEGFR-2. There are many other proteins associated with 
the focal adhesion complexes and these include enzymes, adaptor proteins, 
cytoskeletal proteins, serine/threonine kinases and tyrosine kinases (Zanke et 
al, 1996; Ramirez and Rifkin, 2003).  ECM-degrading proteins such as uPAR 
and MMPs are also included within the integrin-associated proteins group as 
some of the MMPs are found to be cell-associated through interactions with 
integrins. MMP1 is associated with collagen-binding I-domain of the α subunit 
and is required for α2β1 integrin-mediated keratinocyte migration on type I 
collagen (Sato et al, 2000; Xu et al, 2000, 2001).  
 
1.6.1 Cell Adhesion Receptors 
1.6.1.1 Integrins  
Cell adhesion is very important in many pathological and physiological 
processes including wound healing, development, neoplasia and metastasis. 
Integrins are a family of heterodimeric adhesion receptors, that play a central 
role in transducing signals that provide support, regulate movement and affect 
gene expression (Aumailley and Gayraud, 1998; Hynes, 2002; Yamada, 2002; 
Juliano, 2004). They consist of non-covalently associated α and β subunits, 
with 18 different α subunits and 8 different β subunits having been detected in 
vertebrates. These combine to form 24 different integrin heterodimers (Fig 1.3) 
(Gullberg and Lundgren-Akerlund, 2002). Screening of the human genome 
identified 24 α and 9 β chains suggesting the number could be higher (Velling 
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et al, 1999; Humphries, 2000). About half of these heterodimers contain the 
β1 subunit (Al-Jamal and Harrison, 2008). The particular combination of α and 
β subunits determine ligand specificity, although a great redundancy is 
inherent in the system (Zutter and Santoro, 1990). Both subunits fold into an 
extracellular N-terminal globular head, which create the ligand-binding surface, 
a long stalk region connecting the ligand-binding head with the type I 
transmembrane stretch and the C-terminal cytoplasmic tail (Hynes, 2002; 
Humphries, 2000; Shimaoka and Springer, 2003).      
                                    
Figure 1.3 The integrin family. The currently known integrin chains of the vertebrate 
integrin family are shown. Integrin α subunits containing the I domain are labelled in 
dark gray. Integrins comprise non-covalently associated α and β subunits, with 18 
different α subunits and 8 different β subunits having been detected in vertebrates. 
These combine to form 24 different integrin heterodimers (Gullberg and Lundgren-
Akerlund, 2002).  
The cytoplasmic tails are 10-50 residues long and do not contain any catalytic 
activity or consensus protein binding-motifs, except for the internalisation 
motif in β subunits. The only known exception is the β4-subunit with two 
fibronectin type II repeats in its uniquely long cytoplasmic domain (~1000 
residues). Integrins bind to different macromolecules and transmit signals 
bidirectionaly, the so called ‘inside out’ and ‘outside in’ signaling. Under 
normal conditions, integrins exist in their inactive state bound to GDP. Their 
ligand binding affinity is regulated through conformational changes which can 
originate from the cytoplasmic domain or extracellular interactions (Adams 
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and Watt, 1990). Integrins bind ECM proteins and depending on the subunit 
composition will have different functions and ligand specificities. For example 
α5β1 binds fibronectin and α6β1 binds laminin.  
X-ray crystal structural analysis of the α subunits revealed that the seven 
homologous repeats in the N-terminal part fold into a seven-bladed β propeller 
(Heino, 2000). The headpiece of the heterodimer is composed of this β 
propeller domain of the α subunit which closely interacts the β A domain (also 
known as the I-like domain) of the β subunit (Shimaoka and Springer, 2003). 
On the α subunit the most important regions involved in ligand-binding are 
clustered on the upper surface of the β propeller while binding motifs for 
regulatory divalent cations are exposed on the lower surface in the three of 
four last repeats. Half of the α subunits, such as  the collagen binding α1, α2, 
α10 and α11, contain an I-domain (also known as the von Willebrand factor A 
domain) of around 200 residues inserted between the second and third 
propeller repeat (Shimaoka and Springer, 2003). The I-domain is exposed on 
the upper surface of the propeller and is involved in direct recognition and 
binding of the ligand (Humphries, 2000, Hynes and Zhao, 2000). The I domain 
contains a MIDAS site (metal-ion-dependent adhesion site). This 
characteristic MIDAS site binds negatively charged residues in the ligand 
(Plow et al 2000). The I-domain is able to fold correctly without being 
associated to the β subunit (Humphries, 2000). 
The stalk region of α subunits lacking the I-domain are post translationally 
cleaved creating an N-terminal heavy chain and C-terminal light chain joined 
by a disulfide bond, except for α4 and α9. This acts as a lever, as the angle 
between the I-like domain and the hybrid domain controls the receptor 
conformation and the ligand binding affinity. The ‘legs’ of the integrins are 
composed of multiple globular domains known as the EGF-like repeats 
(Humphries, 2000; Heino, 2000). These EGF repeats are linked to a 
cytoplasmic tail domain via a single transmembrane domain. The β subunit 
has an N-terminal cystein-rich region, called a PSI-domain, homologous to 
other membrane proteins (Bork et al, 1999). This domain co-operates with a 
more C-terminal cystein-rich region in restraining the integrin in an inactive 
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state (Zutter and Santoro, 1990; Zang and Springer, 2001). The β subunits 
also contain an I-like domain with a MIDAS. When bound to an α subunit 
lacking the I domain, this I-like domain takes direct part in ligand binding and it 
is also involved in the actual association with the α subunit (Heino, 2000; 
Humphries, 2000). Some of the well-studied integrins include the collagen-
binding integrins.  
1.6.1.1.1 Collagen-binding integrins 
The four integrins known to bind triple helical collagens are α1β1, α2β1, 
α10β1 and α11β1 (Knight et al, 1998; Xu et al, 2000). The α subunits of these 
integrins have the I domains and associate with the β1 subunit only. Ligand 
specificities of the four collagen binding integrins point to both unique and 
potentially overlapping physiological functions (Santoro et al, 1986; Heino 
2000; Gullberg and Lundgren-Akerlund, 2002). α1β1 and α2β1 have been 
known for much longer and hence have been studied in detail while α10β1 
and α11β1 have been recently identified. The α10β1 integrin was identified as 
a type II collagen-binding integrin in chondrocytes while α11β1 as a type I 
collagen-binding integrin on cultured muscle cells although studies later 
showed that α11β1 is not expressed on muscle cells in vivo (Camper et al, 
1997, 2001; Velling et al, 1999; Tiger et al, 2001). These four integrins are 
expressed in different tissues, with α1β1 and α11β1 predominantly found in 
mesenchymal cells while both α1β1 and α2β1 are present in epithelial, 
stromal cells and platelets (Zutter and Santoro, 1990).  
 Ligand specificity differs among the four collagen-binding integrins. α1β1 
mediates cell spreading on collagen type I, III, IV, V and XIII substrates. α2β1 
mediates cell spreading on collagen types I-V but not on collagen type XIII. It 
appears that other factors are involved in the regulation of cell spreading. 
Recombinant I-domains from the four integrins have been used in binding 
assays and the results support the idea that these integrins differ in ligand 
specificity and perhaps function (Camper et al, 1997; Humphries, 2000). 
These four integrins also bind to other ECM proteins such as laminins.  
There is no consistency in the expression pattern of collagen-binding integrins 
during metastasis. These integrins are up-regulated in some melanomas and 
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downregulated in others (Dahlman et al, 1998; Zutter et al, 1994, 1995) while 
two of these integrins, α1β1 and α2β1 have been shown to be negative 
regulators of collagen synthesis (Langholz et al, 1995, Kubota et al, 2003). 
The major collagenase, MMP 1, is upregulated by α2β1 and binds the I-
domain of the α2 subunit, thereby suggesting that α2β1 downregulates 
collagen synthesis partly by causing its degradation (Langholz et al, 1995; 
Mimura et al, 2006). In fibroblasts seeded in a collagen lattice, α2β1 has been 
shown to induce MMP 13 in a p38 MAPK-dependent manner. α2β1 integrin 
has been implicated in numerous physiological and pathological conditions. 
During angiogenesis, α1β1 and α2β1 integrins interact with each other to 
regulate gene expression such as VEGF expression (Heino et al, 2008). 
1.6.1.1.2 The α2β1 Integrin 
Of the collagen-binding integrins, α2β1 integrin is the most studied. It was first 
identified on T-cells activated in vitro and was named VLA-2, but was later 
shown to be a collagen receptor on a number of cells including fibroblasts and 
fibrosarcoma cells (Santoro, 1986). It is a classical I domain-containing 
receptor (Zutter and Santoro, 1990; Takeuchi et al, 1997) and is widely 
expressed during embryonic development (Xu et al, 2000). Despite being 
widely expressed in human tissue no α chain is expressed in skeletal muscle. 
α2β1 integrin is the only collagen-binding integrin known to be expressed in 
platelets (Heino, 2000). Langholz et al (1995) showed the importance of α2β1 
integrin in the regulation of MMP-1 expression in human skin fibroblasts. It 
was also demonstrated that membrane-type 1 (MT1) MMP expression is 
regulated by the activation of α2β1 integrin receptors (Koblinski et al, 2005; 
Xu et al, 2000; Montgomery et al, 1994).    
The collagen receptor integrins are structurally distinct when compared to 
other extracellular matrix binding integrins. They have a specific ‘inserted’ or I-
domain as a part of the α subunit (Heino, 2000) that is responsible for 
collagen recognition. α2β1-mediated stimulation of cell proliferation is 
dependent on cyclin E/cdk2 induction and α2β1-mediated cell migration 
involve the stress-regulated MAPK p38 (Hynes, 2002). The mechanism 
whereby integrin signaling results in stimulation or inhibition of cell 
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proliferation is unclear but might involve different transcription factors 
downstream of the signaling cascade. The use of monoclonal antibodies in 
inhibition studies has shown that both α1β1 and α2β1 have a role in VEGF-
driven angiogenesis (Gullberg and Lundgren-Akerlund, 2002). α2β1 integrin is 
a promising target molecule for blocking inflammatory reactions in different 
disorders as it is expressed in leukocytes (Goldman et al, 1992). Other 
receptors involved in cell-cell and cell-matrix interactions include cadherins. 
1.6.1.2 Cadherins 
Cadherins are found in an amazingly wide range of organisms and their 
primary role is cell-cell adhesion via the extracellular transmembrane 
glycoproteins domains. Cadherins are calcium-dependent membrane proteins 
with an ectodomain consisting of five cadherin motifs (Prockop, 1998; Aplin et 
al, 1999). The two well known cadherins are E- and N-cadherin. Epithelial 
cells express E-cadherin whereas fibroblasts and neuronal cells express 
mainly N-cadherin (Kim et al, 1998, 2005). E-cadherin is a cell surface protein 
involved in homophilic cell-cell interactions, found at adherens junctions and 
associates with the actin cytoskeleton via catenins. The cell-cell adhesion is 
mediated by binding of the cytoplasmic tail of E-cadherin to cytoplasmic 
catenins, α-, β-, and γ-catenin (Takeichi, 1988, 1993; Jou et al, 1995). Just as 
integrins function to mediate cell-ECM interactions in anchorage-dependent 
survival, cadherins may also act in such a capacity, possessing a functional 
role in the regulation of intercellular adhesion-dependent survival. Changes in 
the structure or in the expression of the components of the E-cadherin/catenin 
complex, result in the suppression of cell-cell adhesion. E-cadherin 
expression decreases sequentially in progression from normal mucosa to 
adenoma and from adenoma to carcinoma (Gagliardi et al, 1995). N-cadherin 
expression induces a mesenchymal phenotype in breast carcinoma and in 
other epithelial cancer cells in vitro and it promotes invasion and metastasis in 
vivo (Hazan et al, 2000; Hazan et al, 2004). Recent studies have shown that 
exogenous introduction of N-cadherin was sufficient to confer invasive 
properties in bladder cancer cells by activating Akt (Rieger-Christ et al, 2004; 
Wallerand et al, 2008). 
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1.6.2 Integrin receptor-mediated signaling 
Specialised cells are surrounded by different combinations of ECM proteins 
and express an array of tissue-specific integrin receptors. This diversity may 
represent one way to generate unique intracellular signals that give rise to 
tissue-specific phenotypes (Boudreau and Jones, 1999). The majority of 
signaling molecules implicated in ECM-integrin interactions appear to be 
rather ubiquitous mediators of signal transduction. Integrin-mediated signaling 
can be roughly divided into two categories. The first is ‘direct signaling’ in 
which ligation and clustering of integrins is the only extracellular stimulus. 
Adhesion to the ECM proteins can activate serine/threonine kinases, such as 
FAK and those in the mitogen-activated protein kinase (MAPK) cascade. 
Although many such direct signaling events have been described (Aplin et al, 
1998), the mechanisms underlying these events have not been fully resolved. 
The second is ‘collaborative signaling’, in which integrin-mediated cell 
adhesion modulates signaling events that are initiated through other 
receptors, particularly receptor tyrosine kinases that are activated by 
polypeptide growth factors.  
 
Several potential mechanisms for integrin-mediated signaling have emerged 
recently, with the focus placed either at the level of tyrosine kinase activation 
or within the downstream signaling cascade. In all cases, however, integrin-
mediated adhesion seems to be required for efficient transduction of signals 
with origins at the cell surface and targets in the cytosol or nucleus might 
include FAK and the Ras/Raf/MEK/ERK pathway.  
 
1.6.2.1 Focal Adhesion Kinase (FAK) 
Signals from cell-matrix interactions are mainly transduced through tyrosine 
phosphorylation. Integrins are not known to exhibit any kinase activity and 
hence the need for active tyrosine kinases at the adhesion sites. Focal 
adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that is localised at 
focal adhesion complexes and is activated in response to integrin clustering. 
FAK provides a link to several intracellular signaling cascades that lead to 
mitogenic responses, cell survival and cell migration (Ilic et al, 1998, 2008). 
Integrin-dependent autophosphorylation of FAK allows it to interact with 
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paxillin, tensin and Grb2/SOS, which in turn are able to activate downstream 
signaling mediators such as Src, Ras, and Raf that are implicated in growth 
control.  
  
The use of FAK-null cells has shown that FAK is not vital for integrin activation 
but is important in cell migration (Ilic et al, 1998).  The kinase domain of FAK 
contains several tyrosine residues that are phosphorylated and participates in 
autoregulation. Treatment of cells with tyrosine kinase inhibitors show that 
FAK and integrins associate independently of tyrosine phosphorylation 
(Miyamoto et al, 1995). Integrin-mediated FAK activation has been shown to 
require Rho-activity during the later phases of activation while the initial 
phosphorylation is independent of Rho-GTPases (Zhang et al, 2004). The 
FAK-phosphatidylinositol-3 kinase (PI3-K) interaction has been implicated in 
cell survival signaling via the Ser/Thr kinase Akt and in cell migration (Asano 
et al, 2004; Ilic et al, 1998).  
 
1.6.2.2 Ras/Raf/MEK/ERK Signaling 
The ras family, H-ras, K-ras and N-ras proteins have almost identical 
structures reflecting the similarity in their functions. Ras cycles between the 
GDP-bound inactive form and the GTP-bound active form (Chetoui et al, 
2005; Leaner et al, 2005). Ras is activated by the guanine nucleotide 
exchange factor Sos1, which complexes with the adaptor protein Grb2. 
Grb2/Sos can bind directly to the Ras molecule associated with the inner 
leaflet of the plasma membrane. The binding of SOS to Ras causes a change 
in the Ras conformation and leads to the dissociation of GDP which allows 
Ras to bind GTP. In its activated form, Ras binds the Ser/Thr kinase Raf-1 
that in turn initiates activation of the MEK/ERK MAPK pathway (Stewart and 
Guan, 2000).  
 
The MAPK signal transduction pathway provides a common route leading to 
transcriptional regulation of genes that are crucial for cell growth and 
differentiation. Family members that are sequentially activated include MEK 
and ERK1/ERK2 (Stewart and Guan, 2000). MEK-dependent phosphorylation 
of ERK 1,2 results in their translocation  to the nucleus, where they 
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phosphorylate and activate a number of transcription factors (Sun et al, 2003; 
Chen et al, 1996).  
 
The mechanistic basis for the commonly observed integrin-mediated 
activation of MAPK, through Ras, is controversial at present. Several studies 
indicate the existence of a Ras-independent component in integrin-mediated 
MAPK activation (Chen et al, 1996) whilst many others show Ras involvement 
in integrin-mediated MAPK activation (Kubota et al, 2003; Ge et al, 2007). 
Three models have been proposed and two of these show Ras as a critical 
part in the activation of MAPK, with one model showing a Ras-independent 
MAPK activation. The first mechanism has FAK acting as a surrogate tyrosine 
kinase domain and the integrin engagement leads to FAK 
autophosphorylation, generating a binding site for the SH2 domain of Src. Src 
then phosphorylates FAK at several positions, where SH2-containing adaptor 
proteins such as Grb2 bind. Binding of Grb2 to FAK results in membrane 
localisation of SOS, a guanine nucleotide exchange factor, which in turn 
promotes GTP loading and activation of Ras. Activated Ras binds Raf and 
localises it to the membrane, where it is activated. Once activated, Raf 
phosphorylates and activates MEK which in turn phosphorylates ERK1/2. The 
second mechanism is FAK-independent activation of MAPK by integrins and 
involves the interaction of integrin subunits with the membrane protein 
caveolin. The Shc adaptor protein associates with caveolin, is tyrosine 
phosphorylated and recruited into integrin-associated complexes. Tyrosine-
phosphorylated Shc is then bound by a Grb2-Sos complex and activation of 
MAPK occurs through the Ras-mediated pathway (Ge et al, 2007; Roux and 
Blenis, 2004). The third mechanism is Ras-independent and the localisation of 
Raf at the membrane is important for this activation but the membrane-
associated components responsible are as yet to be identified.     
 
These Ras-signaling cascades are only transiently activated because each 
normal Ras has low intrinsic GTPase activity that gradually inactivates its own 
signaling function by hydrolysing the bound GTP. Interestingly there is 
crosstalk between the Ras GTPase and PI3-K in that they interact and are 
able to activate each other (Stewart and Guan, 2000). The critical nuclear 
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targets of Ras/Raf/MEK/MAP kinase pathway include transcription factors 
such as Sp1 and Fos. The Fos protein forms a heterodimer with jun to yield 
the active AP-1 complex. The c-fos promoter has been well studied and the 
regulatory elements have been characterised (Treisman, 1994). Cancer cells 
are self-sufficient in terms of growth factors and their surface receptors are 
generally overexpressed. This can lead to the activation of Ras and 
subsequently the MEK/ERK pathway, facilitating the continued proliferation of 
cancer cells. Mutational activation of Ras has been reported in approximately 
30 % of human tumours and might play a crucial role at the early steps of 
tumorigenesis and metastasis that triggers downstream signaling pathways 
that affect the expression of many genes (Ge et al., 2007; Uemura et al, 
2003)..  
Some of the protein tyrosine phosphatases involved in cell-ECM signaling 
events include PTEN, LAR and PTP. The tumour suppressor PTEN has been 
found to be a tyrosine protein phosphatase and a lipid phosphatase. When 
overexpressed PTEN inhibits stress fibre formation and thus inhibits cell 
spreading and migration with reduced activation of FAK and ERK (Gu et al, 
1998). SHP-2 is another protein phosphatase shown to be involved in both 
integrin and growth factor signaling. SHP-2 is known to modulate the 
recruitment of Ras-GAP and the subsequent signaling via the Ras/Raf/ERK 
pathway (Ekman et al, 2002). The α2β1 integrin has been shown to mediate 
negative cell survival signaling by inducing dephosphorylation of Akt.  
1.7 Definitions 
The terms fibroblast-derived extracellular matrix (ECM) and matrix are used in 
the results section to mean the pre-formed matrix produced by fibroblasts in 
culture and then coated onto plastic culture dishes (Serebriiskii et al, 2008). 
The control used is the normal plastic culture dish. These definitions are 
important as some researchers use the term matrices to refer to artificial 
matrices of purified extracellular matrix proteins such as fibronectin and 
laminin (Fukuda et al, 2006; Elliot et al, 2005).   
 
32 
 
Un
ive
rsi
ty 
f C
ap
e T
ow
n
1.8 Objectives of the study 
The recent development of fibroblast-derived matrices (Serebriiskii et al, 2008) 
have the potential to produce a new and physiological assay system in which 
to study interactions between cells and also between cells and the ECM. To 
date, the reciprocal regulatory effects of the ECM on cells such as fibroblasts 
have been elucidated only to a minor degree. This study investigated the 
regulation of type I collagen synthesis, a major component of the ECM, in the 
presence of a preformed fibroblast-derived ECM. Furthermore, the study 
explores the mechanisms of signaling involved in the type I collagen synthesis 
in the presence of the matrix and also the differences in type I collagen 
synthesis when fibroblasts are plated on the fibroblast-derived ECM and two 
matrix components, purified type I collagen and fibronectin.  
 
1.9 Aims 
1. To determine the effect of a fibroblast-derived ECM on type I collagen gene 
expression in fibroblasts 
2. To determine the effect of the fibroblast-derived ECM on the gene 
expression and activities of type I collagen proteases 
3. Functional mapping of the matrix responsive element (MRE) in the COL1A2 
promoter 
4. To identify possible transcriptional factors involved in the regulation of type 
I collagen gene expression by the fibroblast-derived ECM 
5. To elucidate the signal transduction pathway involved in the matrix-
mediated regulation of type I collagen genes 
6. To determine the nature and origin of the stimulus from the fibroblast-
derived ECM 
7. To determine receptors involved in the interaction between the matrix and 
fibroblasts 
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CHAPTER 2 
 
THE EFFECT OF A PRE-FORMED FIBROBLAST-DERIVED 
ECM ON TYPE I COLLAGEN GENE EXPRESSION 
 
2.1 INTRODUCTION 
Normal cells and tissues exist in a defined relationship with components of the 
ECM in their immediate microenvironment. Cell adhesion to the extracellular 
matrix (ECM) plays an important role in regulating cellular processes such as 
proliferation, migration, differentiation and survival (Giancotti and Ruoslahti, 
1999; Hoshiba et al, 2006). In many pathological processes the interaction 
between cells and the surrounding extracellular matrix is altered. Gene 
expression patterns are changed and in doing so, cells synthesise an 
extracellular matrix that may differ from the normal ECM. During this process, 
cells normally degrade the extracellular matrix components such as types I 
and IV collagens, but elevated levels of these ECM components also has 
been reported in many pathological conditions such as fibroproliferative 
disorders.  
 
Previous studies have shown that collagen gene regulation is a complex 
process whereby both the N-terminal and C-terminal extension peptide of type 
I collagen may function as negative feedback inhibitors of collagen 
biosynthesis in a variety of cells (Streuli and Bissell, 1990; Asano et al, 2004; 
Aycock et al, 1986; Bornstein and Sage, 1989). Collagen and fibronectin 
production are specifically induced in subconfluent cells by a pentapeptide 
(KTTKS) and residues 212-216 of the carboxy propeptide of the α1(1) 
procollagen protein (Aycock et al, 1986; Karsenty et al, 1995). This inductive 
effect is completely abolished as the cells become confluent. Many studies 
indicated that cellular behaviour and intracellular signal transduction are 
regulated by the type of ECM molecules (Giancotti and Ruoslahti, 1999; Koide 
et al, 1989; Nagaki et al, 1995). ECM composition can affect cell functions as 
well as matrix synthesis (Powell et al, 1997). In mammary glands for example, 
modification of the ECM at the stromal epithelial interface influence ductal 
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branching, end-bud development and epithelial proliferation in the prepubertal 
gland in mice (Silberstein et al, 1992; Sympson et al, 1994). In addition, the 
expression of COL1A1 is induced in attached fibroblasts compared to the 
same cells maintained in suspension (Dhawan et al, 1991) while in monocytes 
a different subset of genes is regulated, depending on the substratum on 
which the cells are cultured (Eierman et al, 1989).  
 
ECM molecules such as fibronectin, vitronectin, laminins and collagens have 
been used before as substrates for studying gene regulation in cultured cells 
(Giancotti and Ruoslahti, 1999; Koide et al, 1989; Nagaki et al, 2002). 
However, none of these components, in their purified states, match the 
physical and biochemical characteristics of the natural ECM made by cells. 
Some of the most important ECM molecules include the collagens which are 
crucial in tissue structure and their structures also play a critical role in healing, 
in the pathology of diseases and as primary material for many tissue-
engineering applications. The remodelling of collagen as a component of the 
extracellular matrix is integral to maintenance of tissue structure and function 
(Abraham et al, 2007; Moon et al, 2001, 2002; Mook et al, 2004). The process 
of wound healing and tissue remodelling depend on the degradation and the 
deposition of new extracellular matrix by fibroblasts (Diegelmann and Evans, 
2004). Under certain pathological conditions such as invasion and metastasis, 
there is unregulated breakdown of collagen and therefore the assessment of 
collagen and its breakdown products is essential for monitoring and managing 
the patients (Abraham et al, 2006; Demers et al, 2000).  
 
Several investigations have been done to identify the factors and the signal 
transduction pathways involved in collagen gene regulation in fibroblasts 
(Moon et al, 2001; Mook et al, 2003; Xiao et al, 2002). A better understanding 
of the role the ECM plays may offer opportunities to identify diagnostic 
markers and therapeutic targets for the many pathological conditions that are 
currently known. Therefore there is need to understand how the ECM controls 
fibroblast activity. A novel approach beyond the use of individual ECM 
components and collagen gels involves using natural, cell-derived 3D 
extracellular matrices, for example fibroblast-derived extracellular matrix 
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(ECM). These matrices are highly fibrillar and contain spaces originally 
occupied by the cells that generated the matrix. In this chapter, the effect of a 
fibroblast-derived ECM on the expression of type I collagen genes in normal 
and transformed fibroblasts was examined. This is the first time that such a 
natural fibroblast-derived ECM has been used to study the regulation 
mechanisms of type I collagen. The elucidation of the molecular basis of this 
process would be invaluable in the diagnosis, prognosis and therapeutic 
regimens not only in cancer but in other prevalent fibroproliferative disorders.  
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2.2 Results 
2.2.1 Effect of fibroblast-derived ECM on cell proliferation 
Fibroblast-derived ECM was prepared as described in section 7.2.3 and both 
normal (WI38 and FGo) and transformed (CT-1) cells were grown on the 
matrix or on plastic. To determine the effect of the fibroblast-derived ECM on 
cellular proliferation, the growth kinetics of WI38, CT-1 and FGo cells were 
determined using either direct cell counting or the MTT assay. Cell 
proliferation was followed over 72hrs and at each time-point cells were 
trypsinised and counted using a haemocytometer or the MTT assay was 
performed as described in section 7.2.4. In all cells, there was no noticeable 
differences between the proliferation curves of those plated on plastic and 
those on a matrix (Figure 2.1.A-C). 
      A                                                                            B 
                 
                                                      C                                                                                 
                                                              
Figure 2.1 Influence of the fibroblast-derived ECM on cell proliferation. 3x 105 WI 38, 
CT-1 and FG0 fibroblasts were plated on culture dishes with or without the fibroblast-derived 
ECM for 24 hrs and then grown in DMEM for the indicated times (24hrs, 48 hrs, and 72 hrs). 
Fibroblast-derived ECM was prepared as described in section 7.2.3. At the end of the 
experiment the fibroblasts were trypsinised and counted. A). Plot of WI38 cells. B). Plot of 
CT1cells. C). Plot of FGo cells. Control cells are shown as blue lines whilst those on matrix 
are shown as pink lines. There was no difference in growth rate between fibroblasts grown on 
a matrix and the control cells. Data are expressed as the mean ± S.D of three independent 
experiments.  
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Similar results were obtained using the MTT assay. These results suggest 
that the fibroblast-derived ECM does not alter the proliferation of the cells 
used in the study.  
 
2.2.2 Effect of fibroblast-derived ECM on fibroblast morphology 
To study the morphological differences between fibroblasts plated on plastic 
and those on matrix, fibroblasts were plated on plastic or on matrix for 48 hrs 
and then observed by phase-contrast microscopy. All pictures were taken 
under 100 x magnification. There were slight differences in the morphology of 
the fibroblasts plated on a matrix compared to those plated on plastic (Fig 2.2).  
A     control                                  matrix 
                
B      control                                  matrix 
                
     C       control         matrix 
                
Figure 2.2 Effect of fibroblast-derived ECM on cell morphology.   
WI38, CT-1 and FGo fibroblasts were seeded on dishes with or without fibroblast-derived 
ECM for 24 hrs and then grown in DMEM media for 48 hrs. Cells were observed under phase 
contrast at 100 x magnification: (A) WI38 on plastic or on fibroblast-derived ECM; (B) CT-1 on 
plastic or on fibroblast-derived ECM; (C) FGo fibroblasts on plastic or on matrix. Although 
fibroblasts on the matrix appear slightly elongated than those on plastic, there were no major 
changes in morphology. Scale bar is (     ) approximately 125 μm  
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Fibroblasts cultured on the fibroblast-derived ECM have a slightly elongated, 
spindle shaped morphology. The mechanism underlying this difference in 
morphology remains to be clarified. 
 
2.2.3 Downregulation of type I collagen levels by fibroblast-derived ECM 
The effect of growing fibroblasts on a pre-formed fibroblast-derived ECM on 
type I collagen production in cellular lysates and the medium was investigated. 
Human fibroblasts were plated on plastic or on fibroblast-derived ECM for 24 
hrs in complete medium, followed by growth in serum-free medium for 48 hrs 
in order to facilitate the identification of secreted collagens in the absence of 
serum proteins. Medium was digested with pepsin (section 7.3.1) and the 
remaining proteins were precipitated. Since type I collagen is resistant to 
pepsin digestion it remains intact while practically all other secreted proteins 
are digested. SDS polyacrylamide gel electrophoresis was performed to 
determine secreted type I collagen. For the analysis of intracellular collagens, 
cell lysates were fractionated by SDS polyacrylamide gel electrophoresis, 
transferred to nitrocellulose membrane and  probed with anti-type I collagen 
antibody as described in section 7.3.2. The antibody used in the study is 
made to type I collagen and interaction with the type I collagen chains does 
not necessarily show the α1 and α2 chains in the ratio 2.1. The results show 
that the levels of both intracellular and secreted type I collagen decreased 
significantly when fibroblasts were plated on a pre-existing fibroblast-derived 
ECM (Fig 2.3 A, C). A similar decrease was observed in WI38, CT-1 (a γ-
radiated transformed cell line derived from WI-38 cells) and FGo skin 
fibroblasts. A time course analysis of the fibroblast-derived ECM-mediated 
inhibition of type I collagen gene expression in CT-1 cells showed that this 
was effective within 24 hrs of cellular contact with the pre-formed fibroblast-
derived ECM (Fig 2.3 B). 
 
2.2.4 Downregulation of collagen α2(1) mRNA levels by fibroblast-
derived ECM  
In order to understand the mechanism(s) by which the fibroblast-derived ECM 
mediates downregulation of collagen production, we examined the effect of 
matrix on the steady state levels of collagen mRNA.  Fibroblasts were plated  
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on either plastic or matrix as previously described and total RNA was 
extracted for quantitation of α1(1) and α2(1) collagen mRNA by quantitative 
real time RT PCR using GAPDH as the normaliser. The matrix decreased the 
levels of α 2(1) collagen mRNA in all fibroblasts (Fig 2.4 A-C).   
 
A            Intracellular type I collagen 
              
B            Intracellular type I collagen            
                     
C            Secreted type I collagen 
                  
Figure 2.3 Effect of the fibroblast-derived ECM on the type I collagen synthesis.  
(A) WI38, CT-1 and FGo fibroblasts were seeded on dishes with or without fibroblast-derived 
ECM for 24 hrs and then grown in DMEM for 48 hrs. Cell lysates (50 μg total protein) were 
separated by 7.5 % SDS PAGE and subjected to immunoblotting with goat anti-type I 
collagen antibody (1:1000). The secondary antibody used was donkey anti-goat IgG 
conjugated to horse radish peroxidase (1:1000). Arrows indicate the two α chains. β-tubulin 
was used as a loading control to confirm equal loading of samples. (B) Time-dependent effect 
of the fibroblast-derived ECM on the type 1 procollagen synthesis. CT-1 fibroblasts were 
treated as described above and incubated for the periods indicated (0, 24, 48, 72 hrs). Type 1 
procollagen protein levels in the cell lysates were determined by immunoblotting as described 
in (A). (C) WI38, CT-1 and FGo fibroblasts were seeded on dishes with or without fibroblast-
derived ECM for 24 hrs and then grown in serum-free DMEM for 48 hrs. The medium was 
harvested and secreted type I collagen was isolated by pepsin digestion (10 μg/ml) and TCA 
(10%) precipitation (section 7.3.1). Precipitated proteins were separated by 7.5 % SDS PAGE 
and the gels were stained with Coomassie BB. After destaining the collagen bands were 
identified based on the molecular weight markers. The media used in the quantification of 
secreted type I collagen was based on 1x 106 cells.   
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Interestingly, there was no change in α1(1) collagen mRNA levels when 
fibroblasts were plated on fibroblast-derived ECM. These results suggest that 
matrix-mediated regulation of α1(1) and α2(1) collagen gene expression 
occurs via different mechanisms. Since the reduction in mRNA levels for the 
three fibroblasts cell lines were similar, only CT-1 fibroblasts were used in a 
time-dependent study and other subsequent studies. The maximum reduction 
in α2(1) mRNA levels was already manifested after 24 hrs, following the same 
trend seen with the proteins (Fig 2.4 D). COL1A2 mRNA levels were 
  
   
Figure 2.4 Effect of fibroblast-derived ECM on COL1A1 and COL1A2 mRNA levels. 
WI38, CT-1 and FGo fibroblasts were seeded in dishes with or without fibroblast-derived ECM 
for 24 hrs and then cultured for 48 hrs. Cells were washed with PBS and RNA was extracted 
using Trizol reagent according to the manufacturer’s instructions. Five micrograms of total 
RNA isolated from both control fibroblasts plated on plastic and fibroblasts plated on a matrix 
were used in cDNA synthesis and qRT-PCR was performed to evaluate COL1A1 and 
COL1A2 mRNA levels using GAPDH as a control as described in section 7.2.6. (A-C). The 
data is shown as mean ± S.D. of three independent experiments. The * indicates significant 
differences (p ≤ 0.05) compared to fibroblasts plated on plastic. (D) Time-dependent effect of 
the matrix on COL1A2 gene expression. CT-1 fibroblasts were treated as described above 
and incubated for the periods indicated for COLIA2 mRNA quantitation using qRT-PCR.  The 
data is shown as the mean ± S.D. of three independent experiments. The * indicates 
significant differences (p ≤ 0.05) compared to fibroblasts plated on plastic.  
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significantly down in fibroblasts plated on ECM, suggesting transcriptional 
regulation. 
 
2.2.5 Type I collagen mRNA stability  
The effect of the fibroblast-derived ECM on the stability of α1(1) and α2(1) 
collagen mRNA was determined by plating fibroblasts on either plastic or 
ECM as previously described. After 24 hrs, actinomycin D was added to a 
final concentration of 1mg/ml (Mimura et al, 2006; Sohara et al, 2002). At 
designated time points after addition of actinomycin D (6, 12, 18 hrs), α1(1) 
and α2(1) collagen mRNA levels were determined by qRT PCR using GAPDH 
as the normaliser. The COL1A1 and COL1A2 mRNA levels for control and 
those plated on a matrix were expressed relative to the value at time 0 hrs 
(before addition of actinomycin) which was designated the value 1. The 
results demonstrate similar decay curves for both α1(1) and α2(1) collagen 
mRNA in fibroblasts plated on plastic and on a matrix (Figure 2.5, 2.6). The 
matrix therefore does not affect the stability of α1(1) and α2(1) collagen 
mRNA in fibroblasts. 
 
2.2.6 Analysis of collagen degradation and matrix metalloproteinases 
The COL1A1 mRNA levels did not change in the presence of the matrix while 
the α1(1) protein chain was significantly downregulated. This implies that the 
fibroblast-derived ECM not only inhibited the synthesis of type I collagen but 
could also be associated with its degradation. The effect of the fibroblast-
derived ECM on the expression of major proteases of type I collagen was 
examined by quantitative real time RT PCR, immunoblot analysis and gelatin 
zymography.  To evaluate the potential contribution of MMP1 in the matrix-
mediated downregulation of type I collagen, real time RT PCR was used to 
determine the MMP 1 mRNA levels. The expression of MMP1 mRNA in the 
presence of the fibroblast-derived ECM did not show any significant difference 
as compared to that of controls, in any of the three cell lines (Fig 2.7). The 
promoter activity of MMP1 was also determined using the luciferase reporter 
gene in fibroblasts transfected with a construct containing the 4.3 kb MMP 1 
promoter region fused to the luciferase (LUC) reporter gene (Znoyko et al, 
2006). Similar to the mRNA levels, there were no significant differences in 
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promoter activity between fibroblasts plated on plastic and those grown on a 
matrix (Fig 2.8).  
 
A                                                                             B 
  
                                             C 
                                                                              
Figure 2.5 Effect of fibroblast-derived ECM on the stability of COL1A1 mRNA. WI38, CT-
1 and FGo fibroblasts (A-C) were seeded in dishes with or without fibroblast-derived ECM for 
24 hrs and then cultured for the periods indicated (6, 12, 18 hrs) after the addition of 
actinomycin D to a final concentration of 1mg/ml. Cells were washed with PBS and RNA was 
extracted using Trizol reagent as described in section 7.2.6.1. Five micrograms of total RNA 
was quantified by qRT-PCR using GAPDH as a control. The COL1A1 mRNA levels for control 
and those plated on a matrix were expressed relative to the value at time 0 hrs (before 
addition of actinomycin) which was designated the value 1. The data are shown as the mean 
± S.D. of three independent experiments.  
 
Collagen-degrading activity is considered to be one of the most important 
biological activities of MT1 MMP (Holmbeck et al, 1999). The effect of the 
fibroblast-derived ECM on the MT1 MMP protein levels was determined.  
As shown in Fig 2.9, there were no significant differences in the protein levels 
of MT1 MMP in fibroblasts plated on the matrix compared to controls. The 
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bands corresponding to the pro-MT1 MMP and the active MT1 MMP were 
constitutively present in absence and presence of the fibroblast-derived ECM.  
A                                                                             B 
  
                                             C 
                                         
Figure 2.6 Effect of fibroblast-derived ECM on the stability of COL1A2 mRNA.  
WI38, CT-1 and FGo fibroblasts (A-C) were seeded in dishes with or without fibroblast-
derived ECM for 24 hrs and then cultured for the periods indicated (6, 12, 18 hrs) after the 
addition of actinomycin D to a final concentration of 1mg/ml. Cells were washed with PBS and 
RNA was extracted using Trizol reagent as described in section 7.2.6.1. Five micrograms of 
total RNA was quantified by qRT-PCR using GAPDH as a control. The COL1A2 mRNA levels 
for control and those plated on a matrix were expressed relative to the value at time 0 hrs 
(before addition of actinomycin) which was designated the value 1. The data are shown as 
the mean ± S.D. of three independent experiments.  
 
 
The ¾ and ¼ fragments expected from type I collagen degradation by the 
collagenases were not observed on SDS-polyacrylamide gels implying that if 
any degradation is taking place then type I collagen was being degraded to 
smaller fragments by the combined action of collagenases and gelatinases. 
To evaluate the potential contribution of the gelatinases, MMP-2 and MMP-9, 
in the matrix-mediated downregulation of type I collagen, the MMP-2 and 
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MMP-9 mRNA levels were determined by real time RT PCR. The expression 
of MMP-2 and MMP-9 mRNAs in the presence of the fibroblast-derived ECM 
did not show any significant difference as compared to that of controls in any 
of the three cell lines (Fig 2.10).                                                              
          
Figure 2.7 Effect of fibroblast-derived ECM on MMP-1 mRNA levels. 
WI38, CT-1 and FGo fibroblasts were seeded in dishes with or without fibroblast-derived ECM 
for 24 hrs and then grown in DMEM media for 48 hrs. Cells were washed with PBS, RNA 
extracted using Trizol reagent and five micrograms of total RNA were used in cDNA synthesis 
for qRT-PCR to evaluate MMP-1 mRNA levels using GAPDH as a control. The data are 
shown as the mean ± S.D. of three independent experiments.  
       
       
Figure 2.8 Effect of fibroblast-derived ECM on MMP-1 promoter activity. 
WI38, CT-1 and FGo fibroblasts were transiently transfected with either empty vector or 4.3 
kb MMP-1 promoter construct linked to the luciferase reporter gene. Transfectin reagent was 
used in all transfection assays as described in section 7.2.8. Transfected fibroblasts were 
harvested by trypsinisation and equal numbers of fibroblasts (3 x 105) were seeded in 6-well 
plates with or without fibroblast-derived ECM for 48 hrs.  Cell extracts were obtained using 
passive lysis buffer and assayed for luciferase activity. Reporter activities are expressed as 
ratios of firefly luciferase to renilla luciferase. The fibroblast-derived ECM does not affect the 
promoter activity. The data is shown as mean ± S.D. of three independent experiments.  
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Figure 2.9 Effect of the fibroblast-derived ECM on MT1 MMP protein levels.  
WI38, CT-1 and FGo fibroblasts were seeded on dishes with or without fibroblast-derived 
ECM for 24 hrs and after changing media, were cultured for 48 hrs. Cell lysates (50 μg total 
protein) were separated by 7.5 % SDS PAGE and subjected to immunoblotting with mouse 
anti-MT1 MMP antibody (1:1000). The secondary antibody used was goat anti-mouse IgG 
conjugated to horse radish peroxidase (1:1000). Arrows show the two bands corresponding to 
pro- and active MT1 MMP respectively (p-MT1 MMP and MT1 MMP). β-tubulin was used as a 
loading control to confirm equal loading of samples 
 
A                                                         B 
         
                                      C 
                                              
Figure 2.10 Effect of fibroblast-derived ECM on MMP-2 and MMP-9 mRNA levels. 
WI38, CT-1 and FGo fibroblasts (A-C) were seeded in dishes with or without fibroblast-
derived ECM for 24 hrs and then grown in DMEM media for 48 hrs. Cells were washed with 
PBS and RNA was extracted and five micrograms of total RNA were used in cDNA synthesis 
and qRT-PCR was performed to evaluate MMP-2 and MMP-9 mRNA levels using GAPDH as 
a control. The data are shown as the mean ± S.D. of three independent experiments.  
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The levels of MMP mRNAs and overall MMPs protein abundance do not 
translate into active MMPs, therefore it is important to check the actual 
activities of the MMPs. The activities of the gelatinases, MMP-2 and MMP-9, 
were determined by gelatin zymography of the culture media. The fibroblast-
derived ECM did not significantly alter the activities of either MMP-2 or MMP-9 
after 24 hrs and 48 hrs of incubation (Fig 2.11). The minor differences in 
activities observed especially at 24 hrs might contribute to bring about the 
differences in type I collagen levels as observed in this study. There was a 
time-dependent activation of both latent pro-MMP-2 and pro-MMP-9 as the 
active enzymes are clearly visible. Active MMP-2 was visualised as a clear 
band at 67 kDa whilst active MMP-9 was also visible at around 88 kDa. The 
activity of MMP-9 was less prominent in all fibroblasts compared to the activity 
         
Figure 2.11 Effect of fibroblast-derived ECM on MMP-2 and MMP-9 activity.  
WI38, CT-1 and FGo fibroblasts were seeded in dishes with or without ECM for 24 hrs and 
then incubated in DMEM for 24 hrs (upper panel) or 48 hrs (lower panel) at 370C. Gelatin 
zymography was performed on the media samples as described in section 7.2.7. Media 
samples (50 μg total proteins) were subjected to electrophoresis on 10 % SDS 
polyacrylamide gels containing 1 mg/ml gelatin. After electrophoresis gels were washed in 
2.5 % Triton X-100 (to remove SDS), incubated in digestion buffer (50 mM Tris (pH 7.5), 5 
mM CaCl2, 1 μM ZnCl2, 0.2 M NaCl and 0.02 % Brij-35) for 18 hrs at 370C then stained with 
Coomassie Brilliant Blue R250. After destaining, the gelatinolytic activity was observed as 
clear bands in the gels. Bands corresponding to pro- and low molecular weight, active MMP-2 
and MMP-9 are clearly visible in the 48 hr samples (lower panel). Data are representative of 
three independent experiments.    
 
of MMP-2. Not all proteases were investigated and therefore other proteases 
may be responsible for the difference between mRNA and protein levels. An 
alternative explanation could be decreased translation of the COL1A1 mRNA 
in the presence of the fibroblast-derived ECM and the possible involvement of 
microRNAs.  
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2.2.7 Functional mapping of the matrix-responsive element (MRE) in the 
human COL1A2 promoter 
To determine whether the decrease in α2(1) mRNA levels in the presence of a 
matrix was due to an alteration in promoter activity, a series of 5’ deletion 
constructs of the human COL1A2 promoter, spanning from -2389 bp to +54bp 
relative to the transcription start site,  linked to the luciferase gene were used 
in mapping the promoter (Fig. 2.12). These COL1A2/luciferase reporter 
constructs were transiently transfected into WI38, CT-1 and FGo fibroblasts. 
Transfected fibroblasts were harvested by trypsinisation and equal numbers 
of fibroblasts (3 x 105) were seeded in 6-well plates with or without fibroblast-
derived ECM. Six hours after transfection the media was changed and 
incubation was continued for 48 hrs. The luciferase activities were then 
measured. The fibroblast-derived ECM down-regulated the promoter activity 
in constructs COL -2389/LUC, COL -721/LUC and COL-375/LUC, matrix vs 
control. The downregulation was similar for the above constructs, but no 
significant change in the activity of COL -107/LUC construct was observed, 
matrix vs control. These findings suggest that the fibroblast-derived ECM 
effect was mediated via a regulatory element(s) located between residues -
375 and -107 of the human COL1A2 promoter (Fig 2.12). Similar results were 
also obtained for WI38 and FGo fibroblasts. 
 
This region of the COL1A2 promoter contains the binding sites for many 
transcription factors, chief among them being Sp1/Sp3, AP1 and the Smads 
that are implicated in the regulation of type I collagen synthesis (Kubota et al, 
2003; Wang et al, 2005; Ghosh, 2002). Sp1 is implicated in both 
downregulation and upregulation of COL1A2 promoter activity depending on 
the other transcription factors it associates with. Sp1 has been found to be a 
repressor of COL1A2 promoter activity when it interacts with Fli-1 (Ramirez et 
al, 2006; Asano et al, 2009). The Fli-1 response element has been mapped 
between -353 and -186 bp of the COL1A2 promoter which contains Ets and 
Sp1/Sp3 binding sites (Czuwara-Ladykowska et al, 2001). Evidence from 
many studies implicates Sp1 and Sp3 along with other factors such as Fli-1 
and NF-1 in the control of type I collagen synthesis in normal fibroblasts as 
well (Asano et al, 2009; Ghosh, 2002; Czuwara-Ladykowska et al, 2001).   
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Figure 2.12 Promoter activity of the human proximal α2(1) procollagen promoters. CT-1 
fibroblasts were transiently transfected with either empty vector or 5’ deletion COL1A2 
constructs linked to the luciferase reporter gene as shown. Transfectin reagent was used in 
all transfection assays as described in section 7.2.8. Transfected fibroblasts were harvested 
by trypsinisation and equal numbers of fibroblasts (3 x 105) were seeded in 6-well plates with 
or without fibroblast-derived ECM. Six hours after transfection the media was changed and 
incubation was continued for 48 hrs. Reporter activities were expressed as ratios of firefly 
luciferase to renilla luciferase. The fibroblast-derived ECM decreased α2(1) promoter activity 
significantly via a DNA responsive element located between nucleotides -375 and -107. 
Similar results were obtained when WI38 and FG0 fibroblasts were used. The data are shown 
as the mean ± S.D. of three independent experiments. The * indicates significant differences 
(p ≤ 0.05) compared to fibroblasts plated on plastic (control).  
 
 
 
Further evidence that the matrix responsive element (MRE) could be located 
in the COL1A2 promoter, as suggested by both mRNA and promoter studies, 
comes from studies on SV-WI38 fibroblasts. SVWI38 cells synthesise type I 
collagen trimer comprising mainly α1(1) chains (Parker et al, 1989). When SV-
WI38 fibroblasts were grown on a pre-formed fibroblast-derived ECM, 
COL1A1 mRNA and protein levels in cellular lysates did not change 
compared to controls. This is contrary to what was observed in WI38, CT-1 
and FGo fibroblasts, where COL1A2 decreased significantly in the presence 
of the matrix.  
 
2.2.8 Effect of Sp1 on type I collagen gene expression 
Within the -375 to -107 region of the COL1A2 promoter are binding sites for 
many transcription factors including Sp1. To study the influence of Sp1 on 
matrix-mediated downregulation of type I collagen, a direct loss of function 
approach by silencing the endogenous Sp1 by RNAi was used (Lee et al, 
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2006; Tatenhorst et al, 2006). Since previous results for the three fibroblasts, 
WI38, CT-1 and FGo, were similar, only CT-1 were used in this and 
subsequent studies. Western blot analysis and real time PCR revealed that 
the siRNA duplex targeted to nucleotides of the human Sp1 gene led to 
marked reduction in the amount of endogenous Sp1 in CT-1 fibroblasts 
(Figure 2.13 A, B). The highest reduction of Sp1 was observed within 24 
hours, so experiments addressing type I collagen gene expression using 
siRNA-transfected fibroblasts were performed using the 24 hour period. Since 
Sp1 siRNA successfully downregulated Sp1 mRNA and protein levels (in both 
cellular and nuclear proteins) in fibroblasts, it was used in experiments to 
examine whether this downregulation affected type I collagen gene 
expression.  
A                                                                  B 
 
Figure 2.13 Effect of Sp1 small interfering RNA (siRNA) on Sp1 gene expression in 
fibroblasts. CT-1 fibroblasts were seeded on dishes with or without fibroblast-derived ECM 
for 24 hrs and then transfected with siRNA targeting endogenous human Sp1. An irrelevant 
siRNA molecule of similar size was used as a negative control in experiments where indicated. 
Incubation was continued for 24 hrs. (A) Cells were washed with PBS, RNA extracted using 
Trizol reagent and five micrograms of total RNA were used in cDNA synthesis. Quantitative 
RT-PCR was performed to evaluate Sp1 mRNA levels using GAPDH as a control. The data 
are shown as the mean ± S.D. of three independent experiments (*p ≤ 0.05). (B) Cell lysates 
(50 μg total proteins) were separated by 7.5 % SDS polyacrylamide gel electrophoresis and 
subjected to immunoblotting with anti-Sp1 antibody. β-tubulin was used as a loading control to 
confirm equal loading of samples. 
 
 
As shown in Figure 2.14 and Figure 2.15, transfection with siRNA duplex 
targeting Sp1, reversed the effect of the matrix on type I collagen protein and 
mRNA levels. The negative control siRNA when used in the presence of the 
matrix had no effect. Thus siRNA technology, provided evidence that Sp1, 
possibly in combination with other transcription factors, is involved in the 
matrix-mediated downregulation of the COL1A2 gene. 
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Figure 2.14 Effect of Sp1 small interfering RNA (siRNA) on type I collagen protein 
levels. CT-1 fibroblasts were seeded on dishes with or without fibroblast-derived ECM for 24 
hrs and then transfected with siRNA targeting endogenous human Sp1. An irrelevant siRNA 
molecule of similar size was used as a negative control in experiments where indicated. 
Incubation was continued for 24 hrs. Cell lysates (50 μg total protein) were separated by 
7.5 % SDS polyacrylamide gel electrophoresis and subjected to immunoblotting with goat 
anti-type I collagen antibody (1:1000). The secondary antibody used was donkey anti-goat 
IgG conjugated to horse radish peroxidase (1:1000). Arrows indicate the two pro-α chains. β-
tubulin was used as a loading control to confirm equal loading of samples.  
 
              
Figure 2.15 Effect of Sp1 small interfering RNA (siRNA) on COL1A2 mRNA levels in 
fibroblasts. CT-1 fibroblasts were seeded on dishes with or without fibroblast-derived ECM 
for 24 hrs and then transfected with siRNA targeting endogenous human Sp1. An irrelevant 
siRNA molecule of similar size was used as a negative control in experiments where indicated. 
Incubation was continued for 24 hrs. Cells were washed with PBS, RNA extracted using Trizol 
reagent and five micrograms of total RNA were used in cDNA synthesis. Quantitative RT-
PCR was performed to evaluate COL1A2 mRNA levels using GAPDH as a control. The data 
are shown as the mean ± S.D. of three independent experiments. The * indicates significant 
differences (p ≤ 0.05) compared to fibroblasts plated on plastic.  
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2.2.9 DISCUSSION 
Traditionally the extracellular matrix is viewed as a relatively stable structural 
substrate for cells, but recent work has shown that it plays a prominent role in 
providing information to specific receptors on the cell surface and determine 
how they interpret biochemical data from their surrounding stroma (Stefanovic, 
2005; Mauch and Kreig, 1990; Ramirez and Rifkin, 2003). The matrix contains 
specific receptor binding ligands and also conveys mechanical information to 
cells. It is now clear that cell-matrix interactions induce biological responses 
that are similar to those induced by growth factors, hormones and cytokines 
through specific receptors. In order to accurately determine how the 
properties of the matrix influence cellular behaviour, it is very important to be 
able to prepare experimental model systems that allow reliable reproduction 
of the in vivo matrix. Purified individual components of the ECM such as type I 
collagen, fibronectin and laminin have been used in previous studies and are 
all intended to mimic the ECM microenvironment, but the usefulness of these 
models is unknown. Under in vivo conditions, the ECM components are 
synthesised in a specific ratio to each other and mixing of these components 
in vitro will not truly represent the in vivo conditions under which cells 
synthesise and assemble the extracellular matrix. Accordingly, a natural 
fibroblast-derived ECM was used in this study in an attempt to closely 
simulate the in vivo environment.  
 
This study showed downregulation of type I collagen gene expression when 
fibroblasts are plated on this fibroblast-derived ECM. The matrix-mediated 
downregulation of type I collagen synthesis resides mainly at the 
transcriptional level for the COL1A2 gene. There was no change in COL1A1 
mRNA levels when the fibroblasts were plated on the matrix but there was 
significant downregulation of COL1A2 mRNA levels. There is compelling 
evidence that the steady-state levels of many proteins is regulated at multiple 
steps. When there is a large change in the amount of either mRNA or protein, 
it is likely that multiple steps in the metabolism of the mRNA and protein have 
been altered (Stefanovic, 2005; Lindquist et al, 2000). The steady-state level 
of the mRNA encoding the specific protein is determined not only by the rate 
of transcription, but also by the half-life of the mRNA in the cytoplasm. 
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Collagen mRNAs belong to the long-lived mRNAs and its stability depends on 
the culture conditions (Stefanovic, 2005). It has been reported that fibroblasts 
grown within Matrigel downregulate collagen α1(1) mRNA steady state levels 
by destabilising the mRNA (Eckes et al, 1993, 1999, 2000; Mauch and Kreig, 
1990; Stefanovic et al, 1997). Therefore in this study, the stability of the α1(1) 
and α2(1) mRNAs were determined using Actinomycin D. There was no 
significant difference in the stability of both α1(1) and α2(1) collagen mRNA.. 
The next control step could be at the level of translation. Substantial evidence 
has accumulated in recent years showing that type I collagen synthesis is 
regulated at a post transcriptional level in various cell types (Eckes et al, 1993, 
1999; Focht and Adams, 1984; Mauch and Kreig, 1990; Sato, 1995, 2000; 
Stefanovic, 1997, 1999, 2000, 2005). The possible degradation of type I 
collagen was therefore examined.  
 
A correlation between the secretion of MMPs and TIMPs and collagen levels 
has been reported (Laliberte et al, 2001). We therefore analysed cell lysates 
and the media for MMPs, specifically MMP1, MT1 MMP, MMP 2 and MMP 9. 
Since MMP1 is one of the major type I collagenases its mRNA and promoter 
activity were determined. There were no significant differences in both MMP1 
mRNA levels and promoter activities or MT1 MMP protein levels in the 
presence and absence of the fibroblast-derived ECM. There were no 
significant differences as well in MMP 2 and MMP 9 mRNAs levels and 
activities. It is likely that the fibroblast-derived ECM might affect other stages 
of collagen synthesis such as mRNA translation. It is also possible that a new 
area of regulation of type I collagen involving microRNAs is involved. Vast 
amount of information on the involvement of microRNAs in the regulation of 
other genes is available but no such information is available on the type I 
collagen gene. The substrate upon which cultured fibroblasts are maintained 
has been shown to be capable of phenotypic modification of cells (Vlodasky et 
al, 1980; Gospodarowcz et al, 1978). In our study there appear to be slight 
morphological differences between fibroblasts plated on plastic and ECM. 
Fibroblasts cultured within the fibroblast-derived ECM had a slightly elongated, 
spindle shaped morphology. The mechanism underlying this difference in 
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morphology remains to be clarified although it is possible that a loss of polarity 
may contribute to this effect (Beningo et al., 2004) 
 
Deletion analysis showed that a 268-bp DNA element (-375/-107) in the 
human COL1A2 gene contains the matrix-responsive element (MRE) that 
mediates the matrix-downregulation of type I collagen synthesis. This region 
contains the binding sites for many transcription factors that affect type I 
collagen synthesis, with Sp1/Sp3, Ets1, the Smads and AP1 being well-known 
examples (Wang et al, 2005; Ghosh, 2002). These transcription factors 
interact with several co-factors and /or other promoter-bound complexes (Ihn 
et al, 1996; Sengupta et al, 2002). Wan et al (2001) reported that the 
expression of several transcription factors including Fli1, Sp1, c-jun and c-fos 
is required to activate or deactivate the transcription of many other genes. The 
COL1A2 proximal promoter is under the control of several clusters of cis-
acting elements, which bind positively and negatively trans-acting factors 
(Ramirez et al, 2006). These proteins exert their different effects on 
transcription by binding to their respective sites and through interactions with 
other components of the promoter-bound protein complexes (Czuwara-
Ladykowska et al, 2001). These combinatorial interactions amongst positive 
and negative nuclear factors determine the end point activity of the COL1A2 
promoter under different cellular and experimental conditions. The present 
findings indicating Sp1-mediated downregulation of COL1A2 expression in 
fibroblasts extend the scope of functional Sp1 activity in fibroblast growth and 
differentiation. siRNA to Sp1 was used in this study and provided evidence 
that Sp1 has a negative regulatory role on type I collagen gene expression in 
fibroblasts in the presence of fibroblast-derived ECM. It has been shown 
before that Sp1 activates or represses different promoters depending on the 
other transcription factors it binds to or form complexes with (Santiago and 
Khachigian, 2004). Further investigation is needed to clarify the transcriptional 
machinery and to verify whether other transcription factors, such as Fli1, are 
also involved. These in vitro studies provide key insights into the role of Sp1 
activity in COL1A2 transcription and could be studied further through whole 
animal analyses in transgenic mice bearing COL1A2 promoter mutations in 
the Sp1 elements.  
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 Collagen remodelling by fibroblasts appear to have a critical effect on healing 
and in invasion and metastasis, thus gaining more information on how 
fibroblasts respond to its ECM is important. This study has shown that the 
gene expression of ECM proteins and type I collagen in particular can all be 
regulated by the environment with which cells interact. We propose that ECM-
dependent regulation of proteins is part of a general mechanism whereby 
cells react to different substrata and establish necessary cell-matrix 
interactions essential for survival and differentiation. An improved 
understanding of the signaling pathways involved in cellular remodelling of 
collagen would be beneficial in understanding collagen diseases and many 
pathological conditions such as cancer cell invasion and metastasis. In 
conclusion, the present study has demonstrated that the proximal region of 
the COL1A2 gene promoter mediates the matrix–mediated downregulation of 
the human COL1A2 gene in fibroblasts. The present study offer the possibility 
of manipulating transcription factors as potential chemotherapeutic tools for 
modulating type I collagen in conditions such as fibrosis and in wound healing.  
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CHAPTER 3 
 
SIGNALING PATHWAYS IN THE MATRIX-MEDIATED 
DOWNREGULATION OF TYPE I COLLAGEN SYNTHESIS 
 
3.1 INTRODUCTION 
The response of cells to extracellular stimuli is mediated by a number of 
intracellular kinases and phosphatases enzymes. The mitogen-activated 
protein kinases (MAPKs) for example are members of discrete signaling 
cascades that are focal pathways for diverse extracellular stimuli and regulate 
fundamental cellular processes. Most of these signaling cascades are 
activated through attachment of cells to the ECM via receptors such as the 
integrins. Integrin-mediated attachment to the ECM can activate several 
signaling pathways including focal adhesion kinase (FAK), PI3-kinase, 
MAPKs p38, JNK and the MEK-ERK pathways (Figure 3.1) (Giancotti and 
Ruoslahti, 1999; Ge et al, 2007; Chetoui et al, 2005; Ihn et al, 1996; Roux and 
Blenis, 2004; Pearson et al, 2001).  
 
Figure 3.1 The various cellular signaling pathways found in fibroblasts. Most of these 
signaling cascades are activated by external stimuli via receptors such as the 
integrins. Integrin-mediated attachment to the ECM can activate several signaling 
pathways including focal adhesion kinase (FAK), PI3-kinase, MAPKs p38, JNK and the 
MEK-ERK pathways (Tsukada et al, 2006). 
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A number of observations strongly suggest that the activation of FAK by 
integrins plays a central role in initiating many of the signals that regulate 
growth of cells (Boudreau and Jones, 1999). Activation of the PI3-kinase 
pathway is mainly involved in cell survival whilst activation of the MAPKs by 
integrins provides a pathway to cell survival and to transcription of genes 
involved in cell growth and differentiation (Chetoui et al, 2005). p38 MAPK is 
generally activated in response to growth factors, cell stress and injury (Howe 
et al, 1998, 2002) whilst JNK is a well known positive regulator of cellular 
proliferation in fibroblasts. JNK activity is regulated by two upstream signaling 
kinases MKK4 and MKK7. The mechanistic basis for the integrin-mediated 
activation of the MAPKs is somewhat controversial and has not yet been fully 
elucidated. Both Ras-dependent (Lee and Juliano, 2004) and Ras-
independent (Chen et al, 1996; Howe et al, 1998) mechanisms have been 
described. Another unresolved issue regarding integrin-mediated signaling is 
whether integrins themselves actually initiate the signaling or whether they 
simply modulate or enhance signals generated by soluble mediators such as 
growth factors (Boudreau and Jones, 1999, Chen et al, 1996).  
 
The MEK-ERK signaling pathway is one of the principal cytoplasmic signal 
transduction systems governing eukaryotic cellular proliferation, differentiation 
and survival (Bobick and Kulyk, 2006; Chang et al, 2003; Johnson et al, 1988). 
The pathway consists of three serially phosphorylating protein kinases, Raf, 
MEK and ERK. This basic triple kinase cascade functions downstream of a 
diverse array of membrane receptors such as receptor tyrosine kinases 
(Schlessinger, 1994; Schlessinger and Bar-Sagi, 1995), G-protein coupled 
seven transmembrane receptors (Naor et al, 1997, 2008), integrins (Giancotti 
and Ruoslahti, 1999) and ion channels (Rane, 1999). Depending on the 
extracellular activating stimuli, the MEK-ERK pathway is triggered by a set of 
adaptor proteins. These adaptor proteins link the receptor to GDP/GTP 
exchange factors which subsequently activate small GTP-binding proteins 
such as Ras, Rap1 and Rac.  
 
Ras is a membrane-bound GDP/GTP-binding protein that serves as a 
‘molecular switch’ converting signals from the cell membrane to the nucleus. 
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The Ras family includes several distinct members such as H-Ras, K-Ras, M-
Ras and N-Ras. The recruitment and involvement of Ras in the activation of 
the MEK-ERK pathway has been supported by many studies through the use 
of N17Ras, a dominant negative mutant used to block activation of MAPK 
(Stewart and Guam, 2000; Clark et al, 2000). Activation of Ras is followed by 
the sequential activation of Raf-1, MEK 1,2 and ERK 1,2 in the MEK-ERK 
pathway (Pinzani et al, 1998). Other studies indicate the existence of a Ras-
independent component of integrin-mediated MAPK activation (Katsumi et al, 
2004; Chen et al, 1996). Some of the observed differences may be due to the 
existence of several overlapping signaling pathways, with one pathway or 
another predominating in a particular cell type or experimental situation. 
Furthermore, activation of Raf-1 has been shown to regulate integrin-
mediated ERK activation through MEK 1 (Barberis et al, 2000). Most of these 
studies have been done with plastic tissue culture dishes or using ECM 
components such as fibronectin and laminin.  
 
The GTP binding proteins activate the Raf family of serine threonine kinases 
upstream of the triple kinase phospho-relay unit of the cascade (Bobick and 
Kulyk, 2006; Lewis et al, 1998).The phosphorylated ERK 1,2 subsequently 
translocate into the nucleus (Ge et al, 2007). Once in the nucleus, the kinases 
phosphorylate and activate several transcription factors including Elk-1and the 
fos proteins, resulting in various cellular responses including differentiation 
and regulation of specific metabolic pathways. In this study, a fibroblast-
derived ECM was used in tissue culture to dissect the signaling pathway 
associated with the matrix-mediated downregulation of type I collagen gene 
expression using specific pathway inhibitors. Finally, to confirm the effects of 
the MEK-ERK signaling pathway and its associated upstream proteins on type 
I collagen gene expression, cultures of fibroblasts were transfected with the 
dominant negative MEK1 and N17Ras expression plasmids. 
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3.2 RESULTS 
3.2.1 Analysis of the MEK-ERK signaling pathway in type I collagen gene 
regulation 
The MAPK pathway is one of the major routes for signal transduction via 
integrins and it has been reported to be activated by plating cells on artificial 
matrices such as type I collagen (Wozniak et al, 2003, 2004). To determine 
the signalling pathway involved in the matrix-mediated downregulation of type 
I collagen gene expression, type I collagen levels were determined in cell 
lysates and the media, 24 hrs after adding the specific kinase inhibitors to 
fibroblasts seeded in dishes with or without the matrix. A dose dependent 
study was done to determine the concentration of U0126 and PD98059 
required for MEK inhibition in the cell types used in the study. The levels of 
phosphorylated ERK 1,2 increased in cells grown on the fibroblast-derived 
ECM while type I collagen levels decreased significantly (Figure 3.2 A-B and 
Figure 3.3 A-B). In the presence of the MEK inhibitors, fibroblasts plated on 
matrix produced the same amount of type I collagen and mRNA as the control 
cells plated on plastic (Fig. 3.2 B-D; Fig. 3.3 B-D). U0126 and PD98059 were 
both able to reverse the matrix-mediated downregulation of type 1 collagen 
synthesis thus implicating the MEK-ERK signalling pathway in the matrix-
mediated downregulation of type I collagen synthesis. This inhibition was not 
due to a reduction in cell growth or viability as the cell proliferation data 
showed that there is no significant difference between control fibroblasts and 
fibroblasts plated on a matrix (data not shown). The effects of U0126 and 
PD98059 on type I collagen synthesis and ERK 1,2 phosphorylation were 
identical and since PD98059 blocks only Raf-dependent phosphorylation/ 
activation of MEK1, it can safely be assumed that Raf-1 is involved as the 
upstream activator of MEK.  
 
3.2.2 Analysis of the p38 MAPK, JNK and the PI3-kinase pathways 
The JNK group of protein kinases are activated in response to a number of 
cellular stresses, including high osmolarity and oxidation (Ip and Davis, 1998; 
Kato et al, 2008). The p38 group kinases have been found to be involved in 
inflammation, cell growth, cell differentiation, the cell cycle, and cell death. It is 
clear, then, that the JNK protein kinases and p38 pathways share many 
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A. Phosphorylated ERK1,2  
                        
B. Intracellular type I collagen 
                       
C. Media type I collagen 
                                                 
D. COL1A2 mRNA  
                                   
Fig 3.2 Effect of U0126 on matrix-mediated downregulation of type I collagen synthesis. 
The effect of the specific MEK 1,2 inhibitor, U0126, on type 1 procollagen gene expression 
was investigated as described in ‘Materials and Methods’. (A) CT-1 fibroblasts were seeded 
on dishes with or without fibroblast-derived ECM and then treated with the indicated 
concentrations of U0126 or 0.1% DMSO (as the solvent control) for 24 hrs. Cell lysates (50 
μg total protein) were separated by 10 % SDS polyacrylamide gel electrophoresis and 
subjected to immunoblotting with anti-p-ERK 1,2 antibody (1:500). The level of beta tubulin in 
the same sample was used as control. (B) CT-1 fibroblasts were treated as described above 
and cell lysates (50 μg total protein) were separated by 7.5 % SDS polyacrylamide gel 
electrophoresis and subjected to immunoblotting to evaluate type 1 procollagen protein levels 
as described in section 7.3.2. (C) Dose-dependent effect of U0126 on secreted type I 
collagen levels in the media.  CT-1 fibroblasts were treated as described above, the medium 
was harvested and secreted type I collagen was determined as described in section 7.3.1. 
The media used in the quantification of type I collagen was based on equal cell numbers (2 x 
106).  (D) Dose-dependent effect of U0126 on COL1A2 mRNA levels. Fibroblasts were 
treated as described above, RNA was extracted using Trizol reagent and five micrograms 
were used for cDNA synthesis. Quantitative real time RT PCR was performed to quantitate 
COL1A2 mRNA levels. The levels of GAPDH in the same sample were used as the 
normaliser.  The * indicates significant differences (p ≤ 0.05) compared to fibroblasts plated 
on plastic.  
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A. Phosphorylated ERK1,2  
                  
B. Intracellular type I collagen 
                       
C. Media type I collagen 
                        
D. COL1A2 mRNA 
                                               
Fig 3.3 Effect of PD98059 on matrix-mediated downregulation of type I collagen 
synthesis. The effect of the specific MEK 1,2 inhibitor PD98059 on type 1 procollagen gene 
expression was investigated as described in ‘Materials and Methods’.  (A) Dose-dependent 
effect of PD98059 on ERK 1,2 phosphorylation.  CT-1 fibroblasts were seeded on dishes with 
or without fibroblast-derived ECM for 24 hrs and then treated with the indicated 
concentrations of PD98059 or 0.1% DMSO (as a solvent control) for 24 hrs. Cell lysates (50 
μg total protein) were separated by 10 % SDS polyacrylamide gel electrophoresis and 
subjected to immunoblotting with anti-p-ERK 1,2 antibody. The level of β tubulin in the same 
sample was used as control. (B) Fibroblasts were treated as described above and 
immunoblotting was performed to evaluate type 1 procollagen protein levels in the cell lysates 
(section 7.3.2). The levels of β tubulin in the same sample were used as controls. (C) Dose-
dependent effect of PD98059 on secreted type I collagen levels in the media.  Fibroblasts 
were treated as described above and the medium was harvested. Secreted type I collagen 
was determined as described in section 7.3.1. The media used in the quantification of type I 
collagen was based on equal cell numbers (2 x 106).  (D) Dose-dependent effect of PD98059 
on COL1A2 mRNA levels. Fibroblasts were treated as described above, RNA was extracted 
five micrograms were used in qRT PCR to quantitate COL1A2 mRNA levels. The levels of 
GAPDH in the same sample were used as the normaliser. The * indicates significant 
differences (p ≤ 0.05) compared to fibroblasts plated on plastic.  
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similarities with the other MAP kinase cascades. The possible involvement of 
the p38 MAPK, JNK and PI3-kinase pathways in the matrix-mediated 
downregulation of type I collagen gene expression was investigated using 
their respective inhibitors, SB203580, SP600125 and wortmanin. As shown 
below in Figure 3.4 A-F, none of these inhibitors reversed the effect of the 
A     Intracellular type I collagen                  D            COL1A2 mRNA  
      
B                                                                    E 
           
C                                                                    F 
           
Fig 3.4 Analysis of the p38 MAPK, JNK and PI3-kinase pathways on matrix-mediated 
downregulation of type I collagen gene expression.  
The effect of p38 MAPK inhibitor, SB203580, JNK inhibitor, SP600125 and PI3-K inhibitor, 
wortmanin, on type 1 procollagen gene expression was investigated as described in ‘Material 
and Methods’. CT-1 fibroblasts were seeded on dishes with or without fibroblast-derived ECM 
and then treated with the indicated concentrations of SB203580 (A), SP600125 (B) and 
wortmanin (C) or 0.1% DMSO (as a solvent control) for 24 hrs. Cell lysates (50 μg total 
protein) were separated by 10 % SDS polyacrylamide gel electrophoresis and immunoblotting 
was performed to evaluate type 1 procollagen protein levels using β tubulin as a control. 
Dose-dependent effect of SB203580, SP600125 and wortmanin on type I collagen COL1A2 
mRNA levels. CT-1 fibroblasts were treated with SB203580 (D), SP600125 (E) and 
wortmanin (F) as described above, RNA was extracted using Trizol reagent and five 
micrograms were used for cDNA synthesis. Quantitative real time RT PCR was performed to 
quantitate COL1A2 mRNA levels, using GAPDH as the normaliser.  The * indicates significant 
differences (p ≤ 0.05) compared to fibroblasts plated on plastic.  
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ECM on type I collagen protein and mRNA levels as observed with the MEK-
ERK inhibitors.  
 
3.2.3 Confirmation of the involvement of the MEK-ERK signaling 
pathway in matrix-mediated downregulation of type I collagen synthesis 
To substantiate the results obtained with PD98059 and U0126, fibroblasts 
were transiently transfected with a dominant negative (dn) MEK 1 construct. 
The dominant negative MEK1 contains serine to alanine substitutions at 
Ser218 and Ser222 . Because these serine phosphorylation sites are required 
for activation of MEK1, alanine substitution prevents activation. Preliminary 
experiments showed that 2μg dn MEK was sufficient to reduce the 
phosphorylation of ERK 1,2 significantly (Figure 3.5 A). Transient transfection 
studies confirmed that the MEK-ERK signaling pathway is involved in the 
matrix-mediated downregulation of collagen gene expression. Analysis of type 
I collagen and COL1A2 mRNA show that transfection with dn MEK reversed 
the matrix-mediated downregulation of collagen synthesis (Fig 3.5 B-C).  
 
3.2.4 Analysis of COL1A2 promoter activity 
To investigate the role of the MEK-ERK signaling pathway in the 
transcriptional regulation of type I collagen gene expression, the COL1A2 
promoter activity was determined in fibroblasts treated with U0126 and 
PD98059. Dose dependent studies established that 400 nM of each inhibitor 
was enough to reduce ERK 1,2 phosphorylation significantly hence this 
concentration was used to study the effect of the fibroblast-derived ECM on 
COL1A2 promoter activity. The MEK-ERK inhibitors, U0126 and PD98059, 
and the dn MEK reversed the matrix-mediated inhibition of COL1A2 promoter 
activity (Fig 3.6 A-C), thus confirming the MEK-ERK pathway as the signal 
transducer.   
 
3.2.5 The activation of the MEK-ERK signaling pathway is Ras-
dependent 
To investigate whether the matrix-mediated downregulation of COL1A2 
through the MEK-ERK signaling pathway is dependent on Ras activation, a 
dominant negative mutant Ras, N17Ras, was used in transient transfection 
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assays. N17Ras is a GDP-bound negative mutant, used to analyse Ras 
dependent activation in many systems. The N17Ras binds GDP with 
preferential affinity over GTP, thus allowing N17Ras to inhibit endogenous 
Ras activation. Transfection of cells with N17Ras inhibited ERK 1,2 
phosphorylation (Fig 3.7 A) and reversed the matrix-mediated inhibition of 
type I collagen and mRNA synthesis and promoter activity (Fig 3.7 A-C). Thus 
the matrix-mediated downregulation of type I collagen production through the 
MEK-ERK signaling pathway is Ras dependent.  
A 
            
B 
              
C 
                 
Fig 3.5 Effect of a dominant negative MEK 1 mutant on matrix-mediated 
downregulation of type I collagen synthesis. (A) CT-1 fibroblasts, transfected with 2 μg of 
the dn MEK or the empty vector, were trypsinised and seeded on dishes with or without 
fibroblast-derived ECM for 24 hrs. and immunoblotting was performed as described in section 
7.3.2 to quantitate phosphorylated ERK 1,2 levels in cell lysates. The levels of β tubulin in the 
same sample were used as controls. (B) CT-1 fibroblasts were treated as described above 
and immunoblotting was performed to evaluate type 1 procollagen protein levels in cell 
lysates. The levels of β tubulin in the same sample were used as controls. (C) Effect of dn 
MEK1 on COL1A2 mRNA levels. CT-1 fibroblasts were treated as described in section 7.2.6, 
RNA was extracted using Trizol reagent and five micrograms were used for cDNA synthesis. 
Quantitative real time RT PCR was performed to quantitate COL1A2 mRNA levels using 
GAPDH as the normaliser. The * indicates significant differences (p ≤ 0.05) compared to 
fibroblasts plated on plastic.  
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A. U0126 
                  
B. PD98059 
                            
C. dn MEK 
                
Fig 3.6 Effect of U0126, PD98059 and dn MEK on -375 COL1A2 promoter activity. 
 (A) Effect of U0126 on type I collagen promoter activity. Fibroblasts (3 x 105) were 
transfected with 2 μg of the -375 COL1A2/LUC construct, seeded in dishes with or without 
fibroblast-derived ECM for 24 hrs and then treated with 400 nM of U0126 or 0.1 % DMSO (as 
the solvent control). Cell extracts were obtained using passive lysis buffer and were assayed 
for luciferase activity. (B) Effect of PD98059 on type I collagen promoter activity. Fibroblasts 
(3 x 105) were transfected with 2 μg of the -375 COL1A2/LUC construct, seeded in dishes 
with or without fibroblast-derived ECM for 24 hrs, and then treated with 400 nM of PD98059 
or 0.1 % DMSO (as a solvent control). Cell extracts were assayed for luciferase activity. (C) 
Effect of dn MEK 1 on type I collagen promoter activity. Fibroblasts (3 x 105) were co-
transfected with 2 μg of the -375 COL1A2/LUC construct and 2 μg of the dn MEK and seeded 
in dishes with or without fibroblast-derived ECM. Control fibroblasts were transfected with the 
empty vector. Cell extracts were obtained using passive lysis buffer and assayed for 
luciferase activity. Data are presented as the mean ± standard error (* p< 0.05), matrix vs 
control. 
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 A. Phosphorylated ERK 1,2  
 
            
 
B. Cellular type I collagen synthesis 
 
                
 
C. COL1A2 mRNA levels                           D. COL1A2 promoter activity 
         
Fig 3.7 Investigation of Ras in the activation of MEK-ERK signaling pathway.  
The effect of dominant negative mutant Ras (N17Ras) on ERK 1,2 phosphorylation and type 
1 procollagen gene expression was investigated as described in ‘Materials and Methods’. (A) 
CT-1 fibroblasts were transfected with 2 μg of N17Ras or the empty vector. Transfected 
fibroblasts were trypsinised and seeded on dishes with or without fibroblast-derived ECM for 
24 hrs. Cell lysates (50 μg total protein) were separated by 10 % SDS polyacrylamide gel 
electrophoresis and immunoblotting was performed to evaluate ERK 1,2 phosphorylation 
using β tubulin as a control. (B) Effect of N17Ras on type I collagen synthesis. Cell lysates 
(50 μg total protein) were treated as described above and subjected to immunoblotting with 
anti-type I collagen antibody. (C) Effect of N17Ras on COL1A2 mRNA levels. CT-1 fibroblasts 
were treated as described in section 7.2.6, RNA was extracted using Trizol reagent and five 
micrograms were used for cDNA synthesis. Quantitative real time RT PCR was performed to 
quantitate COL1A2 mRNA levels using GAPDH as the normaliser. (D) Effect of N17Ras on 
type I collagen promoter activity. CT-1 fibroblasts (3 x 105) were co-transfected with 2 μg of 
the-375 COL1A2/LUC construct and 2 μg of N17Ras and seeded in dishes with or without 
fibroblast-derived ECM for 24 hrs. Cell lysates were obtained using passive lysis buffer and 
assayed for luciferase activity. Data are presented as the mean ± standard error (* p< 0.05), 
matrix vs control.  
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3.2.6 DISCUSSION 
The elucidation of the regulation of type I collagen gene expression is critical 
in understanding of pathophysiology of fibroproliferative disorders, wound 
healing, tissue remodelling and metastasis. The accumulation of ECM in 
general and type I collagen in particular is the chief pathologic feature of many 
fibrotic disorders (Border and Noble, 1994; Yamane et al, 2002, 2007). There 
is clear evidence that the activation of many signaling pathways including 
PI3K and MAPKs, may be involved in the regulation of type I collagen gene 
expression (Stefanovic, 2005; Mimura et al, 2006). Transmission of 
extracellular signals from the cell surface into the nucleus may involve 
activation of the mitogen-activated protein kinase (MAPK) signaling cascades 
via the ERK, JNK and/or the p38 pathways (Ge et al, 2007).  Mammalian cells 
contain several extracellular signal-regulated kinases including ERK 1 and 
ERK 2. These kinases regulate cell processes stimulated by various 
extracellular agents and have been implicated in control of nuclear 
transcriptional activity (Treisman, 1994). The results shown in chapter 2 
showed that the response of fibroblasts cultured on a fibroblast-derived ECM 
results in downregulation of type I collagen gene expression. The signaling 
events associated with this interaction are still unknown, understandably so, 
since the use of the fibroblast-derived ECM is not well studied.  
 
The MEK-ERK signaling pathway is activated in response to a variety of 
external stimuli, including growth factors, cytokines and environmental stress 
(Mimura et al, 2006; Yamane et al, 2007). Using several different approaches, 
this study showed that MEK-ERK signaling is required for matrix-mediated 
downregulation of type I collagen gene expression. The involvement of Raf 
was proved by the results obtained with the MEK inhibitor PD98059 since it 
blocks only Raf-dependent phosphorylation/ activation of MEK1 and is not an 
effective inhibitor of MEK2 activation (Dudley et al, 1995). However U0126 is 
a more potent inhibitor of both MEK1 and MEK2, regardless of activation state, 
and it is for these reasons that studies were done with both inhibitors. In 
addition, PD98059 do not inhibit already activated MEK1 or MEK2, so the use 
of the two inhibitors would allow us to correctly conclude if the MEK-ERK 
pathway and Raf are involved in the matrix-mediated downregulation of type I 
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collagen gene expression. Treatment with these two inhibitors was associated 
with a similar inhibition of the matrix-mediated downregulation of type I 
collagen gene expression. To confirm that matrix-mediated downregulation of 
type I collagen gene expression occurs through the MEK-ERK signaling 
pathway, the dominant negative mutant MEK1 construct was used and it 
reversed the matrix-mediated downregulation of type I collagen gene 
expression. The p38 MAPK, PI3K and JNK pathways are not involved in the 
matrix-mediated downregulation of type I collagen gene expression. Inhibitors 
of these signaling pathways are well characterised and available 
commercially. These results suggest that the MEK-ERK pathway is critical in 
the regulation of type I collagen by the matrix in fibroblasts.  
 
The MEK-ERK signaling pathway has been reported to play a role in 
modulating the transcription of many genes. The MEK-ERK signaling pathway 
is involved in EGF-mediated downregulation of type I collagen gene 
expression in fibroblasts (Mimura et al, 2006) possibly via transcription 
factors, such as c-fos, c-jun, Elk-1, Sp1/Sp3 and Ets-1 (Stewart and Guan, 
1999; Leaner et al, 2005; Chetoui et al, 2005). This study confirmed that the 
MEK-ERK signaling pathway affects cellular gene expression via the Sp1 
transcription factor. The expression of Ras negatively regulates c-fos and Egr-
1 gene induction in many cell types including lymphocytes (Chen et al, 1996) 
and the activation of ERK is essential for numerous Ras-induced cellular 
responses including transcription activation of immediate early genes such as 
c-fos (Treisman, 1994; Hill and Treisman, 1995). Based on these reports, one 
can speculate the possible involvement of transcription factors such as c-fos 
in the matrix-mediated downregulation of type I collagen gene expression. 
Moreover, this study indicate that the MEK-ERK signaling pathway is involved 
in the modulation of type I collagen and supports the hypothesis that the 
inhibition or activation of the MEK-ERK signaling pathway may have 
therapeutic value. 
 
Growing evidence indicates that external stimuli can activate the MEK-ERK 
signaling pathway through both Ras-dependent and independent pathways 
(Katsumi et al, 2004; Chen et al, 1996; Howe et al, 1998; Lee and Juliano, 
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2004). Experiments using Ras mutants have been instrumental in elucidating 
biological and biochemical functions of Ras. N17Ras is used extensively as a 
dominant negative mutant to probe Ras function because it interferes with 
Ras activation in vivo by forming non-productive complexes with nucleotide 
exchange factors (Stewart and Guam, 2000). In fact, overexpression of 
N17Ras is usually the sole indicator for determining whether a particular 
signaling event involves Ras activation. Ras binds Raf directly in a GTP-
dependent manner which appears to be crucial for the activation of Raf 
(Stewart and Guan, 1999). Through the use of N17Ras, this study provided 
evidence that matrix-mediated downregulation of type I collagen was Ras-
dependent. 
 
The present study indicates that the matrix-mediated signaling occurs through 
the Ras/Raf/MEK-ERK signaling pathway. Additional experiments are 
warranted to examine the upstream events implicated in cell receptor-
mediated Ras activation in fibroblasts. Possible receptors include growth 
factor receptors and integrins. Other reports suggest that protein phosphatase 
2A (PP2A) is required for integrin-mediated activation of the MEK-ERK 
signaling pathway (Coppolino et al, 1995; Suzuki et al, 2004; Chetoui et al, 
2005). However, it was proved that this was true only in Ras-independent 
activation of MEK-ERK signaling pathway. Since this study proved that Ras is 
involved, it follows that there may not be a role for PP2A in the integrin-
mediated activation of the MEK-ERK signaling pathway. Crosstalk between 
the MEK-ERK pathway and other signaling pathways in the matrix-mediated 
downregulation of type I collagen need to be examined. In summary, this 
study showed that the fibroblast-derived ECM-mediated downregulation of 
type I collagen is via activation of the MEK-ERK signaling pathway and 
requires the activity of Ras. The Ras/Raf/MEK-ERK signaling pathway in turn 
might affect type I collagen gene expression via the Sp1 transcription factor, 
possibly in combination with other factors. These findings provide new 
insights into the mechanisms of signaling in fibroblasts and as such may have 
an impact on the regulation of fibroblast proliferation and differentiation, and 
fibroproliferative diseases.  
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    CHAPTER 4 
 
REGULATION OF TYPE I COLLAGEN SYNTHESIS VIA THE 
α2β1 INTEGRIN RECEPTOR 
 
4.1 INTRODUCTION 
Stromal microenvironments include the extracellular matrix, stromal cells such 
as fibroblasts as well as growth factors. These components have important 
regulatory roles in the growth and differentiation of cells. The ECM provides 
cell to cell and cell to matrix communications in addition to structural support. 
The mechanisms of interaction between cells and matrix, the cellular 
receptors that recognise the ECM molecules and the physiological response 
of the cells to attachment to the matrix have not been fully elucidated. The 
ECM proteins can induce diverse intracellular signals by providing both 
mechanical and chemical stimuli to cells. These signals will mitigate and be 
affected by other sources of cell signaling (Langenbach et al, 2006). ECM 
cues are very important in signaling pathways, therefore careful control of the 
matrix is important when studying downstream signaling events or cellular 
responses to soluble factors or external stimuli. Many studies have 
established that intracellular signal transduction depends on the type of 
extracellular components surrounding cells (Koide et al, 1989; Nagaki et al, 
1995; Hoshiba et al, 2006; Giancotti and Ruoslahti, 1999)).  
 
In order to have more a physiological in vitro system to analyse the 
characteristics of fibroblasts, it is becoming common to grow cells within 
support systems that attempt to simulate a natural microenvironment rather 
than on plastic (Fischbach et al, 2007; Kim, 2005; Yamada and Cukierman, 
2007). Thin films of ECM proteins are used to study cell responses and 
behaviour. Thin film technologies provide the means of producing an ECM 
that can be quantitatively characterised and systematically modified to vary 
the characteristics of the ECM presented to cells. The different ECM surfaces 
employed in this study, vary in sites available for receptor engagement 
(fibroblast-derived ECM vs purified type I collagen vs purified fibronectin). In 
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this study the response of fibroblasts to a fibroblast-derived ECM was 
compared to purified matrix components (artificial matrices), comprising type I 
collagen and fibronectin. Purified type I collagen and fibronectin coated on 
tissue culture dishes as thin films have been widely studied (Giancotti and 
Ruoslahti, 1999; Gu et al, 2008; Koide et al, 1989; Nagaki et al, 2002). The 
ECM has been proposed to act as a reservoir for an increasing number of 
growth factors (Vlodavsky et al, 1980; Burgess, 2009) and these can be 
released from the ECM to allow extracellular signaling to proceed without the 
need for de novo protein synthesis.  
 
Extracellular matrix components provide signals that control cellular 
development and whose control depends on integrin-mediated signaling 
pathways (Streuli et al, 1991). Fibroblasts express a rich array of integrin 
receptors on their surfaces (Heino, 2000; Hynes, 2002) and these are known 
to bind to collagen and fibronectin (Dickeson et al, 1997, 1998, 1999; Heino, 
2000). The α5β1 complex mediates adhesion to fibronectin (Li et al, 2003) 
and the α1β1 and α2β1 complexes mediate adhesion to collagen (Heino, 
2000; Dickeson et al, 1999). Integrins are the primary receptors for cellular 
adhesion to the ECM molecules and as a result act as crucial transducers of 
bidirectional cell signaling, regulating cell survival, differentiation, proliferation, 
migration and tissue remodelling (Giancotti and Ruoslahti, 1999).  
 
In chapter 2 we have shown that the interaction between fibroblasts and the 
ECM resulted in the downregulation of type I collagen gene expression. Since 
type I collagen is the major component of the stromal matrix, we focused on 
the functional contributions of the α2β1 integrin, the primary collagen receptor. 
The functional contribution of the α2β1 integrin was then compared to that of 
α3β1 integrin. α3β1 integrin is expressed at high levels on fibroblasts and 
other cells where it is a major receptor for laminin-5. Knockout studies in mice 
have revealed important roles for α3β1 in maintaining tissue integrity 
(DiPersio et al, 1997; Kreidberg et al, 1996).  Some reports however point to 
the fact that α3β1 is a promiscuous receptor that can bind to many other 
ligands besides laminin-5. We therefore examined the possibility that α3β1 
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could also be involved in the downregulation of type I collagen synthesis by 
the fibroblast-derived ECM.  
 
Through the use of a suspended matrix and purified matrix components 
consisting only of type I collagen and fibronectin, this study shows that there 
is a need for direct contact between the fibroblast-derived ECM and 
fibroblasts in order for type I collagen synthesis to be downregulated. 
Furthermore, since type I collagen synthesis is downregulated only in the 
presence of the fibroblast-derived ECM (containing collagen) and purified type 
I collagen, and not in the presence of fibronectin, it indicates a specific 
negative feedback mechanism. Contrasting results have been published on 
the possible involvement of integrins in the activation of the MEK-ERK 
pathway (Chen et al, 1996; Lee and Juliano, 2004). Monoclonal antibodies 
were utilised to block the functions of the α2β1 and α3β1 integrins to study 
their effects on type I collagen gene expression. In this study we also explore 
the possible regulation of integrin gene expression by the fibroblast-derived 
ECM and their possible involvement in the downregulation of type I collagen 
synthesis. Changes in the pattern of expression of integrins alter the way that 
the microenvironment signals are perceived which may trigger the expression 
of different sets of genes. We determined the mRNA levels of the subunits of 
both α2β1 and α3β1 integrins and compared their expression to those of 
fibroblasts cultured on plastic.  
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4.2 RESULTS 
4.2.1 Secreted factors are not involved in fibroblast-derived ECM-
mediated downregulation of type I collagen synthesis 
Many roles have been suggested for the ECM including the sequestration of 
biologically active growth factors. The nature and the origin of the stimulus 
responsible for the downregulation of type I collagen was investigated in 
several ways. The possibility that the results observed so far is as a result of 
the presence of secreted protein factors such as growth factors and cytokines, 
either released into the medium or trapped within the fibroblast-derived ECM 
was investigated. The effect of growth medium, exposed to fibroblasts, and a 
suspended fibroblast-derived ECM on type I collagen synthesis was studied in 
the presence or absence of the fibroblast-derived ECM.   
 
Growth medium, exposed to WI38 fibroblasts, resulted in slightly higher type I 
collagen protein levels and had no effect on COL1A2 mRNA levels (Fig 4.1 
and Fig 4.2). COL1A1 was omitted as the mRNA levels do not change in the 
presence of the fibroblast-derived ECM. Culturing fibroblasts with the growth 
media exposed to WI38 cells for 48 hrs, in combination with the fibroblast-
derived ECM, resulted in type I collagen mRNA and protein levels comparable 
to that produced by the fibroblast-derived ECM alone. This suggests that 
factors secreted by WI38 fibroblasts into the media play no part in the 
downregulation of type I collagen gene expression. The possibility that the 
fibroblast-derived ECM itself contained sequestered protein factors such as 
growth factors, which had accumulated during the production of the matrix, 
was also studied. A pre-formed fibroblast-derived ECM was suspended in 
DMEM medium and then introduced to fibroblasts growing on plastic and on 
matrix. The suspended matrix floated in the media. After an incubation period 
of 24 hrs the levels of type I collagen mRNA and protein levels were 
determined as described in section 7.2.6 and section 7.3.2 respectively. No 
effect could be attributed to the presence of the suspended matrix (Fig 4.3 
and Fig 4.4). Thus it appears that fibroblasts require direct contact with the 
matrix for the downregulation of type I collagen gene expression to occur. The 
use of suspected factors as positive controls is suggested in future studies. 
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         A  
                                     WI38 
                   
B 
                                      CT-1 
          
C 
                                      FGo 
       
Figure 4.1 Effect of growth media, exposed to WI38, on matrix-mediated 
downregulation of type I collagen protein levels. 
WI38, CT-1 and FGo fibroblasts (A-C) were seeded in dishes with or without fibroblast-
derived ECM for 24 hrs and then cultured in media , exposed to WI38 fibroblasts, mixed with 
DMEM media, for 48 hrs. Cell lysates (50 ug total protein) were separated by 7.5 % SDS 
polyacrylamide gel electrophoresis and subjected to immunoblotting with goat anti-type I 
collagen antibody (1:1000). The secondary antibody used was donkey anti-goat IgG 
conjugated to horse radish peroxidase (1:1000). Arrows indicate the two α chains. β-tubulin 
was used as a loading control to confirm equal loading of samples. 
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Figure 4.2 Effect of growth media, exposed to WI38 fibroblasts, on matrix-mediated 
downregulation of COL1A2 mRNA levels. 
WI38, CT-1 and FGo fibroblasts (A-C) were seeded in dishes with or without fibroblast-
derived ECM for 24 hrs and then cultured in media exposed to WI38 fibroblast, mixed with 
DMEM media, for 48 hrs. Cells were washed with PBS, RNA was extracted using Trizol 
reagent and five micrograms of total RNA were used in cDNA synthesis. Quantitative RT-
PCR was performed to evaluate COL1A2 mRNA levels using GAPDH as a control. The data 
are shown as the mean ± S.D. of three independent experiments. The * indicates significant 
differences (p ≤ 0.05) compared to fibroblasts plated on plastic. 
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Figure 4.3 Effect of suspended matrix on matrix-mediated downregulation of type I 
collagen protein levels. 
WI38, CT-1 and FGo fibroblasts (A-C) were seeded in dishes with or without fibroblast-
derived ECM for 24 hrs and then the suspended matrix, in DMEM media, was introduced. 
Incubation was continued for 48 hrs. Cell lysates (50 ug total protein) were separated by 
7.5 % SDS polyacrylamide gel electrophoresis and subjected to immunoblotting with goat 
anti-type I collagen antibody (1:1000). The secondary antibody used was donkey anti-goat 
IgG conjugated to horse radish peroxidase (1:1000). Arrows indicate the two α chains. β-
tubulin was used as a loading control to confirm equal loading of samples. 
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 Figure 4.4 Effect of suspended matrix on matrix-mediated downregulation of COL1A2 
mRNA levels. 
WI38, CT-1 and FGo fibroblasts (A-C) were seeded in dishes with or without fibroblast-
derived ECM for 24 hrs and then suspended matrix was introduced and incubation continued 
for 48 hrs. Cells were washed with PBS, RNA was extracted using Trizol reagent and five 
micrograms of total RNA were used in cDNA synthesis. Quantitative RT-PCR was performed 
to evaluate COL1A2 mRNA levels using GAPDH as a control. The data are shown as the 
mean ± S.D. of three independent experiments. The * indicates significant differences (p ≤ 
0.05) compared to fibroblasts plated on plastic. 
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4.2.2 Effect of matrix components on type I collagen synthesis 
Results from section 4.2.1 appear to suggest that secreted factors are not 
involved in the matrix-mediated downregulation of type I collagen, therefore 
the nature of the stimulus from the fibroblast-derived ECM was explored using 
an additional approach. To identify the fibroblast-derived ECM components 
responsible for the downregulation of type I collagen gene expression, 
fibroblasts were seeded on artificial matrices such as purified type I collagen 
and fibronectin, the predominant components of naturally occurring interstitial 
extracellular matrix. Coated plastic dishes were prepared by allowing type I 
collagen or fibronectin solution to gel. The preparation of thin films of type I 
collagen or fibronectin has been characterised before (Langenbach et al, 
2006; Elliot et al, 2003).   
 
The use of purified matrix components (artificial matrices) of type I collagen or 
fibronectin, showed that the matrix-mediated effect was of structural origin. 
When fibroblasts were seeded on dishes coated with purified type I collagen, 
the synthesis of type I collagen was downregulated to about the same level as 
when seeded on the fibroblast-derived ECM. When seeded on dishes coated 
with fibronectin, however, type I collagen synthesis was not downregulated 
(Fig 4.5 and Fig 4.6). The decrease in the gene expression of type I collagen 
is not due to a reduction in cell growth as the cell proliferation results show 
that there is no significance difference between controls and fibroblasts plated 
on the matrix, purified type I collagen or fibronectin (Fig  4.7). Neither was 
there any significant difference in the rate of attachment to the plastic, 
fibroblast-derived matrix, purified type I collagen and fibronectin (data not 
shown). 
 
4.2.3 Effect of blocking integrin function on type I collagen synthesis 
The extracellular matrix provides signals that control cellular development and 
whose control depends mainly on receptor-mediated signaling pathways 
(Giancotti et al, 1999; Hanagata et al, 2006). The biological responses 
triggered by cell-matrix interactions have been compared to those transduced 
by hormones, cytokines and growth factors (Delcommenne and Streuli, 1995). 
Results obtained so far appear to exclude the involvement of secreted factors 
78 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
therefore the focus was on receptors such as integrins that bind to 
components of the ECM. The integrin family of receptors are known to 
participate in a variety of transduction pathways (Hynes, 2002; Katsumi et al, 
2004; Phillips and Bonassar, 2005).  
 
                 
Figure 4.5 Effect of matrix components on type I collagen protein levels. 
CT-1 fibroblasts were seeded in dishes with or without the fibroblast-derived ECM or its 
purified components, type I collagen and fibronectin, for 24 hrs and then incubated for 48 hrs. 
Cells were washed with PBS and proteins were harvested in RIPA buffer. Cell lysates (50 ug 
total protein) were separated by 7.5 % SDS polyacrylamide gel electrophoresis and subjected 
to immunoblotting with goat anti-type I collagen antibody (1:1000). The secondary antibody 
used was donkey anti-goat IgG conjugated to horse radish peroxidase (1:1000). Arrows 
indicate the two α chains. β-tubulin was used as a loading control to confirm equal loading of 
samples. 
                 
Figure 4.6 Effect of matrix components on COL1A2 mRNA levels. 
CT-1 fibroblasts were seeded in dishes with or without the fibroblast-derived ECM or its 
purified components, type I collagen and fibronectin, for 24 hrs and then incubated for 48 hrs 
in DMEM. Cells were washed with PBS, RNA was extracted using Trizol reagent and five 
micrograms of total RNA were used in cDNA synthesis. Quantitative RT-PCR was performed 
to evaluate COL1A2 mRNA levels using GAPDH as a control. The data are shown as the 
mean ± S.D. of three independent experiments. The * indicates significant differences (p ≤ 
0.05) compared to fibroblasts plated on plastic.  
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Figure 4.7 Influence of fibroblast-derived ECM and its components, purified type I 
collagen and fibronectin, on cell proliferation. 3x 105 CT-1 fibroblasts were plated on 
culture dishes with or without the indicated matrices for 24 hrs and then grown in DMEM 
media for the indicated times (24hrs, 48 hrs, and 72 hrs). Fibroblast-derived ECM were 
prepared as described in section 7.2.3. At the end of the experiment the fibroblasts were 
trypsinised and counted. There was no significant difference in growth rate between 
fibroblasts grown on a matrix and the control cells. Data are expressed as the mean ± S.D of 
three independent experiments.  
 
The contributions of α2β1 and α3β1 integrins in the downregulation of type I 
collagen were evaluated using monoclonal antibodies to block the functions of 
the α2β1 and α3β1 integrins. Blocking α2β1 integrin function through the use 
of monoclonal antibody, MAB1998, reversed the inhibition of type I collagen 
protein (Fig 4.8) and COL1A2 mRNA levels (Fig 4.9) in cells cultured on ECM 
and this was through inhibiting ERK phosphorylation (Fig 4.10). Similar results 
were obtained when P1E6, another monoclonal antibody to human α2β1 
integrin, was used (Fig 4.11-Fig 13). The results show that the α2β1 integrin is 
directly involved in the downregulation of type I collagen synthesis while 
blocking the α3β1 integrin function through the use of monoclonal antibody 
P1B5 had no effect type I collagen protein levels (Fig 4.14), COL1A2 mRNA 
levels (Fig 4.15) and ERK phosphorylation (Fig 4.16). These results suggest 
that matrix-mediated downregulation of type I collagen occurs via the 
interaction of collagen in the matrix with the α2β1 integrin receptor rather than 
α3β1 integrin receptor and that this in turn results in the activation of the 
Ras/MEK/ERK signaling pathway.  
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Figure 4.8 Effect of blocking α2β1 integrin with MA1998 on type I collagen protein 
levels. CT-1 fibroblasts were preincubated with the indicated concentration of MAB1998 
antibody for 30 mins at 370C under standard cell culture conditions prior to addition to dishes 
with or without the fibroblast-derived ECM and then incubated for 48 hrs in DMEM media. 
Cells were washed with PBS and proteins were harvested in RIPA buffer. Cell lysates (50 μg 
total protein) were separated by 7.5 % SDS polyacrylamide gel electrophoresis and subjected 
to immunoblotting with goat anti-type I collagen antibody (1:1000). The secondary antibody 
used was donkey anti-goat IgG conjugated to horse radish peroxidase (1:1000). Arrows 
indicate the two α chains. β-tubulin was used as a loading control to confirm equal loading of 
samples. 
                       
Figure 4.9 Effect of blocking α2β1 integrin with MAB1998 on COL1A2 mRNA levels. CT-
1 fibroblasts were preincubated with the indicated concentration of MAB1998 antibody for 30 
mins at 370C under standard cell culture conditions prior to addition to dishes with or without 
the fibroblast-derived ECM and then incubated for 48 hrs in DMEM media. Cells were washed 
with PBS, RNA was extracted using Trizol reagent and five micrograms of total RNA were 
used in cDNA synthesis. Quantitative RT-PCR was performed to evaluate COL1A2 mRNA 
levels using GAPDH as a control. The data are shown as the mean ± S.D. of three 
independent experiments. The * indicates significant differences (p ≤ 0.05) compared to 
fibroblasts plated on plastic.  
                                                   
Figure 4.10 Effect of blocking α2β1 integrin with MAB1998 on phosphorylated ERK 1,2 
levels. CT-1 fibroblasts were preincubated with the indicated concentration of MAB1998 
antibody for 30 mins at 370C under standard cell culture conditions prior to addition to dishes 
with or without the fibroblast-derived ECM and then incubated for 48 hrs in DMEM media. 
Cells were washed with PBS and proteins were harvested in RIPA buffer. Cell lysates (50 μg 
total protein) were separated by 7.5 % SDS polyacrylamide gel electrophoresis and subjected 
to immunoblotting with anti-p-ERK 1,2 antibody (1:1000). β-tubulin was used as a loading 
control to confirm equal loading of samples. 
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Figure 4.11 Effect of blocking α2β1 integrin with P1E6 on type I collagen protein levels. 
CT-1 fibroblasts were preincubated with the indicated concentration of P1E6 antibody for 30 
mins at 370C under standard cell culture conditions prior to addition to dishes with or without 
the fibroblast-derived ECM and then incubated for 48 hrs in DMEM media. Cells were washed 
with PBS and proteins were harvested in RIPA buffer. Cell lysates (50 μg total protein) were 
separated by 7.5 % SDS polyacrylamide gel electrophoresis and subjected to immunoblotting 
with goat anti-type I collagen antibody (1:1000). The secondary antibody used was donkey 
anti-goat IgG conjugated to horse radish peroxidase (1:1000). Arrows indicate the two α 
chains. β-tubulin was used as a loading control to confirm equal loading of samples. 
                            
Figure 4.12 Effect of blocking α2β1 integrin with P1E6 on COL1A2 mRNA levels. CT-1 
fibroblasts were preincubated with the indicated concentration of P1E6 antibody for 30 mins 
at 370C under standard cell culture conditions prior to addition to dishes with or without the 
fibroblast-derived ECM and then incubated for 48 hrs in DMEM media. Cells were washed 
with PBS, RNA was extracted using Trizol reagent and five micrograms of total RNA were 
used in cDNA synthesis. Quantitative RT-PCR was performed to evaluate COL1A2 mRNA 
levels using GAPDH as a control. The data are shown as the mean ± S.D. of three 
independent experiments. The * indicates significant differences (p ≤ 0.05) compared to 
fibroblasts plated on plastic.  
 
                        
Figure 4.13 Effect of blocking α2β1 integrin with P1E6 on phosphorylated ERK 1,2 
levels. CT-1 fibroblasts were preincubated with the indicated concentration of P1E6 antibody 
for 30 mins at 370C under standard cell culture conditions prior to addition to dishes with or 
without the fibroblast-derived ECM and then incubated for 48 hrs in DMEM media. Cells were 
washed with PBS and proteins were harvested in RIPA buffer. Cell lysates (50 μg total protein) 
were separated by 7.5 % SDS polyacrylamide gel electrophoresis and subjected to 
immunoblotting with anti-p-ERK 1,2 antibody (1:1000). β-tubulin was used as a loading 
control to confirm equal loading of samples. 
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Figure 4.14 Effect of blocking α3β1 integrin with P1B5 on type I collagen protein levels. 
CT-1 fibroblasts were preincubated with the indicated concentration of P1B5 antibody for 30 
mins at 370C under standard cell culture conditions prior to addition to dishes with or without 
the fibroblast-derived ECM and then incubated for 48 hrs in DMEM. Cells were washed with 
PBS and proteins were harvested in RIPA buffer. Cell lysates (50 μg total protein) were 
separated by 7.5 % SDS polyacrylamide gel electrophoresis and subjected to immunoblotting 
with goat anti-type I collagen antibody (1:1000). The secondary antibody used was donkey 
anti-goat IgG conjugated to horse radish peroxidase (1:1000). Arrows indicate the two α 
chains. β-tubulin was used as a loading control to confirm equal loading of samples. 
                     
 Figure 4.15 Effect of blocking α3β1 integrin with P1B5 on COL1A2 mRNA levels. CT-1 
fibroblasts were preincubated with the indicated concentration of P1B5 antibody for 30 mins 
at 370C under standard cell culture conditions prior to addition to dishes with or without the 
fibroblast-derived ECM and then incubated for 48 hrs in DMEM. Cells were washed with PBS, 
RNA was extracted using Trizol reagent and five micrograms of total RNA were used in cDNA 
synthesis. Quantitative RT-PCR was performed to evaluate COL1A2 mRNA levels using 
GAPDH as a control. The data are shown as the mean ± S.D. of three independent 
experiments. The * indicates significant differences (p ≤ 0.05) compared to fibroblasts plated 
on plastic.  
 
                                      
Figure 4.16 Effect of blocking α3β1 integrin with P1B5 on phosphorylated ERK 1,2 
levels. CT-1 fibroblasts were preincubated with the indicated concentration of P1B5 antibody 
for 30 mins at 370C under standard cell culture conditions prior to addition to dishes with or 
without the fibroblast-derived ECM and then incubated for 48 hrs in DMEM. Cells were 
washed with PBS and proteins were harvested in RIPA buffer. Cell lysates (50 μg total protein) 
were separated by 7.5 % SDS polyacrylamide gel electrophoresis and subjected to 
immunoblotting with anti-p-ERK 1,2 antibody (1:1000). β-tubulin was used as a loading 
control to confirm equal loading of samples. 
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4.2.4 Effect of fibroblast-derived ECM on integrins mRNA levels 
The effect of the fibroblast-derived ECM on integrin mRNA levels was 
determined by real time PCR analysis. The expression of integrin β1, α2 and 
α3 mRNAs were determined after plating fibroblasts on plastic or on ECM. 
Fibroblasts cultured on the fibroblast-derived ECM up-regulated the steady 
state levels of mRNAs encoding α2 and β1 integrin subunits, in comparison to 
fibroblasts cultured on plastic (Fig 4.17). These results demonstrate that the 
extracellular matrix controls the gene expression of α2 and β1 integrin 
subunits and that the regulation is exerted at least at the transcriptional level. 
There was no change in the mRNA levels of the α3 integrin subunit (Fig 4.17). 
 
          
Fig 4.17 Effect of fibroblast-derived ECM on β1, α2 and α3 integrin mRNA levels. 
CT-1 fibroblasts were seeded in dishes with or without fibroblast-derived ECM for 24 hrs and 
then grown in DMEM media for 48 hrs. Cells were washed with PBS, RNA was extracted 
using Trizol reagent and five micrograms of total RNA were used for cDNA synthesis. 
Quantitative real time RT PCR was performed to quantitate β1, α2 and α3 mRNA levels. The 
levels of GAPDH in the same sample were used as the normaliser. The data are shown as 
the mean ± S.D. of three independent experiments. The * indicates significant differences (p ≤ 
0.05) compared to fibroblasts plated on plastic. 
 
4.2.5 Effect of fibroblast-derived ECM on E-cadherin mRNA levels 
Cadherins mediate mainly cell-cell adhesion but are also involved in 
attachment to extracellular ligands and have been shown to change during 
processes such as tumorigenesis. The effect of the fibroblast-derived ECM on 
E-cadherin mRNA levels as determined by real time PCR analysis, showed 
that there was no significant difference between fibroblasts plated on ECM 
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compared to those plated on plastic (Figure 4.18). The transcription of the E-
cadherin was therefore not influenced by the substratum.  
 
 
Fig 4.18 Effect of fibroblast-derived ECM on E-cadherin mRNA levels. 
CT-1 fibroblasts were seeded in dishes with or without fibroblast-derived ECM for 24 hrs and 
then grown in DMEM for 48 hrs. Cells were washed with PBS,  RNA was extracted using 
Trizol reagent and five micrograms of total RNA were used for cDNA synthesis. Quantitative 
real time RT PCR was performed to quantitate E-cadherin mRNA levels. The levels of 
GAPDH in the same sample were used as the normaliser. The data are shown as the mean ± 
S.D. of three independent experiments.  
 
 
4.2.6 Effect of fibroblast-derived ECM on fibronectin, laminin α2 and 
COL5A3 gene expression 
Our previous studies on the regulation of type I collagen synthesis by the 
fibroblast-derived ECM showed that different genes, in this case COL1A1 and 
COL1A2, can be affected by the ECM in different ways. We therefore 
examined the effect of the fibroblast-derived ECM on the expression of 
several other ECM genes. The expression of fibronectin, laminin-α2 and type 
IV collagen gene (COL5A3) was determined in the three fibroblasts cell lines 
WI38, CT1 and FGo in response to the presence of the fibroblast-derived 
matrix. There was a significant downregulation of fibronectin protein (Fig 4.19) 
and mRNA levels (Fig 4.20) whilst the fibronectin protein level in FGo appears 
to be unchanged. There was no change in the expression of laminin-α2 gene 
(Fig 4.21 and Fig 4.22) whilst the COL5A3 mRNA was upregulated in the 
presence of the ECM (Fig 4.23).  
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Figure 4.19 Effect of the fibroblast-derived ECM on fibronectin protein levels.  
WI38, CT-1 and FGo fibroblasts were seeded on dishes with or without fibroblast-derived 
ECM for 24 hrs and after changing media, were cultured for 48 hrs. Cell lysates (50 μg total 
protein) were separated by 7.5 % SDS PAGE and subjected to immunoblotting with mouse 
anti-fibronectin antibody (1:1000). The secondary antibody used was goat anti-mouse IgG 
conjugated to horse radish peroxidase (1:1000). β-tubulin was used as a loading control to 
confirm equal loading of samples 
                      
Figure 4.20 Effect of fibroblast-derived ECM on fibronectin mRNA levels. 
WI38, CT-1 and FGo fibroblasts (A-C) were seeded in dishes with or without fibroblast-
derived ECM for 24 hrs and then grown in DMEM media for 48 hrs. Cells were washed with 
PBS and RNA was extracted and five micrograms of total RNA were used in cDNA synthesis 
and qRT-PCR was performed to evaluate fibronectin mRNA levels using GAPDH as a control. 
The data are shown as the mean ± S.D. of three independent experiments. The * indicates 
significant differences (p ≤ 0.05) compared to fibroblasts plated on plastic.  
 
                    
Figure 4.21 Effect of the fibroblast-derived ECM on laminin α2 protein levels.  
WI38, CT-1 and FGo fibroblasts were seeded on dishes with or without fibroblast-derived 
ECM for 24 hrs and after changing media, were cultured for 48 hrs. Cell lysates (50 μg total 
protein) were separated by 7.5 % SDS PAGE and subjected to immunoblotting with mouse 
anti-laminin α2 antibody (1:1000). The secondary antibody used was goat anti-mouse IgG 
conjugated to horse radish peroxidase (1:1000). β-tubulin was used as a loading control to 
confirm equal loading of samples. 
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Figure 4.22 Effect of fibroblast-derived ECM on laminin α2 mRNA levels. 
WI38, CT-1 and FGo fibroblasts (A-C) were seeded in dishes with or without fibroblast-
derived ECM for 24 hrs and then grown in DMEM media for 48 hrs. Cells were washed with 
PBS and RNA was extracted and five micrograms of total RNA were used in cDNA synthesis 
and qRT-PCR was performed to evaluate laminin α2 mRNA levels using GAPDH as a control. 
The data are shown as the mean ± S.D. of three independent experiments.  
                       
Figure 4.23 Effect of fibroblast-derived ECM on COL5A3 mRNA levels. 
WI38, CT-1 and FGo fibroblasts (A-C) were seeded in dishes with or without fibroblast-
derived ECM for 24 hrs and then grown in DMEM media for 48 hrs. Cells were washed with 
PBS and RNA was extracted and five micrograms of total RNA were used in cDNA synthesis 
and qRT-PCR was performed to evaluate COL5A3 mRNA levels using GAPDH as a control. 
The data are shown as the mean ± S.D. of three independent experiments. The * indicates 
significant differences (p ≤ 0.05) compared to fibroblasts plated on plastic.  
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4.2.7 Discussion 
It has been suggested that growth factors or cytokines can adhere to the 
matrix in the stroma (Kao et al, 1983; Yamada and Cukierman, 2006). In vitro, 
growth factors such as PDGF and FGF have been shown to adhere to 
collagen-coated plates (Smith et al, 1999). When in contact with cells, these 
growth factors affect fibroblast proliferation and protein synthesis. In this study, 
the possibility that the matrix-mediated downregulation of type I collagen 
synthesis is caused by the presence of growth factors or other secreted 
factors such as cytokines was examined by using media, exposed to WI38 
cells, and also by using the suspended matrix. When both the growth media 
exposed to fibroblasts and suspended/floating matrix were used, no effect 
was observed. The possibility that a structural component of the fibroblast-
derived ECM was responsible for the results observed, was investigated, and 
only when fibroblasts were plated on purified type I collagen and on the 
fibroblast-derived ECM and was type I collagen synthesis downregulated. 
Thus direct contact between the specific matrix proteins and fibroblasts was 
necessary. It is reasonable to assume that the responsible factor be in 
insoluble form in the fibroblast-derived ECM, since the medium exposed to 
fibroblast and the suspended matrix, when introduced to fibroblasts plated on 
plastic did not affect type I collagen gene expression.  
 
Differences in cell proliferation and thus cell density also did not account for 
the differences in type I collagen synthesis observed in this study. This 
suggests that the matrix effect on the fibroblasts type I collagen synthesis is 
not due to changes in cell proliferation and cell density, but is extracellular 
matrix-specific. Purified type I collagen and fibronectin have been used 
extensively as cell culture substrates that are intended to mimic the ECM 
environment found in tissues. It has been suggested that the use of thin 
collagen films may be useful in elucidating cellular remodelling of the matrix. 
Many studies have established that ECM components can influence gene 
expression (Kao et al, 1982; Streuli et al, 1993, 1995; Powell et al, 1996). Our 
results agree with results obtained by other investigators showing that the 
extracellular matrix composition strongly influences cells protein gene 
expression and organisation (Bissell et al, 2002; Elliott et al, 2003; 
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Langenbach et al, 2006). Bissell et al (2000) reported that the expression 
pattern of ECM genes in cells may vary depending on the type of matrices on 
which the cells are cultured. In the present study, a fibroblast-derived ECM 
and purified type I collagen inhibited collagen synthesis via a feedback 
mechanism. Procollagen mRNAs translation has been shown to be inhibited 
by cleaved collagen peptides. The N- and C-terminal peptides of type I 
collagen are known to inhibit collagen production by affecting polypeptide 
chain elongation and/or termination (Aycock et al, 1986; Wiestner et al, 1979). 
This suggests that collagen production is inhibited depending on the 
availability of specific proteases needed for the generation of the peptides. It 
is possible that the ECM downregulates COL1A2 transcription whilst its 
cleaved peptides affect COL1A1 mRNA translation. These data suggest that 
matrix proteins which normally reside in the stroma can inhibit fibroblast 
matrix synthesis. 
 
The use of artificial matrices, purified type I collagen and fibronectin, 
implicated a structural component of the fibroblast-derived ECM as 
responsible for the downregulation of type I collagen synthesis. Since purified 
type I collagen matrix downregulated collagen synthesis, we focussed on 
known receptors for type I collagen. Receptors for soluble and ECM-bound 
type I collagen have been demonstrated to include integrins (Aplin et al, 1999; 
Barberis et al, 2000; Bork et al, 1999; Borrirukwanit et al, 2007). For 
comparison purposes, the receptor for another matrix protein, laminin, was 
also analysed. The mRNA levels of β1, α2 and α3 integrins were determined 
by real time RT PCR, after seeding fibroblasts on plastic and on matrix. There 
was an upregulation in the mRNA levels of both β1 and α2 integrins when 
fibroblasts were plated on a matrix. There was no change in mRNA levels of 
α3 integrin after plating fibroblasts on the matrix. The intracellular mechanism 
of substrate-dependent control on integrin gene expression is complex, is 
known to occur at both transcriptional and posttranscriptional levels and 
appears to be multifactorial (Delcommene and Streuli, 1994; Globus et al, 
1995; Millward-Sadler and Salter 2004). Mammary epithelial cells and 
fibroblasts were shown to respond differently to the presence of ECM, with 
fibroblasts showing altered transcription of the β1 integrin gene, indicating that 
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the signaling pathways triggered in response to the ECM are cell type-
dependent (Hynes, 1992, 2002; Giancotti, 2003; Brown, 2002; Schwartz and 
Assoian, 2001). It is possible that fibroblasts increase the levels of integrin 
receptors in order to maximise their chances of establishing contacts with the 
ECM, whilst those plated on plastic use other receptors, including other 
integrins, to make contact. Precisely why this should be so important to 
fibroblasts is not clear at this time, but it may reflect a generic wounding 
response that often occurs when cells are placed in tissue culture. There was 
no change in the levels of E-cadherin mRNA, matrix versus control, showing 
that cadherins are unlikely to be involved in the attachment to the fibroblast-
derived ECM.  
 
Furthermore, the use of blocking antibodies showed that integrins are 
involved and in particular α2β1 integrin is involved in the downregulation of 
type I collagen gene expression in the presence of the fibroblast-derived ECM. 
Collagen molecules contain RGD sequences in the helix-forming region, 
however a number of researchers have observed that attachment of integrins 
to several types of native collagens failed to be competed for by linear RGD 
containing peptides (Cardarelli et al, 1992; Davis, 1992; Kramer and Marks, 
1989). Blocking the function of α3β1 integrin did not reverse the effect of the 
fibroblast-derived ECM on type I collagen synthesis. This implies that α3β1 
integrin is not the receptor through which the stimulus, resulting in 
downregulation of type I collagen synthesis, is relayed to the nucleus. A 
general biologic principal can be recognised, that the ECM is informational to 
adjacent cell populations and also to cells that produce the ECM. The 
mechanism(s) by which fibroblast recognise the absence and presence of the 
ECM is presumably based on signalling through cell surface receptors for the 
appropriate matrix components. Occupation of the receptors would then result 
in a repressed transcriptional activity.  
 
As a follow–up on matrix-mediated regulation of type I collagen synthesis, the 
study also investigated the effect of fibroblast-derived ECM on the expression 
of several ECM protein genes. There was a differential response to the 
presence of the ECM among the genes investigated. The expression of these 
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genes has never been studied in the presence of the fibroblast-derived ECM 
and therefore there is need to study more of the ECM genes to gain more 
insight into the expression of many proteins in vivo, which occur in the 
presence of the ECM. Further investigations, including a micro-array analysis, 
would be a necessity to elucidate the regulation of ECM proteins genes in the 
presence of a cell-derived matrix. In conclusion our data show that the gene 
expression of type I collagen is strongly affected by the presence of fibroblast-
derived ECM and suggests a possible negative feedback loop in vivo, 
whereby the presence of the extracellular matrix downregulates type I 
collagen gene expression through integrins and in particular α2β1 integrin.  
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CHAPTER 5 GENERAL DISCUSSION  
Previously viewed as a structural substrate for cells, it is now clear that the 
extracellular matrix, through specific receptors, induces biological responses 
from the cell surface and thus determines how cells interpret biochemical data 
from their surrounding stroma. To accurately determine how the properties of 
the ECM influence cellular behaviour, the experimental model system used 
must properly simulate the in vivo environment. This is because under in vivo 
conditions, the ECM components are synthesised in a specific ratio to each 
other, deposited and crosslinked in a specific sequence.  
 
Studies on cell-matrix interactions have demonstrated the biological impact of 
the extracellular matrix on the structure and function of many cells (Sasser et 
al, 2007; Burgess, 2009; Rhee et al, 2007; Kudo et al, 2007; Che et al, 2006; 
Nho et al, 1990; Xia et al, 2008; Hadden and Henke, 2000).. Most of these 
studies involved cell culture models in which cells are plated on various 
extracellular matrix proteins and the expression of a tissue-specific function is 
assessed. There are reservations concerning the accuracy of these cell-
culture models with respect to the intact tissue, in that the precise composition 
and structure of the ECM is not accurately simulated. The recent development 
of fibroblast-derived ECM provided a new and physiological assay system to 
study cell function (Serebriiskii et al, 2008). In this thesis therefore, a natural 
fibroblast-derived ECM was used to simulate in vivo environment, in the study 
of type I collagen gene regulation in human fibroblasts.  Given the increasing 
prevalence of fibrotic diseases, which are characterised by excessive 
deposition of type I collagen within the stroma of tissue, understanding the 
mechanisms regulating type I collagen synthesis is imperative. As a 
component of the ECM, type I collagen provides essential support for 
maintaining tissue structure.  Most of the type I collagen found in interstitial 
tissues is synthesised by fibroblasts which also synthesise factors that are 
involved in the regulation of collagen such as various growth factors and 
MMPs. Fibroblasts are therefore a useful model in the study of ECM 
regulation.  
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We report the downregulation of type I collagen gene expression when 
fibroblasts are plated on a fibroblast-derived ECM. This matrix-mediated 
downregulation of type I collagen synthesis occur at both transcriptional and 
post-transcriptional levels that is reflected in a significant decrease in both 
intracellular and secreted type I collagen protein levels. There is compelling 
evidence to suggest that when there is a large change in either mRNA or 
protein levels, multiple steps in the metabolism of the mRNA or the protein 
may have been altered (Stefanovic, 2005; Goldstein, 1991). The level of 
mRNA encoding a specific protein is determined by many factors including 
rate of transcription and the half-life of the mRNA. To determine whether gene 
transcription or mRNA stability, which may decrease α2(1) collagen mRNA 
expression level, was involved , an RNA stability study was performed using 
the transcription inhibitor actinomycin D. It was shown that there was no 
significant differences in α1(1) and α2(1) mRNA half lives between cells 
plated on plastic and matrix. Signal transduction pathways which trigger the 
changes in stability of collagen α1(1), mRNA are being elucidated. It is known 
that the activation of phophatidylinositol 3-kinase (PI3K) leads to stabilisation 
of collagen α1(1) mRNA in both liver, lung and skin fibroblast (Stefanovic, 
2005; Friedman et al, 1992). In this study, however, there were no differences 
in the mRNA half lives and the possible involvement of any signaling 
transduction pathway in stabilising the mRNAs was not examined. 
 
Remodeling of the ECM is primarily mediated by MMPs, which can 
collectively degrade all structural proteins of the ECM. MMPs are the driving 
force for degradation of ECM during remodeling and changes in MMP levels 
have been described in human cells in many pathological conditions. 
Differences in intracellular mRNA levels and not in protein levels may result 
from the secretion of MMPs into the media (Stefanovic, 2005). Correlation 
between the secretion of specific MMPs and the levels of type I collagen has 
been reported before (Laliberte et al, 2001). In this study we found that the 
fibroblast-derived ECM does not affect the gene expression levels of MMP-1, 
MMP-2, MMP-9, and MT1 MMP and the gelatinases activities. Work done by 
others show that when cells are plated on Matrigel, they increase the levels of 
at least the gelatinases activity (Ala-aho and Kahari, 2005; Ray and Stetler-
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Stevenson, 1994). Differences in composition between the fibroblast-derived 
matrix and Matrigel might have contributed to the contrasting results obtained. 
The fibroblast-derived matrix is synthesised by human fibroblasts and some of 
its major components include type I collagen and type III collagen whereas 
Matrigel is made from EHS tumours (Kleinman et al, 1986), is comparable to 
the gel-like composition of the basement membrane and is rich in laminin, 
type IV collagen and other non-fibrous components of the matrix (Serebriiski 
et al, 2008).  
 
Transient transfection with COL1A2 gene promoter constructs containing the 
sequences spanning -2300 to -107 base pairs driving the luciferase reporter 
gene revealed that the promoter activity was significantly decreased in 
response to the fibroblast-derived ECM. Deletion analysis of the 5’-flanking 
region of the COL1A2 gene promoter indicated that the response to the 
fibroblast-derived ECM depended on the region between -375 to -107 base 
pairs, where there are putative binding sites for AP1, Sp1, Sp3,Ets1 and Fli1 
(Ihn, 2007) (Figure 5.1). Any one of these transcription factors and /or other 
still-to be identified factors could be responsible for the matrix-mediated 
downregulation of type I collagen as observed in this study. Amoung these 
 
Figure 5.1. Transcriptional regulation of the human a2(I) collagen gene. The human 
a2(I) collagen promoter is regulated by transcription factors Sp1/Sp3, Ets1/Fli1, 
C/EBPb, AP-1, Smad3/Smad4, YB-1 and CCAAT-binding factor (CBF). (Adopted from Ihn, 
2007).   
 
transcription factors, the role of AP1 and Sp1 in the regulation of the COL1A2 
gene expression has been extensively studied (Jinnin et al, 2006; Ihn et al, 
2006). Electrophoretic mobility shift assays employing COL1A2 gene 
promoter constructs and the nuclear extracts from chick embryonic 
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chondrocytes indicated the involvement of an Sp1 factor in the cartilage-
specific expression of the gene, since the addition of anti-Sp1 antibodies to 
the binding reaction resulted in a supershift of the DNA-protein complex. In 
addition, mutations in the Sp1 binding sites abolished the formation of the 
DNA-protein complex (Savagner et al, 1995).  
 
We hypothesised that Sp1 may be involved in the matrix-mediated 
downregulation of type I collagen gene expression. Sp1 is has been reported 
to be involved in both upregulation and downregulation of type I collagen gene 
expression, depending on the other factors that it associates with. Interaction 
with smad3 was shown to increase type I collagen gene expression in 
scleroderma fibroblasts (Jinnin et al, 2006; Ihn et al, 2006) whilst interaction 
with Fli1 was shown to result in transcriptional repression of collagen genes 
including type I collagen (Jinnin et al, 2006). Indeed, deletion analysis showed 
that the longer constructs, -2300 to -107/ -721 to -107/ -375 to -107, resulted 
in the matrix-mediated downregulation of type I collagen whilst the short 
construct spanning the sequences -107/+54, displayed a negligible difference 
in activity, matrix versus control. Therefore the sequences from -375 to -107 
seemed to be required for the decreased transcription of the COL1A2 gene, 
where there are putative binding sites for many Sp1 binding motifs. SiRNA is 
a conserved, genetic surveillance mechanism that allows the sequence-
specific post transcriptional downregulation of target genes (Socker et al, 
1998). We used siRNA technology to silence Sp1 gene expression and then 
determined the effect on type I collagen synthesis. Transfection of cells with 
Sp1 siRNA was not toxic to cells, and led to significant increases in the mRNA 
and protein levels of type I collagen. This pattern of change in mRNA and 
protein levels is consistent with the role of Sp1 as a mediator of the matrix-
mediated downregulation of type I collagen in fibroblasts. The reason of the 
downstream type I collagen gene change after transfection of Sp1 siRNA, in 
the presence of the fibroblast-derived ECM, may arise from the interruption of 
the negative feedback loop in fibroblasts. Ghosh et al (2007) reported the 
involvement of TGF-β and Sp1 in the upregulation of type I collagen in tissue 
fibrosis whilst others report the involvement of Sp1 in the upregulation of type 
I collagen gene expression in scleroderma dermal fibroblasts (Jinnin et al, 
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2006).  It has been reported before that Sp1 activates or represses different 
promoters depending on the other transcription factors it binds to or form 
complexes with (Santiago and Khachigian, 2004). Sp1 was found to be a 
repressor of COL1A2 promoter activity when it interacts with Fli-1 (Ramirez et 
al, 2006; Asano et al, 2009). Further investigation is therefore needed to 
clarify the other transcription factors involved and/or to verify whether Fli1 is 
involved.   
 
Despite an increased understanding of intracellular signaling pathways that 
promote integrin-mediated function and differentiation in many cell types, 
mechanisms whereby specific integrins regulate fibroblast function and 
differentiation, and the role of MEK-ERK signaling in this process, remains 
unclear. Given the established role of MAPKs (JNK, MEK, p38) and PI3-
kinase (Tian et al, 2002; Xia et al, 2008) in mediating many cellular processes, 
we investigated their role in mediating the effects of the fibroblast-derived 
ECM. It was observed that the MEK-ERK signaling cascade was involved in 
the matrix-mediated downregulation of type I collagen gene expression. The 
fact that inhibition of MEK-ERK signaling pathway and/or other pathways, can 
selectively reverse the ability of fibroblast-derived ECM to downregulate type I 
collagen gene expression, suggests a potential for pharmaceutical 
manipulation of the direct effects of the matrix on tissue type I collagen 
content.  
 
In culture, cell substratum adhesion is mediated by at least two adhesion 
structures, weak interactions via close contacts and strong interactions via 
focal adhesions (Kim et al, 1997; Burridge et al, 1988). Focal adhesions are 
the points at which cells make their closest contacts with the substratum and 
provide the primary stabilising force for attachment of cultured cells. Integrin 
receptors are known to selectively localise to focal adhesions. Integrin-
mediated interactions between cells and the ECM play a fundamental role in 
the development and function of a variety of tissues by triggering intracellular 
signals that regulate gene expression. Integrin-function blocking studies 
implicated the α2β1 integrin in the matrix-mediated downregulation of type I 
collagen and qRT PCR showed that only β1 and α2 integrin mRNA levels 
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increased significantly in the presence of the fibroblast-derived ECM. It is 
possible that when fibroblasts are plated on a fibroblast-derived ECM, they 
increase the levels of integrin subunit gene expression in order to increase 
their chances of establishing further contacts with the ECM. Others have 
shown that increased integrin expression is not important in cell adhesion to 
the substratum but integrin avidity (Kudo et al, 2007; Putnins et al, 1999). 
However, substratum-dependent control on integrin gene expression has 
been noted previously in other cell systems (Abraham et al, 2006; Chung et al, 
2007; Hornebeck and Maquart, 2003; Tian et al, 2002; Xia et al, 2008).  
 
Collagen-binding integrins can contribute to disease processes by mediating 
some of the aberrant cell-matrix interactions responsible for such disease. 
The presence of α1β1 and α2β1 integrins on myofibroblasts indicates that 
they might modulate ECM synthesis in fibrotic conditions (Zutter and Edelson, 
2007). Excessive fibrosis is characterised by altered collagen production in 
diseases such as hepatic cirrhosis, pulmonary fibrosis, sclerosis, scarring and 
arterial restenosis (Varga et al, 1995). Available data suggest that α2β1 
integrin might be one integrin candidate involved in lung and liver fibrosis. 
Cooperativity between integrins and growth factor receptors in the regulation 
of MAPK signaling pathways has already been demonstrated (Giancotti and 
Ruoslahti, 1999). Growth factor dependent induction of ERK signaling in NIH 
3T3 cells is strongly dependent on integrin-mediated cell adhesion (Aplin and 
Juliano, 1999; Renshaw et al, 1997). Based on our results, our proposed 
model suggests a mechanism whereby integrins can cooperate with other 
receptors to induce MEK-ERK-dependent gene regulation. Specifically our 
results in fibroblasts showed that α2β1 integrin and not α3β1 integrin, was 
required for ras-mediated MEK-ERK activation in the presence of the 
fibroblast-derived ECM.  
 
These results led us to propose a model to explain the role of the fibroblast-
derived ECM in the regulation of type I collagen gene expression in 
fibroblasts. Key components of this model are as follows: (1) Fibroblasts must 
be in contact with a collagen-containing ECM (2) Fibroblasts bind to the matrix 
via interactions between type I collagen and the α2β1 integrins, possibly 
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among others (3) Integrin liganding activates the Ras/Raf-1/MEK-ERK 
signaling pathway that transduce signals to the nucleus, which might lead to 
the phosphorylation of Sp1 transcription factor and the subsequent 
downregulation of type I collagen synthesis. This proposed model is shown in 
Fig 5.2 and is supported by results obtained in this study. In summary, this 
study showed that the fibroblast-derived ECM-mediated downregulation of 
type I collagen is via receptor-meditated activation of the MEK-ERK signaling 
pathway that requires the activity of Ras. Lastly, this study showed that the 
expressions of several genes are affected differently by the presence of the 
ECM. Whilst most studies are done on plastic, the results obtained from this 
study call for caution when interpreting results obtained from such studies.  
These findings provide new insights into the mechanisms of signaling in 
fibroblasts and as such may have an impact on the regulation of fibroblast 
proliferation and differentiation, and fibroproliferative diseases.  
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CHAPTER 6 CONCLUSION  
This study extends our understanding of ECM-dependent feedback regulation 
of type I collagen gene expression. We have shown that gene expression of 
ECM proteins, in particular type I collagen, and their integrin receptors, can all 
be regulated by cell-matrix interaction. During pathological conditions such as 
in cancer invasion and metastasis and in fibrosis, changes in type I collagen 
content are typically observed. The results of the present study provide 
evidence that the fibroblast-derived ECM downregulates type I collagen gene 
expression through activation of the MEK-ERK signaling cascade and that 
there is need for direct contact between the fibroblasts and the matrix for this 
to occur. These findings, to the best of our knowledge, represents the first 
study to shed light on feedback regulation of type I collagen gene expression 
by a fibroblast-derived ECM.  
 
This study strongly supports the critical role of Sp1 and its associated factors 
such as Fli1 in the matrix-mediated downregulation of type I collagen 
synthesis. Given the complexity of collagen gene regulation, other factors are 
likely to contribute to this process, either as part of the Sp1/Fli1 complex or 
through independent pathways. Future studies should be directed at the 
generation of a mouse model such as transgenic mice with fibroblast-specific 
deletion of Sp1 or Fli1 which will allow better characterisation of the genes 
regulated by these two transcription factors in fibroblasts. The results of this 
study support the notion that the absence of Sp1 and its associated factors 
might play a pathological role in conditions where type I collagen gene 
expression is altered such as in scleroderma. In addition, our data suggest 
that there is a reciprocal relationship between integrin signaling and some key 
transcription factors. Our data also show that ligation of integrins by plating 
fibroblasts on the fibroblast-derived ECM, generates Sp1 transcripts, 
independent of the presence of growth factors and cytokines. The findings of 
this study strongly suggest that the significant number of signaling studies 
published to date using cells grown on artificial substrates or plastic should be 
re-evaluated under arguably more physiological conditions such as the 
fibroblast-derived ECM. While the principles of signaling established using 
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regular tissue culture are likely to remain valid, the extent, nature and 
regulation of specific signaling responses of cells may differ when using cell-
derived matrices such as  the fibroblast-derived ECM.  
 
It is unlikely that any single aspect of remodeling itself, in this case changes in 
type I collagen gene expression, will adequately explain the changes 
observed in pathological conditions such as in cancer invasion and metastasis 
and in fibrosis. However, understanding the potential contributions of the 
extracellular matrix in the regulation of type I collagen synthesis may aid in the 
development of therapeutic strategies for the treatment of the many diseased 
conditions where type I collagen regulation is altered.  
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CHAPTER 7: MATERIALS AND METHODS 
 
7. 1 Materials  
7.1.1 Reagents  
Cell culture reagents were obtained from GIBCO BRL Life Technologies 
(Gaithersburg, MD). Pepsin was obtained from Southern Biotech (Birmingham, 
AL). U0126 (ERK 1, 2 inhibitor) and SB203580 (p38 MAPK inhibitor) were 
from Calbiochem (La Jolla, CA), while PD98059 (ERK 1, 2 inhibitor), PI-3 
kinase inhibitor (Wortmanin) and SP600125 (JNK inhibitor) were from Cell 
Signaling (Upstate, Lake Placid, NY, USA). Transfectin and the SDS-PAGE 
molecular weight standards were from BioRad (Cape Town). The pGL2 basic 
vector, renilla pRL-HSV-TK vector, a dual-luciferase detection system was 
obtained from Promega (Madison, WI).  Purified type I collagen was 
purchased as a solution of acid-stabilized monomer (Vitrogen; Cohesion 
Technologies, Inc., Palo Alto, CA). Purified fibronectin was from Sigma (St 
Louis, MO). The dominant negative mutant MEK and its parent vector, 
pCMV5, were a gift from Prof. R.T Franceschi (University of Michigan, USA) 
(Roca and Franceschi, 2008). Plasmid N17Ras.cmv, a pCMV5 plasmid 
encoding the S17 -N dominant negative mutant Ras protein was a gift from 
Prof. Michael Birrer (National Cancer Institute, USA) (Leaner et al, 2005). 
Other chemicals and solvents if not otherwise specified were purchased from 
either Sigma (St Louis, MO) or Merck Biosciences (Darmstadt, Germany).  
 
7.1.2 Cell Lines 
The cell lines used in this study were the following: 
Human skin fibroblasts (FGo) were originally established from surgical 
biopsies of human skin in South Africa (van der westhuysen et al, 1984) 
Human embryonic lung fibroblasts, (WI38) (ATCC CCL-75) (Manassas, VA, 
USA) 
γ-radiation transformed WI-38 human lung fibroblast, CT-1 fibroblasts (a gift 
from Dr M. Namba (Tokyo, Japan) (Namba et al, 1980) 
Simian virus-40 transformed WI38 fibroblasts, (SVWI38) (de Haan et al, 1986) 
Human fibrosarcoma cells, HT-1080 (ATCC CCL-121) (Manassas, VA, USA). 
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7.1.3 Antibodies 
The anti-type I collagen antibody (Catalogue No: 1310-01, Lot No: D3405-
Y318) was purchased from Southern Biotech (Birmingham, AL). The 
phospho-p44/42 mouse polyclonal antibody was from Cell Signalling 
(Catalogue No: 9106S, Lot No: 27) (Upstate, USA). The anti-fibronectin 
antibody (Catalogue No: CP13L, Lot No: D37065) was from Calbiochem (La 
Jolla, CA). The monoclonal anti-α2β1 integrin antibody (Catalogue No: 
MAB1998, Lot No: LV1430235) was from Chemicon (Temecula, CA, now 
Millipore, USA). The anti-tubulin antibody (Catalogue No: sc-9104, Lot No: 
E2308), monoclonal mouse antibodies to human integrin α2β1 (P1E6, Lot No: 
0083a) and to human integrin α3β1(P1B5, Lot No: 0083b) were from Dako 
Corporation (Carpinteria, CA, USA), anti-MT1 MMP (Catalogue No: sc-12367, 
Lot No: 15), anti-NFk-β (Catalogue No: sc-109, Lot No: L1007), p44/42 ERK 
(Catalogue No: sc-153, Lot No: D1007) and the anti-Sp1 (Catalogue No: sc-
14027, Lot No: E2808) antibodies were obtained from Santa Cruz (USA). 
Secondary antibodies were HRP-conjugated and together with other primary 
antibodies not mentioned here, were from either Santa Cruz or Pierce. 
 
7.2 Methods 
7.2.1 Maintenance of cells in culture 
Cells were cultured at 37 0C in  a humidified atmosphere of 5 % CO2 in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10 % heat 
inactivated fetal calf serum (FCS), 2 mM L-glutamine, 100 U/ml penicillin and 
100 μg/ml streptomycin. For experiments, confluent fibroblasts (70 %) (WI38, 
CT-1 and FGo) were split using 0.5 % trypsin-0.53 mM EDTA and plated in 
culture dishes with or without the matrices used in the study i.e fibroblast-
derived ECM, purified type I collagen and fibronectin. The media were 
changed three times a week. Only early passage cells were used in the 
studies.  
 
7.2.2 Thawing and Freezing down of cells 
To grow cells, vials containing the cells were removed from nitrogen tanks 
and rapidly thawed in a 370C water bath. The vials were then wiped with 70 % 
ethanol and the cells were mixed with fresh DMEM media and spun at 1000 
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r.p.m for 4 minutes. The media were decanted and the cells were then 
suspended in fresh DMEM media in a culture dish or flask. 
In order to store cells for long periods, freezing was done. Freezing of cells 
was done after removing the media by aspiration. Cells were then trypsinised 
with 0.5 % trypsin in PBS containing 10 mM EDTA for 2-3 minutes in the 
incubator at 370C. An equal volume of serum-containing DMEM was then 
added to stop the trypsinisation. Cells were counted and the media was 
removed through centrifugation at 1000 r.p.m for 5 minutes. The cells were 
resuspended with freezing down media (70 % DMEM, 20 % FCS and 10 % 
DMSO) by gently pippetting twice. The cells were aliqouted into 2 ml 
ampoules at about 1 x 106 cells/ml and stored at -80 0C for 48 hrs before 
being transferred to a liquid nitrogen tank. Every two months the cells were 
checked for mycoplasma contamination.  
 
7.2.3 Preparation of fibroblast-derived ECM 
Confluent WI38 cells were split using 0.5 % trypsin in PBS containing 10 mM 
EDTA and cells were seeded in 35 mm or 100 mm tissue culture dishes. The 
cells were grown in DMEM supplemented with 10 % heat inactivated fetal 
bovine serum, 2 mM L-glutamine, 100 U/ml penicillin and 100 ug/ml 
streptomycin. The temperature was maintained at 37 0C in a humidified 
incubator (70 %) and CO2 was be maintained at 5 %. Fresh ascorbic acid (50 
μg/ml) was added every alternate day based on established protocols 
(Serebriiskii et al, 2008). Cells were grown to 8 days post confluence after 
which the medium was drained off, the cells were rinsed with PBS and lysed 
by adding 20 mM freshly prepared ammonium hydroxide for about one minute 
(Green and Yamada, 2008; Serebriiskii et al, 2008). The matrix was washed 
three times with sterile PBS, fixed to the dish with a 50 % ethanol rinse, air 
dried and sterilised overnight under UV light in a tissue culture cabinet. The 
matrices were checked using an inverted phase contrast microscope. This 
treatment removed cells but left a cell-free in vivo-like 3D matrix that remained 
attached to the culture dishes. Matrix-coated dishes were stored at 40C and 
used within two weeks of preparation. Extracellular matrix protein integrity is 
stable under these storage conditions (Serebriiskii et al, 2008). Before use, 
the matrix was rinsed with sterilised PBS followed by one rinse with tissue 
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culture media. The quality of the matrix was checked by staining with 
Coomassie Brilliant Blue. Artificial matrices were made from purified type I 
collagen (Cohesion Technologies) and fibronectin (Sigma). Purified Type I 
collagen and fibronectin were used at a concentration of 0.1 mg/ml and 
incubated in culture dishes at 370C for at least 1 hr. Gelation of the matrices 
occurred in less than 30 minutes.  
 
7.2.4 Cell Proliferation Assay 
Cell proliferation was determined by either counting cells after trypsinisation or 
by the MTT assay. At the end of each experiment, cell were trypsinised then 
counted using a haemocytometer. The MTT assay was carried out using the 
Cell Proliferation Kit I (Roche Diagnostics, South Africa) as described by the 
manufacturer. Briefly, cells (1.5 × 103) were plated in 96-well plates with or 
without matrix, in a final volume of 90 μl DMEM per well. After incubating cells 
for the indicated periods, the cells were washed with phosphate buffered 
saline (PBS) and incubated in fresh medium containing 10 μl (final 
concentration of 0.5mg/ml) of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) for 2 h at 37 0C. The formazan produced 
in the reaction, was dissolved by 200 μl solvent solution (0.1 N HCl in 
isopropanol) overnight. The spectrophotometric absorbances of samples were 
measured at 595 nm using a microtiter plate reader (Model 680, Biorad). The 
MTT data are presented as the mean (±S.D.) of triplicate experiments. The 
statistical analysis was performed with GraphPad Prism 5.0 software (2006). 
 
7.2.5 Cell Attachment Assay 
To determine if the rate of cell attachment to the different matrices (fibroblast-
derived ECM, type I collagen and fibronectin) was the same, the adhesion 
assay was performed. Type I collagen and fibronectin were diluted at 100 
μg/ml in DMEM containing 0.1% BSA and 200 μl of each was added in 
triplicate to 6-well plates. The coated-plates were incubated at 37 0 C for 1hr. 
Control wells or those coated with ECM were then rinsed with PBS containing 
3% BSA for 30 mins at 37 0C. Cells were detached using trypsin/EDTA, 
washed twice with DMEM/BSA and equal number of cells were seeded on the 
matrices. Incubation was continued for 90 minutes after which the media 
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containing unattached cells was removed and then attached cells were 
trypsinised and counted. Each experiment was performed in triplicate and 
three independent experiments were performed.   
 
7.2.6 Quantitative Real Time RT-PCR 
7.2.6.1 RNA Isolation 
Total RNA was extracted according to Chomczynski and Sacchi (1983). 
Fibroblasts were seeded in 35 mm or 100 mm dishes with or without ECM. 
After 24 hrs the medium was changed to fresh DMEM and incubation was 
continued for the different time points used in the experiments. The medium 
was aspirated, the cell surface rinsed with ice cold PBS and Trizol reagent 
(Invitrogen Corporation, California, USA) was used to obtain the RNA 
according to the manufacturer’s instructions. In brief cells were lysed by 
adding 1 ml of Trizol reagent to the culture dishes and passing the 
homogenate several times through a pipette. The homogenised samples were 
incubated for 5 minutes at room temperature to permit a complete dissociation 
of the nucleoprotein complexes. Chloroform (0.2 ml per 1ml of Trizol reagent) 
was added and the tubes were shaken vigorously by hand for 15 seconds and 
incubated at room temperature for 3 minutes. The samples were centrifuged 
at 12 000 r.p.m for 15 minutes at 40C. The upper phase was transferred to a 
fresh tube and the RNA precipitated by mixing with isopropyl alcohol (0.5 ml 
per 1 ml of Trizol reagent for the initial homogenisation). The tubes were 
incubated at room temperature for 10 minutes and centrifuged at 12 000 r.p.m 
for 10 minutes at 40C to pellet the RNA. RNA was rinsed once with 75 % 
ethanol. The RNA sample was vortexed and centrifuged at 7500 r.p.m for 5 
minutes at 40C. The RNA was air-dried for 10 minutes and finally dissolved in 
50 μl RNase-free water by heating at 55 0C for 10 minutes and stored at -
800C. The concentration of RNA was determined spectrophotometrically 
(DU650 spectrophotometer, Beckman Instrument Inc, Fullerton, California, 
USA) by measuring absorbance (OD) at 260 nm and 280 nm. The formula: 
RNA concentration (μg/ml) = OD260 x 40 μg/ml x dilution factor, was used to 
calculate the RNA yield.  RNA quality was checked by electrophoresis on 1% 
agarose formaldehyde gels containing 0.5 μg/ml ethidium bromide.  
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7.2.6.2 RNA Electrophoresis  
7.2.6.2.1 Preparation of a 1% formaldehyde agarose gel 
Agarose formaldehyde mini gels were prepared by boiling 0.5 g high-gelling 
agarose in 45 ml distilled water mixed with 5 ml of 10 x MOPS. After the 
solution has cooled down to approximately 65oC, 2.7 ml of 27 % 
formaldehyde was added. After cooling, ethidium bromide was added to the 
solution and mixed properly. The gel was poured into the gel tank, combs 
were inserted and allowed to set in the fume hood. MOPS (1x) was added to 
the tank and used as the running buffer. Electrophoresis was at 60V for 45 
minutes. 
 
7.2.6.2.2 RNA sample preparation 
Two micrograms of the RNA were analysed by gel electrophoresis. Volumes 
equivalent to 2 μg of RNA were mixed with sterile distilled water and RNA 
loading buffer. The mixture was then added to the wells. Running standards 
were loaded beside the samples. The gel was run at 60 V until the 
bromophenol blue dye has migrated two-third the length of the gel. The gel 
was destained three times by placing it in water for about 30 minutes each 
and then examined under UV transilluminator to visualise the RNA.  The 
integrity of the RNA was ascertained by the intactness of the 18S and 28S 
ribosomal RNA.  
 
7.2.6.3 Synthesis of cDNA 
Complementary DNA (cDNA) was generated from 5 μg of RNA and oligo 
(dT)15  primer by using Impromp II reverse transcriptase (Promega Inc, 
Madison, WI, USA)  in the presence of dNTPs and DTT according to the 
manufacturers’ instructions. Briefly, the following were added to a nuclease-
free microcentrifuge tube: 
50 μM oligo (dT)15    1 ul 
5 μg total RNA                                    X ul 
10 mM dNTPs mix    1 ul 
Distilled water     Y μl                                       
Total volume     9 ul 
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(X = depends on the concentration of the RNA and Y = add up to a final 
volume of 9 μl).  
 
The mixture was heated at 70 0C for 10 minutes and placed on ice 
immediately after removal from the heating block. The mixture was spun by 
brief centrifugation for 4 seconds. A mixture of the following was made: 
5 x First strand buffer    5 μl 
0.1 M DTT      1 μl 
dNTPs mix       1 μl 
RNase inhibitor     1 μl 
MgCl2       1 μl 
Impromp II reverse transcriptase   1 μl 
Water       1 μl 
Total volume               11 μl 
 
 This mixture was mixed with the one above to give a final volume of 20 μl. 
The resultant mixture was properly mixed and incubated at 42 0C for 2hrs. 
The resulting cDNA was now ready to be used as a template for PCR 
amplification.  
 
7.2.6.4 Quantitative real time RT- PCR 
Quantitative RT PCR was performed using the Mini Opticon Monitor 3 (Biorad) 
with the KAPA SYBR qPCR Universal Kit (KAPA BIOSYSTEMS, S.A). The 
PCR reaction was done in a final volume of 25 μl, containing 0.5 μmol of each 
primer and 12.5 μl KAPA SYBR qPCR Universal Kit.  
PCR reaction set up  
Kapa Biosystem mix   12.5 μl 
Primer forward    1.0 μl 
Primer reverse    1.0 μl 
Water      8.5 μl 
cDNA or water (control)   2.0 μl 
Total volume     25    μl 
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Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an 
internal control. Primers and conditions used are shown below: 
 
GAPDH 
Primer pair                                                      qRT PCR Condition  Product Size 
Forward: 5’-GGCTCTCCAGA  95 0C: 10 min 
 ACATCATCC-3’   95 0C: 10 sec  
Reverse: 5’-GCCTGCTTCACC  55 0C: 8 sec      40 cycles          192 bp 
ACCTTC-3’    72 0C: 15 sec 
 
 
COL1A1 
Primer pair                                                      qRT PCR Condition  Product Size 
Forward primer: 5’-CAGCCGCTTCA  95 0C: 10 min 
CCTACAGC-3’    95 0C: 20 sec  
Reverse primer: 5’-TTTTGTATTCAATC 60 0C: 20 sec         40 cycles 83 bp 
ACTGTCTTGCC-3’   72 0C: 20 sec 
 primer sequences were taken over from Martin  et al., 2001          
 
COL1A2 
Primer pair                                                      qRT PCR Condition  Product Size 
Forward primer: 5’-GATTGAGACCCTT 95 0C: 10 min 
CTTACTCCTGAA-3’   95 0C: 20 sec  
reverse primer: 5’-GGGTGGCTGAGTC 60 0C: 20 sec          40 cycles 78 bp 
TCAAGTCA-3’    72 0C: 20 sec 
 primer sequences were taken over from Sengupta et al., 2003          
 
COL5A3 
Primer pair                                                      qRT PCR Condition  Product Size 
Forward primer: 5’-CAGCCGCTTCA  95 0C: 10 min 
CCTACAGC-3’    95 0C: 20 sec  
Reverse primer: 5’-TTTTGTATTCAATC 60 0C: 20 sec            40 cycles 179 bp 
ACTGTCTTGCC-3’   72 0C: 20 sec 
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Fibronectin 
Primer pair                                                      qRT PCR Condition  Product Size 
Forward: 5’-GAAGGAATATC   95 0C: 10 min 
 TCGGTGCCA-3’   95 0C: 30 sec  
Reverse: 5’-CGGGAATCTTCTC 60 0C: 30 sec       35 cycles 228 bp  
TGTCAGC-3’    72 0C: 60 sec 
  primer sequences were taken over from Tripathi et al., 2004                  
 
Human β1 Integrin 
Primer pair                                                      qRT PCR Condition  Product Size 
Forward: 5’-GACTGATCAGTTCA  95 0C: 10 min 
 GTTTGCTGTGTGTTT-3’  95 0C: 15 sec  
Reverse: 5’-CCCTGCTTGTATACAT 58 0C: 15 sec         45 cycles 174 
TCTCCACATGATTT-3’   72 0C: 15 sec 
 primer sequences were taken over from Borrirukwanit et al., 2006                   
 
Human α2 Integrin 
Primer pair                                                      qRT PCR Condition  Product Size 
Forward: 5’-GACCTATCCACTGCCA 95 0C: 10 min 
 CATGTGAAAAA-3’   95 0C: 15 sec  
Reverse: 5’-CCACAGAGGACCACAT 58 0C: 15 sec         45 cycles 160 
GTGAGAAAA-3’   72 0C: 15 sec 
  primer sequences were taken over from Borrirukwanit et al., 2006                           
 
Human α3 Integrin 
Primer pair                                                      qRT PCR Condition  Product Size 
Forward: 5′-GCTGCCAAAAAAGCCA  95 0C: 10 min 
 AGTCTG-3’    95 0C: 10 sec  
Reverse: 5’-TGCTGGTTCGGAGGAA 58 0C: 10 sec         45 cycles 160 
TAGGGTAG-3′    72 0C: 09 sec 
  primer sequences were taken over from Kudo et al, 2007                           
 
E-cadherin 
Primer pair                                                      qRT PCR Condition  Product Size  
Forward: 5’-GGCTCTCCAGA  95 0C: 10 min 
 ACATCATCC-3’   95 0C: 10 sec  
Reverse: 5’-GCCTGCTTCACC  55 0C: 10 sec           45 cycles 133 bp 
ACCTTC-3’    72 0C: 10 sec 
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Sp1  
Primer pair                                                      qRT PCR Condition  Product Size 
Forward: 5’-AATTTGCCTGC  95 0C: 5 min 
 CCTGAGTGC-3’   95 0C: 20 sec  
Reverse: 5’-TTGGACCCATG  57 0C: 30 sec           50 cycles 169 bp 
CTACCTTGC-3’   72 0C: 30 sec 
           
Sp3 
Primer pair                                                      qRT PCR Condition  Product Size  
Forward: 5’-ACAGCTTGGCTA  95 0C: 10 min 
 GGCCTGCTC-3’   95 0C: 10 sec  
Reverse: 5’-TGGCAGCGTAGGT 60 0C: 15 sec           45 cycles 141 bp 
TTTCGAGAGC-3’   72 0C: 10 sec 
           
MMP 1 
Primer pair                                                      qRT PCR Condition  Product Size  
Forward: 5’-GCTGGGAGCAAAC 95 0C: 10 min 
 ACATCTGACCT-3’   95 0C: 30 sec  
Reverse: 5’-TGAGCCGCAACACG 60 0C: 10 sec           40 cycles 146 bp 
ATGTAAGTTG-3’   72 0C: 30 sec 
primer sequences were taken over from Qu et al., 2006                                     
 
MMP 2 
Primer pair                                                      qRT PCR Condition  Product Size  
Forward: 5'-TGTGTCTTCCCCTTAC  95 0C: 10 min 
 CTTT-3'    95 0C: 30 sec  
Reverse: 5'-GATCTGAGCGATGC  60 0C: 10 sec           40 cycles 146 bp 
CATCAA-3’    72 0C: 30 sec 
primer sequences were taken over from Madani et al, 2006.        
 
MMP 9 
Primer pair                                                      qRT PCR Condition  Product Size  
Forward: 5'- GAGACAGCATGGCCAA   95 0C: 10 min 
ATTA-3'    95 0C: 30 sec  
Reverse: 5'-CTCTAGAAACTGCTGAGG 60 0C: 10 sec           40 cycles 146 bp 
GC-3'     72 0C: 30 sec 
primer sequences were taken over from Qu et al., 2006              
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7.2.6.5 Comparative Ct Method 
Real-time RT PCR data were analysed using a comparative method based on 
the critical threshold, (Ct), previously called the crossing point. In this method 
the amount of the gene of interest was normalised against the housekeeping 
gene, GAPDH, and expressed as fold induction using the 2-∆∆Ct (Hundley et al., 
2006). The experiments were done three times in triplicate. 
Fold induction = 2-∆∆Ct   
Where ∆∆Ct = {Ct GI (unknown sample) – Ct (GAPDH) (unknown sample)} - 
{Ct GI (calibrator) – Ct (GAPDH) (calibrator)} 
The calibrator sample is any sample chosen to represent 1 x expression of 
the gene of interest. Results are shown as fold induction of mRNA compared 
to control. 
 
7.2.7 Gelatin Zymography 
Zymographic analysis of protease activity was performed as described by 
Helary et al (2005). Polyacrylamide gels contained 1 mg/ml gelatin in a 
buffered solution consisting of 5 ml 1.5 M Tris-HCl, pH 8.8, 200 μl 10 % SDS, 
8 ml 30% Acrylamide/bis Acrylamide (29:1) and 5 ml distilled water. Stacking 
gels contained 4% polyacrylamide in 0.125 M Tris-HCl, pH 6.8. Gels were 
polymerised by adding 50 μl of 10 % ammonium persulfate and 10 μl of 0.1 % 
TEMED. Samples (the loading volume was normalised for protein 
concentrations as measured by the Bradford method (Biorad) were added to 
2x loading buffer (non-reducing) and electrophoresis was done at 25 mA for 
2hrs. After electrophoresis gels were washed twice (30 mins each) in 200 ml 
of 2.5 % Triton X-100 with constant stirring and incubated in incubation buffer 
(50 mM Tris-HCl, pH 7.5, 5 mM CaCl2, 0.2 M NaCl and 0.02 % Brij-35) for 18 
hrs at 370C. Gels were then stained with Coomassie brilliant blue RR-250 
(20 % methanol) and destained in 15% acetic acid, 10 % methanol. 
Gelatinolytic activity was evident as transparent zones in the blue gels. The 
area of the cleared zones was analysed with the Fluor-S Multimager (Biorad).  
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7.2.8 Transient Transfections and Promoter Assays 
Fibroblasts were transiently transfected with the indicated COL1A2/Luciferase 
constructs, MMP-1/LUC construct, the dominant negative mutant MEK 
expression vector, the dominant negative mutant Ras expression vector, 
N17Ras, and the necessary parental vectors. In all experiments 50 ng of 
renilla luciferase construct (pRL-HSV-TK) was co-transfected as an internal 
control. Fibroblasts were seeded in 35 mm or 100 mm dishes and incubated 
with DNA/transfectin reagent for 6 hrs after which the media were changed 
and incubation continued for 24 hrs. Fibroblasts were then trypsinised and 
seeded in 35 mm or 100 mm dishes with or without matrices. Cell lysates 
were prepared using a passive lysis buffer (Promega) and luciferase activities 
were measured using a dual Luciferase Assay System (Promega, Madison, 
USA). Reporter gene activities (firefly luciferase) were normalised to the co-
transfected renilla activity. Matrix-mediated change was determined as the 
fold change in the luciferase activity relative to that in cells cultured in the 
absence of matrix. 
 
7.2.9 Propagation of plasmid DNA 
7.2.9.1 Preparation of competent E.coli (XL1-blue) cells 
The method used is a modification of that described by Sambrook (Sambrook 
et al., 1989).  Fifty microlitres of E.coli (XL1-blue) cells from a frozen glycerol 
stock were inoculated into 3 ml of Luria broth and grown overnight at 370C 
with shaking. The overnight culture was inoculated into 300 ml of Luria broth 
in a 2 L conical flask and incubated at 370C with vigorous shaking until the 
cultures reached an OD650nm of 0.4 to 0.6. The cells were pelleted by 
centrifugation at 5000 rpm at 40C in a Beckman JA10 rotor for 10 mins. The 
media was decanted and the pellet was resuspended in 40 ml of ice cold 60 
mM CaCl2, 10 mM Pipes pH 7.2. This suspension was left on ice for 30 mins, 
transferred to Corex glass centrifuge tubes and centrifuged at 5000 rpm at 
40C for 5 mins in a Beckman JA-20 rotor. The media was decanted and the 
tubes were inverted for one minute to allow any trace of the fluid to drain away. 
Four ml of a solution of 60 mM CaCl2, 10 mM Pipes and 15% glycerol were 
added to the pellet and gently mixed. The cell suspension was stored in 
aliquots of 200 μl at -800C.     
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7.2.9.2 Transformation of Competent Cells with plasmid DNA 
The transformation of the E. coli (XL1-blue) cells was done using the different 
plasmids used in the study (Sambrook et al., 1989).  An aliquot of competent 
cells were thawed on ice and 100 μl transferred to a 15 ml sterile tube. To the 
cells, was added 1 ng of the required plasmid DNA, mixed gently by swirling 
and incubated on ice for 30 mins, followed by heat shock at 42 0C for 2 mins 
before the addition of 1 ml of pre-warmed (370C) Luria Broth (LB) and 
incubation at 370C for 1hr. Aliquots of 50, 100 and 200 μl aliquots were plated 
out on Luria agar plates containing 50 μg/ml ampicillin and incubated 
overnight at 370C. A successful batch of competent cells usually formed 
between 107 and 108 colonies per μg of plasmid DNA after overnight 
incubation. 
 
7.2.9.3 Preparation of plasmid DNA 
A 500 ml overnight culture of E.coli containing the desired plasmid was 
harvested at 5000 rpm for 10 mins in a Beckman JA-20 rotor at 40C. The 
Qiagen plasmid DNA extraction kit was used to prepare plasmid DNA as 
described by the manufacturers. After precipitation the DNA was washed with 
70% ethanol and resuspended in sterile TE or sterile water depending on the 
final use of the DNA. The concentration of DNA was determined 
spectrophotometrically (DU650 spectrophotometer, Beckman Instrument Inc, 
Fullerton, California, USA) by measuring absorbance (OD) at 260 nm and 280 
nm. The formula: DNA concentration (μg/ml) = OD260 x 50 μg/ml x dilution 
factor, was used to calculate the DNA yield.    
 
7.2.9.4 Isolation of DNA fragments 
A known amount of plasmid DNA was digested with the required restriction 
enzymes for at least 1 hr, depending on the enzyme being used, and the 
digested material resolved on 1% agarose gels containing 0.5 µg/ml ethidium 
bromide. DNA molecular weight markers were routinely included in all 
agarose gels to determine the approximate sizes of the DNA bands. The DNA 
fragment of interest was excised from the gel, excess agarose was removed 
and gel pieces transferred to a microfuge tube containing 500 μl of Promega 
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DNA binding solution. The DNA was extracted using the Promega gel 
extraction kit (Promega) according to the manufacturer’s instructions.  
 
7.2.10 Nuclear Protein Extraction  
Nuclear proteins were extracted from cells using the method of Lee and 
Green (1990). Briefly, cells grown in 35 mm or 100 mm diameter tissue 
culture dishes were rinsed and harvested in ice cold PBS using a rubber 
policeman and pelleted in a Beckman TJ 6 centrifuge at 2000 rpm at 40C for 
10 minutes. The cells were pelleted and resuspended in 5 packed cell 
volumes of buffer A and allowed to swell on ice for 10 minutes, pelleted again 
and resuspended in 2 original packed cell volumes of buffer A. The 
suspended cells were lysed through five cycles of slow aspiration and rapid 
ejection using a syringe with a 26-gauge needle. Cell lysis was checked by 
microscopy. The nuclei were pelleted by centrifugation at 13000 rpm at 40C 
for 30 minutes. Pelleted nuclei were resuspended in buffer C, containing 1 
μg/ml aprotinin, 1 μg/ml pepstatin and 1 μg/ml leupeptin. The homogenised 
nuclei were stirred on ice for 30 minutes. The salt soluble proteins were 
separated from nuclei debris by centrifugation in a Beckman JA-20 rotor for 
30 minutes, at 13000 rpm at 40C. The supernatant was dialysed against buffer 
D for 2 hrs at 40C. The dialysate was centrifuged at 13000 rpm for 30 minutes 
in a Beckman JA20 rotor at 40C, and the supernatant stored at -800C in 
aliquots of 50 μl. 
 
7.2.11 Preparation of medium for determining the presence of secreted 
factors in medium 
To determine if secreted factors are released into the media, media exposed 
to WI38 fibroblasts was used. WI38 fibroblasts were used since these are the 
fibroblasts used in the preparation of the fibroblast-derived ECM. WI38 
fibroblasts were grown in DMEM medium containing 10 % fetal calf serum 
supplemented with 100 μg/ml penicillin and 100 units /ml streptomycin. After 2 
days of incubation, the fibroblasts were rinsed with PBS and fresh media was 
added. After 3 days of incubation the medium was harvested and centrifuged 
at 5 000 rpm for 1 hr at 4 0C remove any cellular debris. In one set of 
experiments the media was used just after harvesting and in another the 
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media was treated as follows: The medium was then dialysed against distilled 
water in dialysis tubing which had been boiled in 1mM EDTA and water. The 
tubing was then allowed to cool to 40C. Dialysis was done overnight at 40C. 
Two separate experiments were done. The medium was used either as 
unlyophilised, mixed with fresh DMEM or was lyophilised and reconstituted in 
1/10th the original volume of sterile water. Before use both unlyophilised and 
lyophilised media were filter sterilised through 0.2 μm Millipore filters. For 
experiments half of the unlyophilised medium was mixed with half fresh 
DMEM media and then added to plated fibroblasts. In the same manner half 
of the reconstituted lyophilised media was mixed with fresh DMEM media and 
added to fibroblasts. After incubation, RNA and proteins were harvested for 
real time RT PCR and western blot analysis as described elsewhere.        
 
7.3 Protein Analysis 
7.3.1 Isolation of secreted type I collagen in media  
Cells (1.5 x 106) were seeded in 100 mm culture dishes with or without 
matrices in DMEM containing 10 % fetal calf serum (FCS) for 24 hrs before 
being changed to serum-free DMEM media containing ascorbic acid (50 μg/ 
ml) and 50 μg/ml β-aminopropionitrile for 48 hrs. The media was harvested 
and total proteins in the medium were quantified using the Bradford protein 
determination assay (Biorad) using bovine serum albumin as a standard. The 
samples were incubated overnight with pepsin (100 μg/ml, pH 2.5, 40C) to 
cleave all proteins present in the sample except type I collagen. Subsequently 
the proteins were TCA precipitated (10 % TCA) and the samples resuspended 
in SDS loading buffer and electrophoresed on a 7.5 % polyacrylamide gel. 
Gels were fixed, stained with Coomassie Brilliant Blue and destained. Cells 
were counted before and after the experimental period to exclude the 
possibility that any change in type I collagen levels may have resulted from a 
change in cell numbers. 
 
7.3.2 Western Blot Analysis 
7.3.2.1 Harvesting proteins 
Cells (1.5 x 106) were seeded in 100 mm culture dishes with or without 
matrices in DMEM containing 10 % fetal calf serum (FCS) for 24 hrs before 
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addition of fresh media and incubation continued for 48 hrs. At the end of 
each experiment cells were washed with cold PBS and treated as follows: 
cells cultured on plastic were scraped with a rubber scraper and lysed using 
lysis buffer for 30 mins on ice; cells cultured on matrices were liberated from 
the matrices by trypsinisation and washed with cold PBS, centrifuged at low 
speed (1000 rpm) and lysed with lysis buffer for 30 mins on ice. The lysis 
buffer used contained 10 mM Tris-HCl pH 7.6, 10 mM NaCl, 3 mM MgCl2 and 
1 % (v/v) Nonidet P-40 with pepstatin, leupeptin and aprotinin. The cell lysates 
were sonicated for 10 seconds on ice (Heat System-Ultrasonics, Inc, 
Plainview, New York), centrifuged at 10 000 rpm for 10 mins at 40C and the 
clear supernatant was used in subsequent experiments. Total proteins in the 
cell lysates were quantified as described in section 7.3.1 above. 
 
7.3.2.2 SDS-Polyacrylamide gel electrophoresis 
7.3.2.2.1 Preparation and electrophoresis of gels 
Glass plates were cleaned with distilled water and 70 % ethanol. The plates 
were assembled, ensuring the plates are even at the bottom. The plates were 
locked into the casting frame and clipped into the stand. The resolving and the 
stacking gels were prepared in 10 ml Falcon tubes and 10 % APS and 
TEMED were added when ready to pour (see Table 7.1). Separate gels were 
poured into a Biorad Miniprotean system and their compositions are shown in 
Table 7.1. Once the resolving gel has been poured either water or saturated 
butanol was added on top to remove air bubbles and to obtain an evenly level 
interface with the stacking gel. After the resolving gel has set, the water or the 
butanol was decanted and the stacking gel was added on top. Combs were 
inserted and once the gel had polymerised, the combs are removed. The 
wells are then rinsed with 1 x electrophoresis buffer. Equal amounts of total 
protein lysates were mixed with the loading buffer and water up to the same 
volume. The samples (20-50 μg/lane) were heated for 5 minutes at 950C 
before loading and the gel was run at 150 V for 70 minutes to separate the 
proteins.  
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Table 7.1 Different concentrations of SDS-PAGE used in the study 
 Stacking 
gel 
          Resolving gels              
 4 % 12% 10% 7.5% 
Distilled water  3.65 ml 2.15 2.72 3.70 
Buffer 0.625 3.75 3.7 3.75 
30 % acrylamide 0.650 4 3.3 2.5 
10 % SDS 50 ul 50 50 50 
10 % APS 25 ul 50 50 50 
TEMED 10 ul 10 10 10 
N.B Add the 10 % APS and TEMED last and when ready to pour as polymerisation will be 
fast. 
 
7.3.2.2.2 Transfer of proteins to nitrocellulose membranes  
Transfer of proteins to Hybond C nitrocellulose membranes was done using 
the Biorad minigel transfer system. Transfer buffer (1x) was prepared and 
cooled to 4oC. Nitrocellulose membrane and Whatman 3M filter paper were 
cut to the size of the gel, about 6 cm x 7 cm, and soaked in transfer buffer for 
15 minutes. A sandwich of black side of cassette, sponge, filter paper, gel, 
nitrocellulose membrane, filter paper and sponge was prepared and placed in 
the transfer apparatus. Transfer was carried out at 100 V for 1.5 hours at 40C. 
After proteins were transferred to a membrane, the protein side of blot was 
marked. The membrane was rinsed twice with TBS containing 0.1% Tween 
20 (TBS-T). In order to check if equal loading was done, the gel was placed in 
fixing solution for 1 hr, immersed in Coomassie blue soln and shaken for 1hr. 
The gel was destained until the bands were visible and then dried on the gel 
drier for about an hour at 75 0C. 
 
7.3.2.2.3 Immunoblotting 
The membrane was blocked with 5 % fat-free milk in TBS-T. The membranes 
were then incubated overnight at 40C with diluted primary antibodies, most of 
which are shown in Table 7.2 below. After two washes in TBS-T buffer, the 
membranes were incubated with horseradish peroxidase (HRP)-conjugated 
secondary antibodies for 1 hr at room temperature. After two TBS-T washes, 
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detection was done using the Lumiglo substrate (KPL, USA), and the blot was 
exposed to photographic film. 
 
Table 7.2 Primary and secondary antibodies used for western blot 
analysis 
Ag Blocking 
Soln 
Primary 
antibodies  
Secondary Antibodies 
Type I collagen 5% milk  Southern Biotech 
1:1000 dilution in  
5 % milk 
Donkey anti-goat (Santa 
Cruz) 
1:1000 dilution in 5% milk 
phospho-ERK 1,2 5% milk + 3 
% BSA 
Cell Signaling  
1:500 dilution in  
1 % BSA 
Goat anti-mouse (Pierce) 
1:1000 dilution in 1% BSA 
ERK 2 5% milk Santa Cruz 
1:1000 dilution in  
5 % milk 
Goat anti-rabbit (Pierce) 
1:1000 dilution in 5% milk 
β- Tubulin 5% milk Santa Cruz 
1:1000 dilution in  
5 % milk 
Goat anti-rabbit (Pierce) 
1:1000 dilution in 5 % milk 
Fibronectin 5% milk Calbiochem 
1:1000 dilution in  
5 % milk 
Goat anti-rabbit (Pierce) 
1:2000 dilution in 5% milk 
Laminin α2 5% milk+ 3 
% BSA 
Santa Cruz 
1:1000 dilution in  
5 % milk + 3 % BSA 
Goat anti-mouse (Pierce) 
1:1000 dilution in 5% milk 
MT1 MMP (MMP 
14) 
5% milk Santa Cruz 
1:1000 in 5 % milk 
Goat anti-rabbit (Pierce) 
1:3000 dilution in 5% milk 
p-p38 5% milk Santa Cruz 
1:1000 dilution in  
5 % milk + 1 % BSA 
Goat anti-rabbit (Pierce) 
1:1000 dilution in 5% milk 
Sp1 5% milk Santa Cruz 
1:500 dilution in  
5 % milk 
Goat anti-rabbit (Pierce) 
1:1000 dilution in 5% milk 
 
7.3.2.2.4 Stripping a blot 
For subsequent analysis of the same blot with a second antibody, the blot was 
immersed in 1M glycine, pH 2.5 for 10 minutes  at room temperature with 
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shaking and then neutralised by the addition of 1/10th volume of 1M Tris, pH 
7.5 for 5 minutes. The blot was then washed twice in TBS-T, followed by 
blocking as described above. 
 
7.4 Treatment with kinase inhibitors  
For the analysis of signaling pathways, fibroblasts were seeded in 35 mm or 
100 mm dishes with or without matrices. Fibroblasts were treated with the 
indicated doses of U0126 or PD98059 (MEK inhibitors) for 24 hrs in DMEM 
(Ihn et al, 2002; Ihn and Tamaki, 2000; Ihn and Tamaki, 2002). Fibroblasts 
were also treated with the indicated doses of p38 MAPK inhibitor, SB203580, 
the JNK inhibitor, SP600125, and the PI3-K inhibitor, wortmanin. Dose-
dependent studies were done to determine the concentrations of inhibitors 
required for the inhibition of the different signaling pathways. Cells were also 
treated with 0.1 % DMSO alone, as the solvent control. The levels of type I 
collagen in cell lysates and in the media, mRNA and promoter activity were 
determined as described above after treatment with the various inhibitors.  
 
7.5 Blocking of α2β1 and α3β1 integrins functions in fibroblasts 
Treatment of fibroblasts treatment with integrin-blocking antibodies was 
perfomed according to a published protocol with minor changes (Langholz et 
al, 1995). Briefly cells cultured for 24 hrs were trypsinised, washed in PBS 
and resuspended in fresh DMEM. Equal number of cells were incubated with 
either 10 μg/ml or 20 μg/ml of the well characterised blocking monoclonal 
mouse anti-human integrin α2β1 antibodies (MAB1998, clone BHA2.1, 
Chemicon, USA; P1E6, Lot No: 0083a, Dako Corporation (Carpinteria, CA, 
USA), to human integrin α3β1(P1B5, Lot No: 0083b, Dako Corporation, 
Carpinteria, CA, USA), or with PBS (control) for 30 minutes at 370C. Cells 
incubated with non-specific mouse IgG showed similar results to cells 
incubated in PBS, the latter were therefore used as controls throughout. 
Integrin-blocked fibroblasts were seeded on control dishes or on matrices and 
the experiments were stopped after 24 hrs for mRNA and protein analysis. 
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7.6 Sp1 siRNA transfection 
To study the influence of Sp1 gene expression on matrix-mediated 
downregulation of type I collagen gene expression, a direct loss of function 
approach of silencing the endogenous Sp1 by RNAi was used (Lee et al, 
2006; Tatenhorst et al, 2006). 5 x 105  fibroblasts were seeded in 35 mm 
culture dishes with or without the fibroblast-derived ECM a day before 
transfection. The transfection of siRNA was carried out using Transfectin 
(BioRad) according to the manufacturer’s instructions. Transfectin (6 μl) was 
mixed with 4 μl (0.5 μg) of 10 μM siRNA double strands and incubated 20 
mins at room temperature. The siRNA mixtures were added to the cells 
dropwise and incubated for 6 hrs. After 6 hrs the medium was changed and 
transfected cells were grown for 48 hrs at 370C in 5 % CO2. After incubation, 
the proteins and RNA were harvested for western blot and real time RT PCR 
analysis respectively. The siRNA used was the small interfering RNA (siRNA; 
Santa Cruz) targeting endogenous human Sp1. A negative control siRNA 
molecule of identical size was used in all experiments, consists of a non-
targeting 20-25 nucleotide siRNA. The negative control is a scrambled 
sequence that will not lead to the specific degradation of any known cellular 
mRNA.  
 
7.7 Cell Microscopy 
Cultured cells were viewed with an inverted  microscope (Carl Zeiss 
Microimaging, Inc., Germany) equipped with phase contrast optics and 
photographed using a SPOT digital microscope camera and corresponding 
software, SPOT advanced , version 3.5.6 for Windows (Diagnostic 
Instruments Incorporated, Michigan, USA). 
 
7.8 Statistical Analysis 
Statistical analysis was performed using GraphPad Prism version 3.02. All 
data were expressed as means +-SEM. Paired Student’s t test was used to 
evaluate the statistically differences between control fibroblasts (no matrix) 
and fibroblasts seeded on matrix. Values of P < 0.05 were considered 
significant. All experiments were repeated at least three times.  
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Appendix A: Buffers and Solutions 
Acrylamide/Bisacrylamide Solution (30%) (29:1) 
29 g Acrylamide 
1 g Bisacrylamide 
Made to 100 ml with distilled water and stored in dark at 4 0C 
 
Acrylamide Stock Solution (40%) (38:2) 
38 g Acrylamide  
2 g Bisacrylamide 
Made to 100 ml with distilled water and stored in dark at 4 0C 
 
7.5 M Ammonium acetate, pH 7.4 
Dissolve 57.81 g ammonium acetate in 60 ml of distilled water, adjust pH to 7.4 with ammonia 
solution, make up to 100 ml with distilled water and sterilise by filtration using a filter of 0.45 
μm pore size 
 
2 M Ammonium acetate, pH 7.4 
Dissolve 15.416 g ammonium acetate in 60 ml of distilled water, adjust pH to 7.4 with 
ammonia solution, make up to 100 ml with distilled water and sterilise by filtration using a filter 
of 0.45 μm pore size 
 
10 % Ammonium persulfate (APS) 
Dissolve 100 mg of APS in 1 ml of distilled water, store at 40C 
 
Ampicillin Stock Soln (10 mg/ml) 
Dissolve 500 mg Ampicillin in 50 ml of distilled water. Sterilise by filtration through a filter of 
pore size 0.22 μm and store at -80 0C. Dilute to a working solution of 50 μg/ml. 
 
Aprotinin (10 mg/ml) 
Dissolve 100 mg aprotinin in 100 ml of autoclaved distilled water. Aliquot the solution and 
store at -20 0C.   
 
0.1 M CaCl2 
Dissolve 2.94 g of CaCl2 in 200 ml of distilled water and autoclave. 
 
Coomassie blue staining solution 
0.5 g Coomassie BB 
500 ml methanol 
100 ml acetic acid  
400 ml distilled water 
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DEPC-Treated water (0.01 %) 
Add 10 μl of DEPC to distilled water (100 ml) and stir at room temperature. Leave overnight 
and then autoclave 
 
Destaining Solution (10 % Acetic acid (v/v)) 
100 ml acetic acid 
100 ml methanol 
800 ml distilled water 
 
1 M Dithiothreitol (DTT) 
Add 3.09 g DTT to 20 ml of 10 mM sodium acetate (pH 5.2) and mix. Filter sterilise using a 
0.22 μm pore size filter. Store aliquots at -20 0C. 
 
0.5 M EDTA, pH 8.0 
Add 37.22 g of Na2EDTA.2H2O to 140 ml of distilled water. Adjust the pH to 8.0 with 10 N 
NaOH then add distilled water to a final volume of 200 ml. Autoclave and store at room 
temperature. 
 
0.5 M EDTA (DEPC-treated), pH 8.0 
Add 37.22 g of Na2EDTA.2H2O to 140 ml of distilled water.. Adjust the pH to 8.0 with 10 N 
NaOH then add DEPC-treated water to a final volume of 200 ml. Autoclave and store at room 
temperature 
 
DNA Elution Buffer 
0.5 mM ammonium Acetate 
10 mM Magnesium Acetate 
1 mM EDTA 
 
70 % Ethanol 
70 ml of absolute ethanol 
Add 30 ml of distilled water 
 
75 % DEPC- Ethanol 
75 ml absolute ethanol 
25 ml DEPC-treated water 
 
Fixing Solution  
100 ml acetic acid 
500 ml methanol 
400 ml distilled water 
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Freezing down media 
70 % Fetal bovine serum 
20 % DMEM media 
10 % Dimethylsulphoxide (DMSO) 
Store at 4 0C 
 
Glycerol Storage Buffer 
50 mM Tris-HCl (pH 8.3) 
40% Glycerol 
5 mM MgCl2 
0.1 mM EDTA 
 
10 x HBS for transfection (per 100 ml of distilled water) 
5.0 g Hepes 
8.0 g NaCl 
0.37 g KCl 
1.0 g Dextrose 
0.103 g Na2HPO4 (anhydrous -1.45 mM) 
 
HSB Buffer for nuclear extraction 
0.5 M NaCl 
50 mM MgCl2 
2 mM CaCl2 
10 mM Tris-HCl (pH 7.4) 
 
250 mM KCl 
Dissolve 1.86 g KCl in distilled water up to 100 ml. Autoclave 
 
L-agar (per litre) 
10 g Tryptone 
5 g Yeast extract 
5 g NaCl 
15 g Bacto-agar. Autoclave 
 
L-Broth (per litre) 
10 g Tryptone 
5 g Yeast Extract 
5 g NaCl 
Add distilled water to 1L and adjust pH to 7.0 with 10 N NaOH. Autoclave 
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LB plates (with Ampicillin) 
Weigh 15 g agar and add LB medium to 1L. Autoclave and allow to cool to about 40 0C then 
add Ampicillin to a final concentration of 100 μg/ml. Pour into 100 mm dishes and let the agar 
harden. Store at 4 0C  
 
10 X Loading Buffer 
0.25 % bromophenol blue in 40 % glycerol (v/v) 
 
Lysogen Extract Buffer  
50 mM Tris- HCl (pH 7.5) 
1 mM EDTA 
1 mM DTT 
1 mM PMSF 
 
2 M MgCl2 
Dissolve 40.66 g MgCl2. 6H2O in 80 ml of distilled water and then make up to 100 ml and 
autoclave. 
 
10 x MOPS Buffer 
0.4 M MOPS, pH 7.0 
0.1  M Sodium acetate 
0.01 M EDTA , pH 8.0 
Dissolve 20.6  g MOPS  in 400 ml 50 mM sodium acetate, adjust pH to 7.0 with 10 N NaOH , 
add 10 ml 0.5 M EDTA , make up to 500 ml with autoclaved DEPC-treated water 
 
1.5 M NaCl 
Dissolve 8.75g NaCl in 80 ml of distilled water, make up to 100 ml. 
 
2,5 % non-fat milk blocking solution 
Dissolve 1.25 g non-fat milk powder in 30 ml TBS-T, make up to 50 ml with TBS-T 
 
5 % non-fat milk blocking solution 
Dissolve 2.5 g non-fat milk powder in 30 ml TBS-T, make up to 50 ml with TBS-T 
 
PBS (pH 7.4) 
137 mM NaCl 
2.7 mM KCI 
4.3 mM Na2HPO4.2H2O, 1.4 mM KH2 PO4 
Made to 1 litre with distilled water. Autoclave 
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1 mg/ml Pepstatin A  
Dissolve Pepstatin A in absolute ethanol to a final concentration of 1 mg/ml and freeze 
aliquots at -200C. 
 
Phenol: Chloroform: Isoamyl alcohol (25:24:1) 
Mix one part of phenol and one part of chloroform: isoamyl alcohol (24:1) 
 
100 mM PMSF 
Dissolve PMSF in absolute ethanol to a final concentration of 100 mM and freeze aliquots at -
200C. 
 
5 x Protein loading buffer 
Dissolve 1.75 g Tris in 10 ml distilled water and add 30 ml glycerol. Adjust the pH to 6.8 with 
concentrated HCl and add 5g SDS, make up to 50 ml with distilled water. 
 
5 x Protein loading dye 
200 μl 5 x protein loading buffer 
50 μl of β-mercaptoethanol, 10 μl of bromophenol blue 
 
2 x Reaction Buffer without nucleotides  
10 mM Tris-HCl (pH 8.0) 
5 mM MgCl2 
0.3 M KCI 
 
RIPA Buffer 
200 μl RIPA solution 
2 μl of 2 mg/ml pepstatin 
2 μl of 10 mg/ml aprotinin 
2 μl of 100 μM PMSF 
 
RIPA Solution 
150 mM NaCl  
1 % Triton X-100 
0.1 % SDS 
25 mM Tris, pH 7.5 
1 % sodium deoxycholate 
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RNA Loading Buffer (25 ml) 
1 mM EDTA, pH 8.0   
0.25 % Bromophenol Blue (w/v) 
0.25% Xylene Cyanol 
50% Glycerol (v/v) 
50 μl DEPC 
Add distilled water to a final volume of 25 ml, Stir overnight and autoclave 
 
RNA Running Buffer (10 x) 
200 mM Morpholinopropanesulfonic acid (MOPS) (pH 7.0) 
50 mM Sodium Acetate 
10 mM EDTA 
 
RNA Sample Buffer 
10 ml deionised formamide 
3.5 ml 37 % formaldehyde 
1.0 ml 10 x MOPS running buffer 
Prepare in nuclease-free water, use high grade glycerol to avoid ribonuclease activity. 
Dispense into 200 μl aliquots and store at -200C. 
 
Screening Binding Buffer (10 x) 
200 mM Hepes 
30 mM MgCl2 
400 mM KCI 
10 mM DTT 
 
10 % SDS 
Dissolve 10 g sodium dodecyl sulphate in 80 ml distilled water (heat to 800C) , make up to 
100 ml with distilled water 
 
10 × Running buffer 
29 g Tris 
144 g Glycine 
10 g SDS 
Made to 1 Litre with distilled water. 
 
SDS-PAGE Running Buffer (5 x) 
0.25 M Tris-HCl (pH 8.3) 
1.92 M Glycine 
0.5 % SDS 
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SDS/Tris  Buffer 
5% SDS (w/v) 
0.5 M Tris-HCl (pH 7.4 ) 
0.125 M EDTA 
 
Solution 1 (Rapid plasmid prep) 
25 mM Tris-HCl (pH 8.0) 
10 mM EDTA 
50 mM Glucose 
 
Solution 2 (Rapid plasmid prep) 
200 mM NaOH 
1% SDS 
 
Solution 3 (Rapid plasmid prep) 
3 M Potassium Acetate (pH 4.8) 
 
Stop Buffer 
0.05% Bromophenol Blue 
0.5% SDS 
1 mM EDTA, 50% Glycerol (v/v) 
 
Stripping Solution 
1.4 ml β-mercaptoethanol 
40 ml 10 % SDS 
12.5 ml Tris-HCl, pH 6.7 
Make up to 200 ml with distilled water 
 
Alternate stripping solution 
1 M Glycine pH 2.5 
 
T4 Polynucleotide kinase buffer (10 x) 
500 mM Tris-HCl (pH 7.6) 
100 mM MgCl2 
50 mM DTT 
1 mM Spermidine 
1 mM EDTA (pH 8.0) 
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TAE Electrophoresis Buffer (1 x) 
40 mM Tris 
5 mM Sodium Acetate 
1 mM EDTA 
Adjust pH to 7.8 with glacial acetic acid 
 
TAE Electrophoresis Buffer (1 x) (pH 8.3) 
90 mM Tris 
90 mM Boric Acid, 2.5 mM EDTA. Adjust pH to 8.3.   
TBS-Tween 
50 ml 1M Tris base 
30 ml 5M NaCl 
250 μl Tween-20 
Make up to 1litre with distilled water 
 
TE buffer (10x) (pH 8.0) 
100 mM Tris-Cl 
10 mM EDTA 
Adjust pH to 8.0 
   
TES Solution 
10 mM N-tris (hydroxymethyl-2-aminoethanesulforic acid (TES) pH 7.4 
10 mM EDTA 
0.2% SDS 
 
TES/NaCl Solution 
10 mM TES (pH 7.4) 
10 mM EDTA 
0.2% SDS 
0.6 M NaCl 
 
Top agar (per litre) 
10 g Tryptone 
5 g Yeast extract 
5 g NaCl  
7 g Bacto-agar 
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10×Transfer buffer 
144 g glycine 
38 g Tris 
Make up to 1 litre with distilled water. 
 
Tris Buffered Saline (TBS) 
25 mM Tris (pH 7.5) 
0.9% NaCl (w/v) 
 
TTE (transfections) 
1 mM Tris-HCl (pH 8.0) 
0.025 mM EDTA 
 
1M Tris pH 6.8 (per litre) 
Add 121 g Tris base to 800 ml of distilled water 
Adjust pH with concentrated HCl to pH 6.8 and then add distilled water up to one litre. 
Autoclave 
 
1M Tris pH 7.5 (per litre) 
Add 121 g Tris base to 800 ml of distilled water 
Adjust pH with concentrated HCl to pH 7.5 and add distilled water up to one litre. Autoclave 
 
1M Tris pH 8.8 (per litre) 
Add 121 g Tris base to 800 ml of distilled water 
Adjust pH with concentrated HCl to pH 8.8 and then add distilled water up to one litre. 
Autoclave 
 
10 x Transfer Buffer (per litre) 
25 mM Tris 
192 mM Glycine 
20 % methanol 
Add 29.0 g of Tris and 144 g of Glycine to 800 ml of distilled water. 
Mix properly and add distilled water to 1 litre. When preparing 1 x transfer buffer add 
methanol to a final concentration of 20 % (v/v). 
 
TBS-T (per litre) 
50 mM Tris pH 7.5 
150 mM NaCl 
0.05 % Tween-20 
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1 X Trypsin-EDTA solution 
0.05% (w/v) trypsin, 0.53 mM EDTA 
Prepare in a calcium and magnesium-free 1 x PBS 
 
Water-saturated phenol 
Dissolve 100 g phenol crystals in 100 ml of autoclaved DEPC-treated water at 60 to 65ºC, let 
stand in the fumehood overnight, aspirate the upper water phase and store for up to 1 month 
at 4ºC. 
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